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Abstract 
Protection against viruses is provided by the host innate, adaptive and cellular intrinsic 
immunities. Cellular intrinsic immunity, or intrinsic defence, against herpesviruses is in 
part enacted by components that constitute nuclear substructures known as ND10. ND10 
(also called PML nuclear bodies after its major organising component) are dynamic 
nuclear domains that contain various cellular proteins, including PML itself, Sp100, hDaxx 
and ATRX. In the early stages of infection, herpesvirus genomes and sites of immediate 
early transcription become associated with ND10 and their components. Representative 
herpesviruses such as an alphaherpesvirus HSV-1 and a betaherpesvirus HCMV encode for 
strong transcriptional activators, namely the Immediate Early protein ICP0 and the 
tegument protein pp71, respectively. These proteins are known to counteract cellular 
intrinsic defence mechanisms.   
 
In the context of HSV-1 and HCMV infections, the major ND10 component PML has been 
identified as an important constituent of cellular intrinsic defence. In addition, a number of 
research studies have demonstrated that Sp100 and hDaxx contribute to these processes 
during infection with HSV-1 and HCMV, respectively. The general hypothesis of the 
present study implies that cellular chromatin-associated factors within ND10 may act to 
repress viral gene expression. The two representative ND10 components present a 
particular interest for the current investigation based on the facts that: (i) hDaxx is a 
transcriptional co-repressor; (ii) ATRX is a chromatin-remodelling enzyme; and (iii) 
ATRX and hDaxx interact with each other to form a chromatin-remodelling complex with 
repressive properties. The purpose of the present study was therefore to investigate the 
roles of these two proteins in HSV-1 and HCMV infection. By using virus mutants 
incapable of efficient stimulation of Immediate Early gene expression (ICP0-null HSV-1 
and pp71-null HCMV) it was possible to analyse the contribution of ATRX and hDaxx to 
the repression mechanism that occurs in the absence of these viral transactivators. An RNA 
interference approach was utilised for generating cell lines depleted of ATRX or hDaxx in 
order to assess their roles in viral infectivity. In addition, cell lines reconstituted with wt 
hDaxx, and ATRX-interaction or SUMO-interaction deficient hDaxx mutants were 
constructed in order to study the contribution of these functional elements to the role of 
hDaxx in the repression of ICP0-null mutant HSV-1. 
 
The key findings presented in the current study can be summarised as follows:    3
(1) ATRX contributes to the intrinsic resistance against HCMV infection, and this 
mechanism is strongly counteracted by viral pp71;  
(2) A chromatin-remodelling complex formed between ATRX and hDaxx contributes to 
the efficient repression of ICP0-null HSV-1 genomes, thereby constituting a part of anti-
HSV-1 intrinsic cellular defence. ICP0 counteracts this process, and the possible 
mechanisms of ICP0 action are proposed.  
 
These data provide the first evidence for the role of ATRX in viral infection and in 
addition demonstrate a role for hDaxx in the regulation of HSV-1 infection. The strong 
indication that ATRX and hDaxx act as a complex opens a possibility of chromatin-
dependent repression of ICP0-null HSV-1 genomes. Whether ATRX and hDaxx contribute 
to the repression of pp71-null HCMV genomes as a complex is yet to be established. In 
summary, the conclusion of the studies presented in this thesis suggests regulatory roles of 
ND10-localised chromatin remodelling proteins ATRX and hDaxx in cellular anti-
herpesvirus intrinsic resistance mechanisms.   
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1  Introduction 
Viruses have evolved to overcome various host anti-viral defences in order to enable 
productive infection. The current thesis represents an in-depth investigation into two large 
double-stranded DNA viruses, herpes simplex virus type 1 (HSV-1) and human 
cytomegalovirus (HCMV), with regard to their ability to overcome intrinsic intracellular 
anti-viral defence mechanisms. Both HSV-1 and HCMV are members of the family 
Herpesviridae and are widely spread in nature. The aims of the following Chapter are to 
provide a detailed background to the life cycles of HSV-1 and HCMV, with a particular 
focus on their immediate-early gene expression. For more details on a specific subject of 
herpesvirus biology, not covered in the present Chapter, the reader is referred to the 
reviews by Roizman et al (2007), Pellet and Roizman (2007) and Mocarski et al (2007) in 
“Fields Virology”, and relevant chapters of “Human Herpesviruses: Biology, Therapy and 
Immunoprophylaxis” (2007), cited throughout.  
 
The various cellular mechanisms developed by the host organism to regulate and prevent 
the spread of viral infection include anti-viral immunity (innate, adaptive and intrinsic) and 
epigenetic mechanisms. A part of intrinsic defences against herpesviruses in humans is 
provided by the nuclear substructures ND10. Since many nuclear proteins involved in the 
regulation of chromatin state reside at ND10, this Chapter presents a detailed account on 
their functions in the viral life cycle. 
 
1.1  Family Herpesviridae 
1.1.1  Overview of the family and key features  
The mammalian, avian and reptile representatives of the herpesviruses constitute the 
family Herpesviridae of the order Herpesvirales. The other two families of the order are 
Alloherpesviridae (fish and frog viruses) and Malacoherpesviridae (oyster virus) (Davison 
et al, 2009). Subfamilies distinguished within the Herpesviridae family are Alpha-, Beta-, 
and  Gammaherpesvirinae. Members of these subfamilies include eight human 
herpesviruses: herpes simplex virus type 1 (HSV-1), a common cause of cold sores; HSV-2, 
the causative agent of genital herpes; human cytomegalovirus (HCMV); varicella-zoster 
virus (VZV), causing chicken pox; Epstein-Barr virus (EBV), human herpesvirus 6 and 7 
(HHV6 and HHV7); and HHV-8, associated with Kaposi’s sarcoma (hence, another name, 
Kaposi’s sarcoma-associated herpesvirus; KSHV) and Castleman’s disease.  
The major biological properties characteristic of all herpesviruses have been previously 
summarised in a following way (reviewed in Pellet and Roizman, 2007): 
  All herpesviruses specify a selection of enzymes involved in nucleic acid metabolism, 
DNA synthesis and processing of proteins.  
  The synthesis of viral DNA, assembly of capsids and DNA packaging into the capsid 
occur in the nucleus. 
  Production of viral progeny during lytic infection is associated with the destruction of 
the infected cell. 
  Herpesvirus genomes are able to persist in the natural hosts in a latent state in the form 
of closed circular molecules called episomes within the infected cell.  
 
The structural characteristics of the virus particles define the members of Herpesviridae. A 
typical herpesvirus virion is approximately 120 to 260 nm in size and consists of the four 
major structural elements: a core, a capsid, a layer of tegument, enclosed within the 
envelope (Figure 1.1). The double-stranded DNA ranges from 124 to 230 kb in size, is 
linear within the virion, but circularizes into an episome immediately upon its release into 
the infected cell nucleus. The icosahedral capsid is approximately 125 nm in diameter and 
consists of capsid proteins. The proteinaceous tegument surrounds the capsid. Within the 
viral envelope viral glycoproteins are embedded with the spikes protruding away from the 
surface. During a productive HSV infection, coordinated gene expression is switched 
between immediate early (IE; α), early (β) and late (γ) genes. The key IE genes of HSV-1 
and HCMV, which are of particular relevance to the present study, will be discussed in 
later sections of this Chapter. 
Glycoprotein
Lipid bilayer
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Tegument
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dsDNA
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Figure 1.1 Architecture of a typical herpesvirus infectious virion particle 
Key structural features are represented by tomographic re-construction of an HSV-1 virion (A; 
Grunewald et al, 2003) and a schematic diagram (B; adapted from Liu and Zhou, 2007). 
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1.1.2  Subfamilies 
Within the family Herpesviridae, three subfamilies are recognised. Their characteristics are 
briefly discussed below (Pellet and Roizman, 2007). Particular attention will be given 
further to the representatives of the α- and β-subfamilies of herpesviruses, HSV-1 and 
human cytomegalovirus HCMV, respectively.  
 
1.1.2.1 Alphaherpesvirinae  
The members of this subfamily are characterised by their variable host range, relatively 
short reproductive cycle, rapid spread in culture, efficient destruction of infected cells, and 
capacity to establish latent infections primarily in sensory ganglia. This subfamily contains 
the genera Simplexvirus (HSV-1), Varicellovirus (VZV), Mardivirus (GaHV-2), and 
Iltovirus (GaHV-1). The former two genera have mammalian hosts, and the latter two have 
avian hosts. Rapid spread of HSV-1 in common laboratory epithelial or fibroblastic cell 
lines make HSV-1 convenient to study in standard laboratory settings.  
1.1.2.2 Betaherpesvirinae 
Betaherpesviruses differ from alphaherpesviruses by their restricted host range. The 
reproductive cycle is long, and the infection progresses slowly in culture, and particularly 
in primary cell lines.  The sites of latency establishment are secretory glands, 
lymphoreticular cells, kidneys, and other tissues. The subfamily is further subdivided into 
genera of Cytomegalovirus (HCMV), Muromegalovirus (MCMV), Roseolovirus (HHV-6), 
and Proboscivirus (ElHV-1).  
1.1.2.3 Gammaherpesvirinae 
The members of Gammaherpeviruses are usually specific for either T- or B-lymphocytes. 
In vitro all members replicate in lymphoblastoid cells, and some also cause lytic infections 
in some types of epithelial and fibroblastic cells. This subfamily contains four genera: 
Lymphocryptovirus,  Rhadinovirus,  Macavirus and Percavirus (Davison et al, 2009). 
Human representatives are EBV and HHV-8 (or Kaposi’s sarcoma-associated virus; 
KSHV). In vitro EBV efficiently infects primary human B lymphocytes, which results in 
nonpermissive conditions for EBV replication and transformation of B cells into long-term 
lymphoblastoid cell lines. The cell culture system for KSHV is primary effusion 
lymphocytes (proliferating B-cells from end-stage AIDS patients), which harbour latent 
KSHV genomes and only 1-5% show lytic replication (for reviews see Kieff and Rickinson, 
2007; Ganem, 2007).   23
1.2  Pathogenesis of herpesvirus infections 
Despite most human herpesvirus infections being asymptomatic, or symptoms being 
generally mild in immunocompetent individuals, life-threatening infections may occur in 
immunocompromised individuals or people with suppressed immunity, and especially 
neonates. Treatment of herpesvirus infections is largely based on nucleoside analogues, 
which target viral DNA polymerase during the process of replication. The clinical 
manifestations of these infections will be summarised in this part of the Chapter. 
 
1.2.1  HSV infections 
Primary or recurrent HSV-1 or HSV-2 infections can be symptomless. Prevalence of HSV-
1 infection is substantially higher than that of HSV-2 but the figures vary largely between 
geographic regions and amongst different age groups. Thus, in the US the population of 
HSV-1 seropositive individuals reaches 80%, and similar values were observed amongst 
European populations. HSV-2 seroprevalence rises from about 20-30% at the age of 15-29 
years and up to 35-60% by the age of 60 in the US. Substantially lower figures were 
obtained for most of the European populations: between 3% in post-adolescent population 
rising to 25% in 40-year olds in the UK, and as low as 2-6% in Spain (Smith & Robinson, 
2002; Whitley & Roizman, 2001).   
 
1.2.1.1 Genital herpes 
Genital herpes can result from both HSV-1 and HSV-2 infections, however it is HSV-2 
that is mostly responsible for recurrent genital herpes (accounting for 85-90% of 
outbreaks). Genital herpes infections are acquired via a sexual route. Primary and recurrent 
infections are associated with appearance of sores, result in physical discomfort and bear a 
psychosocial impact; however in most people symptoms remain unnoticed and 
unrecognized. Due to this, asymptomatic shedding of HSV-2 infections represents the most 
common cause of the increasing rate of HSV-2 transmission. Treatment involves oral 
administration of acyclovir at the time of the appearance of lesions. Suppressive therapy 
using valaciclovir during asymptomatic shedding is known to reduce transmission 
significantly (Leone, 2005).  
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1.2.1.2 HSV infection of the central nervous system  
Although rare, severe HSV-related disorders of the central nervous system can result from 
acquisition of HSV infections via a congenital route causing neonatal herpes. Later in life 
these infections may result in life-threatening encephalitis or the more benign aseptic 
meningitis. In immunocompetent adults, over 90% of herpesviral encephalitis cases result 
from HSV-1 infection and a remainder from HSV-2. The clinical manifestation of herpes 
simplex encephalitis is acute focal, necrotizing encephalitis with inflammation and 
swelling of the brain tissue. Recurrent aseptic meningitis is caused mostly by HSV-2, and 
is associated with repeated episodes of fever, severe headache and meningismus. 
Treatment of both herpes simplex encephalitis and aseptic meningitis involves intravenous 
administration of acyclovir (Gilden et al, 2007; Tyler, 2004). 
 
1.2.1.3 Herpes simplex keratitis 
Following HSV-1 infection of the eye, herpes simplex keratitis (HSK) may develop. HSK 
can represent either primary disease, resulting upon the infection of a subject with no 
previous exposure; initial ocular disease of the host previously exposed to HSV-1; 
recurrent HSK or superinfection with another HSV-1 strain. Notably, infection with HSV-
1 via the ocular route by scarification of the ocular surface is very common in experimental 
approaches studying HSV-1 in mouse models. In these models, infection results in 
subsequent establishment of latency in the cornea, iris and trigeminal ganglia (TG). The 
clinical manifestations of the ocular disease include lid and conjuctival disease, which may 
result in detrimental effects on vision. Recurrent infection is the principal cause of 
blindness, therefore development of suitable treatment strategies to prevent reactivation of 
the virus is of key importance. Acyclovir therapy so far proves to be efficient in the 
prevention strategy (reviewed in Kaye & Choudhary, 2006) 
 
1.2.2  HCMV infections 
Most primary HCMV infections are asymptomatic, and the virus becomes latent within 
months after infecting an immunocompetent individual. Seroprevalence figures vary 
between 35-95% in different populations, although most infected individuals may lack 
clinical manifestations (Malm & Engman, 2007). Since the virus can infect leukocytes, 
endothelial cells, connective tissue cells and epithelial cells, HCMV infection can be 
acquired through blood transfusion, sexual and perinatal routes, or by transplantation. 
HCMV has a potential to transform human tissues, since high viral titres can be detected in   25
a number of cancer biopsies. HCMV-associated malignancies are due to the ability of 
HCMV to inhibit the function of p53 tumour suppressor (reviewed in Doniger et al, 1999).  
 
1.2.2.1 Congenital HCMV infections 
Congenital infections of the newborns present a significant concern. These infections can 
result from CMV infections during pregnancy, which although asymptomatic can be 
manifested in premature delivery (Pereira et al, 2007). About 0.5 to 2.5% of all newborns 
are infected at birth, and HCMV has therefore become the most common cause of viral 
birth defects in congenitally infected babies. About 10-15% of neonates with congenital 
CMV show infection-related symptoms. Cytomegalic inclusion disease is a representative 
consequence of such infections, and is characterised by the involvement of multiple organs, 
in particular reticuloendothelial and central nervous systems, potentially involving ocular 
and auditory damage. Further symptoms include jaundice, hepatosplenomegaly, 
microcephaly, seizures, hypotonia and lethargy. Such congenital infections may cause a 
variety of subsequent disabilities, including mental retardation and learning disabilities, 
hearing impairment and visual deficit (Malm & Engman, 2007).  
 
1.2.2.2 HCMV infections of immunocompromised and immunosuppressed hosts 
HCMV infections are most commonly symptomatic and present significant management 
concerns amongst immunocompromised hosts. HCMV-related disorders of human 
immunodeficiency virus (HIV)-infected adults can be life-threatening. The most common 
disorder in HCMV-infected acquired immunodeficiency syndrome (AIDS) patients is 
retinitis, accounting for 85% of cases (Steininger, 2007). In addition, HCMV infection 
comprises an important complication in organ transplantation, and is known to have been 
associated with significant morbidity and mortality of post-transplant individuals. Over 
75% of solid transplantation patients are newly infected or reactivate latent CMV. CMV 
disease can then be manifested by fever, hepatitis, pneumonitis, gastroenteritis and retinitis, 
but is usually treatable using standard anti-CMV drugs discussed below (Fishman et al, 
2007). 
 
1.2.2.3 Treatment 
No anti-HCMV vaccine exists, but therapies for HCMV disease are based on the 
development of anti-viral drugs. These have become essential in prophylactic treatment of 
transplant patients (Fishman et al, 2007). Five compounds have been approved for the   26
treatment of established HCMV infections: ganciclovir, its oral prodrug valganciclovir, 
foscarnet, cidofovir (polymerase inhibitors) and fomivirsen (an oligonucleotide that acts as 
a translation inhibitor and targets the HCMV IE gene locus). High dose acyclovir or 
valaciclovir have also been used as prophylactic agents against HCMV, since these drugs 
are not sufficient for the use in treatment of active HCMV disease (Malm & Engman, 
2007).  
1.2.3  Other herpesvirus infections 
1.2.3.1 Varicella Zoster Virus 
VZV is another member of Alphaherpesvirinae subfamily and very widely spread among 
the human population. It causes chickenpox and establishes latency in cranial nerve, dorsal 
root and autonomic nervous system ganglia. Herpes zoster (HZ; or shingles) results from 
reactivation of the virus, decades after the establishment of latency and is a consequence of 
declining VZV-specific host immunity. The symptoms of HZ are associated with painful 
rash, which appears anywhere in the body upon reactivation. Antiviral therapy of these 
symptoms is based on valaciclovir or famciclovir rather than acyclovir.  If the virus 
spreads to blood vessels of the brain after herpes zoster, VZV can cause vasculopathy, 
particularly in immunocompromised patients. This can be treated using intravenous 
acyclovir therapy (Gilden et al, 2007). 
 
1.2.3.2 Kaposi’s sarcoma-associated herpesvirus 
KSHV is a gammaherpervirus which establishes latency in lymphoid tissues. KSHV is 
detected in Kaposi’s sarcomas (KS), the most common tumour of AIDS patients. The 
disease is associated with the appearance of its proliferating so-called spindle cells which 
are thought to be of endothelial lineage. KS lesions also contain infiltrating monocytes, T 
cells and plasma cells. Within the tumour, KSHV targets spindle cells, most of which 
become latently infected, however 1%-2% of the infected cells express lytic markers. 
Latently infected spindle cells are positive for KSHV latency-associated transcript LANA, 
which is known to possess a number of tumourigenic properties (such as inhibition of 
tumour suppressor p53 and induction of NF-κB). There are a number of models that 
address how the lytically infected cells contribute to tumour progression but the 
mechanism remains incompletely understood. Treatment of KS in advanced AIDS patients 
relies on addition of parenteral ganciclovir, a drug that blocks lytic but not latent KSHV 
infection, which results in a prompt and dramatic decline in the incidence of new KS 
tumours (reviewed in Ganem, 2007).   27
1.2.3.3 Epstein-Barr virus  
EBV is another human member of gammaherpesviruses. It infects B and T lymphocytes of 
more than 90% of the general population. Primary infection can produce infectious 
mononucleosis. The cell transforming potential of EBV is associated with development of 
several carcinomas amongst which are nasopharyngeal carcinoma, Hodgkin’s disease and 
Burkitt’s lymphoma (BL). BL tumour cells are characterised by the presence of EBV 
episomes and expression of only one EBV protein, EBV nuclear antigen 1 (EBNA-1), 
which functions in maintaining episomal DNA replication in latently infected cells.  The 
characteristic of BL cells is chromosomal translocation resulting in the abnormal 
regulation of the c-myc oncogene (Cohen, 2000).  
 
1.3  Comparative structure of HSV-1 and HCMV virions  
The architecture of both HSV-1 and HCMV virions is consistent with the schematic 
diagram presented on Figure 1.1. The size of the average HSV-1 particle is approximately 
186 nm in diameter whereas that of HCMV is somewhat larger and ranges in size between 
200-300 nm in diameter. The main structural features of the two viruses are described 
further.  
 
1.3.1  Double-stranded DNA core 
The tightly packaged double-stranded DNA genomes of herpesviruses constitute the core 
of the mature infectious viral particles. These genomes replicate by circularization, 
followed by a ‘rolling circle’ mode (see Section 1.4.1.3) to produce linear concatemers 
which are cleaved into unit-length genomes during the process of packaging. The general 
structure of HSV-1 and HCMV genomes is represented in Figure 1.2 (reproduced from 
(McGeoch et al, 1988). Both are of similar arrangement, and are characterised by the 
presence of the unique long (UL) and unique short (US) regions flanked by terminal and 
inverted repeat sequences (TRL and IRL; TRS and IRS, respectively). During DNA 
replication, segment inversion occurs resulting in equimolar amounts of genomes 
containing the two orientations of US and UL regions within the viral population. Terminal 
a and internal a’ (inverted of a) sequences consist of direct repeat (DR) elements that are 
highly conserved, but may vary in numbers. They provide a signal for packaging via two 
conserved elements pac-1 and pac-2 (Roizman et al, 2007; Davison, 2007). The size of the 
HSV-1 genome is approximately 152 kbp, and it comprises around 75 open reading frames (ORFs) (McGeoch et al, 1988). HCMV genome is about 50% larger and is 235 kbp in size. 
It encodes for approximately 165 proteins (Dolan et al, 2004).  
 
 
TRS IRL   IRS TRL
UL US a’ a a
 
Figure 1.2 Organisation of the HSV-1 and HCMV genomes 
 
1.3.2  Capsid 
The typical capsid of the herpesvirus virion is a T=16 icosahedron and composed of 12 
pentons forming the vertices, 150 hexons forming the faces and edges, and 320 triplexes 
interconnecting the pentons and hexons. Three different types of capsids are designated as 
A, B and C-capsids, of which only the latter contains viral DNA (Liu and Zhou, 2007). 
 
1.3.2.1 The HSV-1 Capsid 
Four viral proteins constitute the outer shell of the HSV-1 capsid: the major capsid protein 
(MCP) VP5 (UL19), VP26 (UL35), VP23 (UL18), VP19C (UL38). An additional 
constituent of the HSV-1 capsid VP24 functions as the protease that processes the internal 
capsid scaffold during DNA encapsidation (reviewed in Roizman et al, 2007). Pentons and 
hexons are composed of five and six copies of VP5, respectively. The six copies of VP26 
form a ring on top of the VP5 subunits on each hexon. Triplexes are made up of one 
VP19C molecule and two VP23 molecules that link adjacent capsomeres (Schrag et al, 
1989; Zhou et al, 2000). A portal for viral DNA packaging is formed by the UL6 gene 
product (Chang et al, 2007; Newcomb et al, 2001). 
 
1.3.2.2 The HCMV Capsid 
The HCMV capsid is similarly organised, and the five proteins that constitute its capsid are: 
the MCP encoded by the UL86 gene; triplexes composed of two subunits – the minor 
capsid protein together with the minor capsid protein binding protein; the smallest capsid 
protein (SCP, encoded by UL48A gene) at the MCP tips; and a portal protein (PORT, the 
UL104 gene product) as a specialized vertex in DNA encapsidation (Butcher et al, 1998).  
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1.3.3  Tegument 
The tegument of a herpesvirus virion is defined as the space between the inner surface of 
the envelope and the outer surface of the capsid in a mature particle. Some tegument 
proteins are associated with capsid. The tegument compartments of HSV-1 and HCMV 
particles are largely unstructured (reviewed in Roizman et al, 2007; Kalejta, 2008b).  
 
1.3.3.1 HSV-1 tegument proteins 
Amongst HSV-1 tegument proteins the most studied ones include virion transactivator 
protein VP16 and virion-induced host shut-off (VHS) protein, which are described in more 
detail in the next paragraphs. Other tegument constituents include VP22, VP1/2, VP11/12 
and VP13/14. VP22 encoded by the gene UL49 has a proposed role in cell to cell spread,  
since mutant plaques appear much smaller in size than wt plaques and viral titres of UL49-
mutants are lower (Duffy et al, 2006).  VP1/2 (UL36 gene product) is essential for viral 
replication and plays a role in capsid transport and viral DNA release at the nuclear pore 
during viral entry. IE-gene encoded proteins ICP0 and ICP4 and the Early protein 
thymidine kinase (tk) are also found within HSV-1 tegument but present a significant 
interest from the aspect of their expression as the products of their respective classes of 
genes (reviewed in Kelly et al, 2009).  
 
VP16 is an important protein to consider because of its transactivating functions. It is a 
490-amino acid protein, encoded by a late gene UL48, with an acidic C-terminal 
transcriptional activation domain. In lytic infection, around 500-1000 VP16 molecules 
within the HSV-1 tegument are delivered to the host cell, and the VP16-induced complex 
is assembled (reviewed in Wysocka & Herr, 2003). VP16 associates with cellular proteins 
Host Cell Factor (HCF) and Oct-1, which bind specific sequences of the regulatory 
elements of IE promoters to induce activation of IE gene transcription. Analysis of VP16 
mutant viruses has identified the domains necessary for IE transcription, as well as for 
virion assembly. These mutants are defective in plaque formation, and cells infected at low 
multiplicities of infection (MOI) have a high tendency to harbour HSV-1 genomes in a 
quiescent state (Ace et al, 1988; Ace et al, 1989). Recruitment of cellular chromatin 
remodelling proteins such of SWI/SNF family enzymes and histone acetyltransferases (see 
Section 1.7.1) to VP16-induced complexes (Herrera & Triezenberg, 2004; Memedula & 
Belmont, 2003) strongly correlates with the high transcriptional activity from the IE gene 
promoters very early during the infection.   
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The virion induced host shut-off protein (VHS) is encoded by the UL41 gene and is 
phosphorylated in infected cells (Smibert et al, 1992). VHS contributes to the global 
decline of host mRNA levels (shut-off) by acting as RNase or a subunit of RNase complex 
(Elgadi et al, 1999; Everly et al, 2002). In addition, VHS-induced host cell mRNA 
destabilization promotes loss of the major histocompatibility complex (MHC) class I from 
the cell surface, thereby rendering the infected cells resistant to lysis by cytotoxic (CD8+) 
T lymphocytes (see Section 1.9). This mechanism suggests the role of VHS in immune 
evasion (reviewed in Smiley, 2004).  
1.3.3.2 HCMV tegument proteins 
Most HCMV tegument proteins are phosphorylated, however the purpose of this 
phosphorylation for their function has not been defined. The functions of various tegument 
proteins have been extensively reviewed elsewhere (Kalejta, 2008a; Kalejta, 2008b). These 
include activation of gene expression, immune evasion, and stages of viral entry, assembly 
and egress during the lytic phase of infection. For example, HCMV UL47 and UL48 
proteins that associate with viral capsid can interact with microtubule motor proteins in 
order to facilitate the delivery of capsids to the nuclear pore complex. Pp65 (encoded by 
the UL83 gene) is a major constituent of HCMV particles and is delivered to the nucleus of 
the infected cells at the initial stages of lytic infection, however it is completely 
dispensable for replication in cultured fibroblasts. This protein is the dominant target 
antigen of cytotoxic T lymphocytes. Pp65 and pp71 are neighbouring genes and are 
expressed from an overlapping mRNA transcript of approximately 4 kb (Ruger et al, 1987). 
Pp71 is a very potent transcriptional activator of IE gene expression, and pp71-null mutant 
HCMV replicates in culture very poorly (reviewed in Kalejta, 2008b). A specific section 
dedicated to pp71 and its role in transcriptional activation is presented later (Section 1.6.5), 
because of its direct relevance to the subject of the present thesis.  
 
1.3.4  Envelope 
Approximately 11 different viral glycoproteins are embedded into the lipid bilayer of the 
viral envelope. The HSV-1 virion envelope glycoproteins are gB (VP7 and VP8.5; encoded 
by the UL27 gene), gC (VP8; UL44), gD (VP17 and VP18; US6), gE (VP12.3 and VP12.6; 
US8), gG (US4), gH (UL22), gI (US7), gL (UL1), and gM (UL11) (Roizman et al., 2007). 
Envelope glycoproteins of HCMV include homologues of those found within HSV-1 
envelope, and similarly, mediate roles in attachment and entry into the host cell (reviewed 
in Davison and Bhella, 2007; Mocarski, 2007).   31
1.4  The overview of the HSV-1 and HCMV life cycles  
Herpesviruses life cycles are characterised by the ability to switch between lytic 
(associated with the release of viral progeny) and latent modes of infection. The precise 
mechanisms underlying this switch remain largely unclear. The sequences of events 
occurring during the establishment of lytic herpesvirus infections are very much alike. 
These are addressed below with the focus on HSV-1 and HCMV.  
 
1.4.1  The lytic infectious cycle 
The members of Alphaherpesvirinae and Betaherpesvirinae have similar pathways of the 
initiation of lytic cycle infection due to their abilities to infect mucosal membranes. For the 
purposes of this Chapter, specific molecular mechanisms occurring during each stage of 
the lytic life cycle of HSV-1 and HCMV will not be covered. These can be found in the 
reviews by Roizman et al (2007) and Mocarski et al (2007), as well as those cited 
throughout the next paragraphs. The schematic diagram on Figure 1.3 (p.35) represents the 
overview of the lytic infectious cycle.  
 
1.4.1.1 Viral entry into the host cell 
The process of entry into the host cells involves a series of defined steps prior to the 
release of viral DNA into the nucleus: (i) binding to specific cell surface receptors; (ii) 
fusion of the envelope with the cellular membrane followed by a release of nucleocapsids 
into the cytoplasm; (iii) nucleocapsid association with cytoskeletal elements and 
translocation to the nuclear membrane, where release of viral DNA finally occurs. Initial 
attachment involves interaction between viral glycoproteins and heparan sulphate 
molecules on the host cell membrane. In HSV-1 the initial binding of the viral particle 
involves the interaction of glycoproteins gC and gB with host cell surface heparan sulphate 
and between gD and host cell entry receptors nectins and herpesvirus entry mediator 
HVEM. The process of fusion is facilitated by the heterodimer formed between gH and gL 
(reviewed in Spear et al, 2000). In HCMV the process of viral cell fusion also requires the 
functions of gH/gM heterodimer. In addition to heparan sulphate molecules, host cell β2-
microglobulin and annexin II participate in HCMV entry (reviewed in Campadelli-Fiume 
and Menotti, 2007; Mocarski, 2007). 
 
Trafficking of the infectious virion particles relies on the interactions between viral 
tegument proteins and the components of the cell cytoskeleton. Thus, it has been proposed   32
that the microtubule motor dynein is involved in the intra-cellular trafficking of HSV-1 
capsids (Dohner et al, 2002). The HSV-1 capsid protein VP26 and the largest tegument 
protein pUL36 have been shown to be required for this process (Douglas et al, 2004; 
Shanda & Wilson, 2008). The interactions between HCMV proteins and host-cell 
intracellular trafficking machinery are less understood, but microtubules are also thought to 
be responsible for this process in HCMV infection. The largest tegument protein encoded 
by UL48 may be required for the process of viral replication by analogy with HSV-1 UL36 
functions, in controlling uncoating and release of viral DNA at nuclear pores. Once the 
viral capsid has reached the nuclear membrane, viral DNA is released through the nuclear 
pore. In HSV-1 the protein that is likely to play a role in this process is VP1/2 whereas in 
HCMV the functional homologue of this protein is thought to be the large tegument protein 
pUL48 and its binding partner pUL47 (Mocarski et al, 2007). 
 
1.4.1.2 Gene expression  
Herpesvirus gene expression occurs in a temporally regulated cascade, utilizing pre-
existing viral and cellular proteins for activation of IE gene expression. Thus, the genes are 
classified according to their timing of expression as Immediate Early (IE; or α), Early 
(β; also called Delayed Early for CMV) or Late (γ) genes. IE gene products are essential 
for efficient transcriptional activation (see Section 1.6). Early genes encode enzymes that 
are involved in nucleotide metabolism and DNA replication (for example, HSV-1 tk and 
HCMV viral protein kinase VPK, which function as nucleoside kinase), as well as a 
number of glycoproteins. Late genes are principally responsible for the expression of 
structural proteins that make up the virion. While IE gene expression does not require de 
novo protein synthesis and is activated by viral and host cell transcriptional factors, Early 
and Late gene regulation is highly dependent on the synthesis of IE gene products (Honess 
& Roizman, 1974). The aspects of IE gene regulation and the functions of IE proteins will 
be addressed in more detail later (see Section 1.6).  
 
During infection with either HSV-1 or HCMV, the viral genome circularises into an 
episome upon entry into the nucleus (McVoy & Adler, 1994; Strang & Stow, 2005).  These 
episomal DNA structures become associated with components of nuclear domains termed 
ND10. In wt HSV-1 and HCMV infections, ND10 are disrupted prior to the initiation of 
DNA replication by viral tegument and IE proteins (see Sections 1.5.2, 1.6.3 and 1.6.5). 
With the expression of Early gene products, DNA synthesis begins. At this early stage of   33
viral infection, so-called replication compartments are formed within the nucleus of an 
infected cell (Wilkinson & Weller, 2003). 
 
1.4.1.3 Viral DNA synthesis 
HSV DNA replication  
HSV-1 DNA contains three sites that act as origins of replication. The seven essential 
HSV-1 genes that are required and sufficient for genome replication are the three subunits 
of DNA helicase-primase complex UL5, UL8, and UL52; the origin-binding protein UL9; 
the DNA binding protein ICP8, the product of UL29; DNA polymerase encoded by UL30; 
and the processivity factor UL42. Firstly, pUL9 binds the replication origin on the 
episomal DNA in a sequence-specific manner. Then ICP8 interacts with the C terminus of 
UL9 protein, inducing its DNA-dependent ATPase and DNA helicase activities. This is 
followed by a three-subunit DNA helicase-primase complex interaction with ICP8, which 
promotes DNA unwinding for the access of DNA polymerase. Viral DNA polymerase 
encoded by the UL30 gene also expresses a 3’ → 5’ exonuclease activity, which is 
required for deoxynucleotide polymerization and provides a proof-reading function. An 
additional protein, the processivity factor UL42, acts to enhance the activity of viral DNA 
polymerase. Replication proceeds in a rolling-circle model and generates linear DNA 
concatemers (Lehman & Boehmer, 1999).  
 
HCMV DNA replication 
There are six HCMV proteins that are essential for its DNA synthesis. In common with 
HSV-1 and other herpesviruses, these include the UL54-encoded polymerase catalytic 
subunit associated with the UL44 gene product polymerase processivity factor in a 
polymerase complex; the UL57 encoded single-strand DNA binding protein; and the three-
subunit complex of helicase-primase consisting of gene products of UL105, UL70 and 
UL102. The proteins known as origin binding proteins are IE2 and UL84. These proteins 
are thought to form complexes that stimulate transcription across the HCMV origin of 
replication  oriLyt. The replication model supports the rolling-circle mechanism as for 
HSV-1. Additional proteins with auxiliary roles in viral DNA synthesis are UL36-38 gene 
products, which are thought to maintain a more favourable cellular environment for DNA 
replication in HCMV infected cells. DNA synthesis allows activation of Late gene 
expression, resulting in the production of proteins required for assembly and egress of the 
viral particles (Anders et al, 2007).  
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1.4.1.4 Capsid assembly and packaging of viral DNA 
Apart from infectious virions, non-infectious viral particles and dense bodies are found in 
the culture media of the cells that are lytically infected with HSV-1 or HCMV (Figure 1.3). 
The ratio of these particles to mature infectious virions can sometimes reach 20:1, which 
implies that they are produced in great excess (Liu and Zhou, 2007). Proteins that are 
required for nucleocapsid formation are MCP, triplex proteins (pUL18 and pUL38 of 
HSV-1), and a maturational protease (pUL26 of HSV-1). Additional proteins, the small 
capsid protein at the hexon tips and the portal protein are non-essential in 
alphaherpesviruses for capsid formation but are essential in beta- and gammaherpesviruses 
(Mettenleiter et al, 2009); Mocarski et al, 2007).  
 
Encapsidation of viral DNA is a process conserved between HSV-1 and HCMV and 
involves cleavage of viral progeny DNA concatemers into unit length monomers (Roizman 
et al., 2007). The process of cleavage of the concatemeric DNA is conserved and requires 
the heterotrimeric (HSV) or heterodimeric (HCMV) protein named terminase. HSV-1 
terminase is composed of proteins pUL15 (putative ATPase subunit), pUL28 and pUL33 
(Mettenleiter et al, 2009). In HCMV the terminase consists of ATPase subunit pUL89 
(TER1) and a capsid recognition subunit pUL56 (TER2). The functions of the terminase 
complex include the regulation of the threading of a particular genome length of DNA into 
the capsid, scanning for a pac site and determining the position of DNA cleavage to 
produce genomic ends. The conserved pac elements located within the a sequences (Figure 
1.2) of the HSV and HCMV genomes therefore trigger the packaging and cleavage 
processes (Mocarski et al, 2007).  Tegument
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Figure 1.3 Overview of the herpesvirus lytic infectious cycle  
The infectious virion infects the cell by either endocytosis or fusion with the cell membrane, which 
results in release of the nucleocapsid and some tegument proteins into the cytoplasm. The 
nucleocapsid is transported across the cytoplasm, and the viral DNA is injected into the nucleus 
through the nuclear pore. DNA replication and assembly of virions take place in the nucleus. 
Procapsids mature into the C-capsids (infectious). A-capsids are abortive which result from failure 
to encapsidate DNA. Both B- and C- capsid can acquire some tegument proteins at the nuclear 
membrane. Scaffold protein of the infectious capsids is released prior to DNA encapsidation. 
Cytoplasmic capsids are enveloped and released by exocytosis. The model presented on this 
diagram, which applies to HCMV lytic infection, is consistent with the envelopment-
deenvelopment model of virion assembly. During HSV-1 replication, apart from the infectious viral 
particles, empty L-particles can also be produced (adapted from Liu and Zhou, 2007 and 
Mettenleiter et al, 2009).    
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1.4.1.5 Maturation and egress 
The models of capsid maturation are somewhat controversial. The dominant model states 
that tegument proteins function together with non-structural proteins to control a complex 
two-stage envelopment and egress process that initiates at the nucleus and results in the 
virion release by exocytosis at the plasma membrane. This model is referred to as the 
envelopment-deenvelopment model in some reviews (Mettenleiter et al, 2009); Figure 1.3). 
Alternative models propose different scenarios. One of them suggests a single envelopment 
event at the nuclear membrane and subsequent vesicular transport of the enveloped particle 
to the plasma membrane. The other model proposes enlargement of the nuclear pore to a 
size which readily allows the egress of the unenveloped capsids into the cytoplasm 
(reviewed in Roizman et al, 2007).    
 
According to the first and currently mostly accepted model, in both HSV-1 and HCMV the 
primary envelopment starts at the inner nuclear membrane followed by the de-envelopment 
process at the outer nuclear membrane, releasing the capsid into the cytoplasm. Secondary 
envelopment occurs at the endosomal membranes, which produce vesicles carrying the 
fully mature virions to the cell surface via the cellular exocytosis. The virus-cell 
interactions required for the process of maturation and egress of mature virions are thought 
to be different from those involved in viral entry and are less well understood. The two 
conserved herpesvirus proteins (in HSV-1 referred to as UL31 and UL34 gene products) 
participate in the early steps of the budding process at the nuclear membrane. For the 
nucleocapsids to gain access to the inner nuclear membrane, which is obstructed by the 
nuclear lamins, cellular kinases are recruited by the pUL31/pUL34 complex. At this stage, 
viral kinases (e.g. pUL97 in HCMV and pUS3 of HSV-1) can also induce phosphorylation 
of nuclear lamins in order to gain access for interaction between nuclear capsids and the 
inner nuclear membrane. Since the final envelopment occurs in the cytoplasm, viral 
tegument includes a small amount of cellular proteins, particularly actin as well as small 
RNA molecules. Exocytosis follows the final envelopment stage, where the mature virion 
is carried inside a vesicle to the cell surface for release. The release of the virus particle is 
thought to follow cellular vesicular trafficking pathways. Released infectious viral particles 
can infect adjacent cells by cell-to-cell spread or be carried into the sites of latency 
establishment (reviewed in Mettenleiter, 2002; Mettenleiter et al, 2009; Mocarski, 2007).  
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1.4.2  Latency  
A prominent characteristic of all herpesviruses, that confers their evolutionary success, is 
their ability to persist in the host in a latent state. Herpesvirus latency is generally 
characterised by production of a very small number of transcripts and a gene expression 
profile distinct from that of lytic cycle. Despite extensive research, the mechanisms that 
operate during latency establishment and reactivation remain incompletely understood. 
Some evidence regarding these mechanisms in HSV-1 and HCMV latent infection is 
therefore discussed in the next paragraphs. 
 
1.4.2.1 HSV-1 latency and models of quiescent infection 
Following lytic infection in epithelial tissues, HSV-1 enters sensory nerve fibres within the 
stratified epithelium, and then travels by retrograde axonal transport along the 
microtubules to the cell body of the neurons in order to establish a lifelong latent infection 
of these neurons in the sensory ganglia. Neurons are the primary site of HSV-1 latency 
establishment. In mouse models active viral replication is initially supported during the 
first three to four days of infection during the acute phase, but no infectious viral progeny 
is detected later on, indicating efficient establishment of latency in neurons (Cook et al, 
1974; Speck & Simmons, 1991; Stevens & Cook, 1971). Intermittent reactivation of the 
virus occurs spontaneously and results in axonal anterograde microtubule-associated 
transport of the virus, where the virus crosses back into the epithelia, usually in the area of 
the initial infection, replicates and is shed into oral secretions (Cunningham et al, 2006).  In 
latently infected cells the viral genome is thought to exist in an episomal conformation. 
This conformation is also associated with lytic infection when the viral DNA first 
encounters nuclear environment; however the transcriptional programme of latent genomes 
differs substantially. Hence, there are a number of markers that are known to associate with 
latent HSV-1 genomes.  
 
Firstly, latency is characterised by the lack of detectable lytic gene expression, which is 
thought to be due to the failure of IE transcription. Inability to initiate IE transcription has 
been linked to the lack of the tegument IE transactivator VP16 in neurons. Additional 
factors such as neuronal-specific expression of distinct Oct and HCF proteins, unable to 
associate with VP16 for efficient IE transcriptional stimulation, can also account for 
suppressed IE gene expression during latency (reviewed in Preston, 2000). In tissue culture 
it is possible to establish a model of latent-like infection, referred to as quiescent infection, 
by introducing mutations into the domain of VP16 required for interaction with Oct-1 and   38
HCF resulting in the disruption of activation of IE gene expression (Ace et al, 1989). This 
approach has been extended by introducing additional mutations into ICP0 and ICP4 
coding regions that disrupt their abilities to stimulate gene expression, rendering the 
mutant virus susceptible to cell repression mechanisms even at high MOIs and resulting in 
quiescently infected cell cultures (Preston & Nicholl, 1997; Preston & Nicholl, 2005). 
These models have become useful in identifying cellular and viral factors required for 
reactivation, such as the requirement for ICP0 (see Section 1.6.3.6).  
 
Secondly, latent genomes commonly express latency associated transcripts (LATs) in the 
infected neurons. LATs are processed RNA products of the primary LAT gene transcript of 
approximately 8.5 kb, of which the most abundant is the 2.0 kb transcript derived from an 
intron, and one of lesser abundance of approximately 1.5 kb (Wagner & Bloom, 1997). 
Analysis of the genetic composition of the major LAT intron implicates ICP0 as the target 
for inhibition of its expression by antisense targeting (Farrell et al, 1991), and hence 
correlates with suppressed IE gene expression in such cells. However, evidence in favour 
of this model remains inconclusive. 
 
Another hallmark of the HSV-1 latent genome is its association with the presence of 
markers of facultative heterochromatin (repressed chromatin) (reviewed in Knipe & Cliffe, 
2008), which implicates cellular epigenetic mechanisms in viral genome repression. This 
aspect of latency regulation will be discussed further (Section 1.7.2). In addition, recent 
evidence has suggested a role for LAT-encoded microRNAs (miRNAs), that inhibit 
expression of the HSV-1 neurovirulence factor ICP34.5, ICP0 and ICP4 (Tang et al, 2008; 
Tang et al, 2009; Umbach et al, 2008), suggesting an additional mechanism for 
maintenance of latency at the level of inhibition of lytic gene expression.  
 
1.4.2.2 HCMV latency 
During natural primary infection of the human host, HCMV first infects epithelial cells of 
the rhinopharynx or genital tract depending on the route of transmission, or the vascular 
endothelial cells if acquired during blood transfusion.  Leukocytes are then recruited to the 
sites of infection, take up the virus and viral products, and initiate the spread through the 
blood stream to various tissues including salivary glands, kidneys, liver and mammary 
glands. The virus then establishes and maintains latency in the bone marrow, but the 
precise mechanisms underlying the process of latency establishment are yet to be identified. 
In vivo latency may be established in various cell types, including endothelial cells,   39
monocyte-derived macrophages, smooth muscle cells, epithelial cells, fibroblasts, T-
lymphocytes, granulocytes, stromal cells, neuronal cells and hepatocytes. Critical sites of 
latency establishment in vivo are considered to be certain cell types of the myeloid lineage 
such as CD34+ hematopoietic progenitors within the bone marrow, however reactivation in 
these cells is observed during in vitro infection (reviewed in Jarvis and Nelson, 2007; 
Revello & Gerna, 2010; Sinclair & Sissons, 2006). The latent load of HCMV in healthy 
seropositive individuals constitutes approximately 1 genome-positive cell per 10,000 
peripheral blood mononuclear cells and mainly in the leukocyte fraction of peripheral 
blood, where the genome exists as episomes between two and ten copies. Experimental 
models of latency have largely relied on the use of CD34+ cells, haematopoietic cell 
precursors of monocytes (reviewed in Reeves & Sinclair, 2008).  
 
The properties of the gene expression programme during latency in HCMV infected cells 
are similar to HSV-1 in that lytic transcription is efficiently repressed and the viral genome 
is assembled into a repressed chromatin structure. Maintenance of latency within myeloid 
cells is associated with a repressed chromatin structure assembled on the MIEP (Murphy et 
al, 2002; Reeves et al, 2005). Consistent with these observations, in HCMV latently 
infected cells the major IE proteins IE1 and IE2 (see Section 1.6.6) are not expressed 
(Taylor-Wiedeman et al, 1994). Infected cells express a number of cytomegalovirus 
latency transcripts. These include UL111a (a viral homologue of interleukin 10), UL138 
and LUNA (Revello & Gerna, 2010). Of particular interest here is latency transcript 
LUNA which is partially antisense to genes UL81 and UL82 (Bego et al, 2005). Synthesis 
of the UL82 gene product pp71, required for efficient stimulation of IE gene expression 
(Baldick et al, 1997; Bresnahan et al, 2000; Bresnahan & Shenk, 2000); see Section 1.6.5), 
is therefore inhibited, and this provides a clue to the mechanism of latency control at the 
level of repression of lytic transcription. Additional regulators of the establishment and 
maintenance of latency are suggested to be the gene product of UL138 gene (Goodrum et 
al, 2007) and a number of miRNAs that can target viral genes required in the lytic cycle of 
replication (Stern-Ginossar et al, 2009).  
 
Reactivation of HCMV from latency does not require viral transactivators and therefore 
may be dependent on certain cellular stimuli. Thus, cellular stress is thought to take part in 
this process via recruiting cytokines and other pro-inflammatory factors to the sites of 
reactivation. At the level of molecular changes, reactivation is associated with stress-
induced changes of histone modifications around the MIEP making it permissive for 
activation of IE transcription (Reeves & Sinclair, 2008).    40
1.5  Viral genomes and ND10 during the initial stages of 
infection 
A characteristic of many DNA viruses is the association of their genomes with distinct 
nuclear dot-like substructures known as ND10, followed by their subsequent disruption 
(reviewed in Everett, 2001; Everett, 2006; Maul, 1998). In the case of HSV-1 and HCMV 
this disruption is caused by viral regulatory proteins: HSV-1 ICP0, and HCMV pp71 and 
IE1. The presence of intact ND10 however is not required for initiation of lytic gene 
expression in herpesviruses since removal of the major protein component promyelocytic 
leukaemia (PML) protein permits more efficient replication of HSV-1 and HCMV in the 
absence of their transcriptional activators (ICP0 and IE1, respectively) (Everett et al, 2006; 
Tavalai et al, 2006). Since the discovery of this phenomenon, extensive investigations have 
been undertaken in order to investigate the relationships between viral DNA, the viral 
regulatory proteins and the individual components of ND10.  
 
1.5.1  ND10 and their components 
The nucleus is a highly organised cellular organelle, bounded by a nuclear envelope. A 
number of subnuclear compartments are distinguished, amongst which are the nucleolus, 
which is the site of ribosomal RNA (rRNA) synthesis, rRNA processing and assembly of 
ribosomal subunits, dynamic Cajal bodies comprising pre-mRNA splicing factors and 
ND10 (Nuclear Domain 10; also widely referred to as PML nuclear bodies) (reviewed in 
Spector, 2001). ND10 have been identified as distinct multiprotein domains present in a 
small number (around 10 per cell in human fibroblasts) within the nuclei of different cell 
types (Ascoli & Maul, 1991; Maul & Everett, 1994). Despite initially being detected using 
autoimmune sera from patients with biliary cirrhosis (directed against, amongst other 
proteins, the Sp100 antigen, see later; (Ascoli & Maul, 1991), the most prominent and the 
major organising component of ND10 was later demonstrated to be PML (for 
promyelocytic leukaemia; (Daniel et al, 1993). Amongst the different ND10 components 
present with each single domain are proteins involved in apoptosis, DNA damage and 
repair, transcriptional repression/activation and protein modification. These proteins co-
exist in a dynamic protein-protein interaction relationship (reviewed in Negorev & Maul, 
2001). Specific attention to proteins particularly relevant to the present study is given 
below.    41
1.5.1.1 PML 
PML is so named because of it its implication in the pathogenesis of acute promyelocytic 
leukaemia (APL). Cells from APL patients are characterised by a gene fusion between 
PML and retinoic acid receptor α (RARα) loci as a result of a specific chromosomal 
translocation t(15;17). PML has been linked to roles in tumour suppression, apoptosis, 
transcriptional regulation and senescence (reviewed in Everett & Chelbi-Alix, 2007; 
Salomoni & Pandolfi, 2002; Zhong et al, 2000b). PML-null mice have an impaired 
activation of caspase-dependent signalling, demonstrating PML roles in caspase-dependent 
apoptosis. Other apoptotic pathways, including that of interferon (IFN)-dependent have 
also been implicated in PML function. Importantly, PML expression can be upregulated by 
interferon (IFN) (Chelbi-Alix et al, 1995; Heuser et al, 1998), classifying it as an IFN-
response gene (ISG, for IFN-stimulated gene). More than 100 identified proteins encoded 
by ISGs have roles in IFN-mediated signalling, including anti-tumour and anti-viral 
responses. These pathways are consistent with the roles of PML in these processes 
(reviewed in Regad & Chelbi-Alix, 2001).  
 
The PML gene is alternatively spliced from an ORF of 9 exons to yield six major nuclear 
isoforms and one cytoplamic isoform. Nuclear PML isoforms share the first exons 1-6 and 
differ in length and sequence across their C-terminal regions. They are expressed 
differentially, but all localise to ND10 (Condemine et al, 2006). However, when expressed 
separately none of the individual isoforms can fully reconstitute normal ND10 structures 
(Cuchet et al, 2010, in preparation). The important structural feature of all PML isoforms is 
the presence of the domain composed of a RING-finger, two B-boxes and a coiled coil 
domain (named RBCC motif) that is conserved amongst a large family of Tripartite Motif 
(TRIM) proteins (reviewed in Everett & Chelbi-Alix, 2007). TRIM proteins have a variety 
of cellular functions involved in signalling pathways and in anti-viral intrinsic immune 
responses (reviewed in Nisole et al, 2005).  
 
PML is posttranslationally modified by members of the small ubiquitin modifier (SUMO)-
protein family (Sternsdorf et al, 1997). This modification is important for the regulation of 
its functions, protein-protein interactions and transcriptional repression. Strong evidence 
regarding the roles of SUMO-modified PML in cellular anti-viral defence has been 
demonstrated by several studies (Everett & Maul, 1994; Everett et al, 2008; Everett et al, 
2006; Kyratsous & Silverstein, 2009; Tavalai et al, 2006).  
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1.5.1.2 Sp100 
Sp100 was the first marker of ND10 to be identified as the antigen recognised by sera 
extracted from patients with primary billiary cirrhosis (Ascoli & Maul, 1991; Fusconi et al, 
1991). The Sp100 gene is alternatively spliced to yield four isoforms. Two isoforms of less 
than 500 aa in length and the two higher molecular weight isoforms have been identified 
(Guldner et al, 1999). The major Sp100 isoform is 488 aa in length is also post-
translationally modified by SUMO-1. The longest isoform referred to as Sp100-HMG (for 
high mobility group) contains a conserved HMG domain involved in DNA binding 
(Sternsdorf et al, 1997). Discovery of its interaction with HP1 proteins has provided a 
further insight into a dynamic link between ND10 and the chromatin compartment of the 
nucleus (Seeler et al, 1998).  
 
1.5.1.3 SUMO family proteins 
SUMO (for small-ubiquitin modifier) is a class of small protein molecules, which provide 
post-translational modification of various proteins by covalent linkage to lysine residues in 
their specific consensus modification sites. Consensus sites are defined as ΨKXE where 
Ψ is a large hydrophobic amino acid (isoleucine, leucine or valine), K is the lysine residue 
that is modified; X is any residue and E is a glutamic acid (Rodriguez et al, 2001). SUMO 
family proteins in vertebrates are encoded by three genes SUMO-1, -2 and -3. 
Modification of proteins by SUMO-molecules involves a three-step SUMO-conjugation 
pathway. In brief, the pathway starts with a SUMO-activating enzyme E1, which activates 
the SUMO C-terminus in an ATP-dependent manner and then transfers activated SUMO to 
a SUMO-conjugating enzyme E2, called Ubc9. SUMO is then transferred from Ubc9 to 
the substrate in a process, often enhanced by a SUMO E3 ligase, to form a covalent 
isopeptide linkage to the lysine side chain in the consensus sequence. SUMO-modification 
of different proteins can determine their fate and functions. Thus, it is becoming 
increasingly recognised that SUMO-modification of transcription factors attracts binding 
of transcriptional co-factors via a specific interaction between SUMO and SUMO-
interaction motifs (SIMs) of these proteins (reviewed in Hay, 2005; Johnson, 2004). 
Consensus SIM sequences are defined as V/I-X-V/I-V/I, and are present in nearly all 
proteins involved in SUMO-related processes (Song et al, 2004). Both major ND10 
components PML and Sp100 are modified by SUMO-1 (Sternsdorf et al, 1997). SUMO-
modification of PML is responsible for sequestering several proteins to ND10, including 
CBP and hDaxx (LaMorte et al, 1998; Lin et al, 2006; Zhong et al, 2000a). Recent 
evidence has also demonstrated that modification of PML by SUMO-2 can result in   43
degradation of PML by E3 ubiquitin ligase RNF4 under certain conditions (Tatham et al, 
2008). These reports represent the importance of SUMO-modification for proper 
functioning and organisation of ND10 proteins.  
 
1.5.1.4 ATRX and hDaxx 
The two ND10-localised proteins named ATRX and hDaxx interact to form a chromatin-
remodelling complex that is found localised to ND10 and heterochromatin. Despite the fact 
that no specific target genes of the complex have yet been identified, evidence invokes 
hDaxx as the targeting component and ATRX as the chromatin-remodelling component 
(Ishov et al, 2004; Tang et al, 2004; Xue et al, 2003). Due to the direct relevance of these 
two proteins to the present investigation their structures and cellular roles will be discussed 
in more detail in Section 1.8.  
 
1.5.1.5 Other ND10-localised proteins 
Various additional ND10-associated proteins have been also characterised. Amongst them 
is NDP55, which has been used as an ND10 marker for a number of studies in normal and 
infected cells (Bell et al, 2000; Doucas et al, 1996; Ishov et al, 1999). Other proteins that 
stably localise to ND10 include BLM (Bloom’s syndrome protein; (Bischof et al, 2001), 
which is a helicase involved in DNA recombination and repair. Some proteins are thought 
to be present at ND10 at certain stages of the cell cycle (e.g. HP1), accumulate in response 
to proteasome inhibition (e.g. p53), or when overexpressed (reviewed in Negorev & Maul, 
2001).  
 
1.5.2  Association of viral DNA and sites of Immediate Early 
transcription with ND10 
1.5.2.1 HSV-1 and HCMV DNA at ND10  
One of the earliest indications that herpesvirus genomes may be associated with ND10 
came from the observations that ND10 are disrupted during HSV-1 infection due to the 
function of HSV-1 IE protein ICP0 to cause removal of the major ND10 constituent from 
ND10 (Everett & Maul, 1994; Maul et al, 1993). Indeed, HSV-1 parental genomes were 
found juxtaposed to ND10 foci, indicating that ND10 can mark sites of initiation of DNA 
replication (Maul et al, 1996). Analysis of the HCMV infection has revealed that a similar 
scenario applies to HCMV infected cells, characterised by the co-localisation with PML of   44
the major IE protein (IE1) very early after the onset of infection, followed by subsequent 
disruption of these structures (Ahn et al, 1998; Ahn & Hayward, 1997; Ahn & Hayward, 
2000; Kelly et al, 1995; Korioth et al, 1996). In addition, the HCMV tegument protein 
pp71, which is delivered to the nucleus with the incoming genomes, associates with ND10 
by interacting with hDaxx (Cantrell & Bresnahan, 2005; Ishov et al, 2002). Thus, similarly 
for both HSV-1 and HCMV, one of the earliest outcomes of infection in the host cell 
nucleus is the disintegration of ND10 structures. This phenomenon correlates with HSV-1 
and HCMV functions to abolish SUMO-modification of PML and Sp100 (Everett et al, 
1998a; Lee et al, 2004; Muller & Dejean, 1999; Parkinson & Everett, 2000). This issue is 
also addressed in Chapters 4 and 5.   
 
A unique phenomenon, so far reported only for HSV-1, is the asymmetric re-distribution of 
ND10 proteins into novel ND10-like foci associated with the incoming viral genomes in 
cells at the edge of developing plaques (Everett & Murray, 2005). This event has not yet 
been reported for HCMV infected cells, which may indicate differences in the dynamics of 
initiation of lytic gene expression and in the rapidity of the cellular intrinsic response, 
hence it may also be more difficult to observe in HCMV plaques. In HCMV infection, as 
the viral genomes are released into the cell nucleus, IE gene products induce the formation 
of so-called Immediate Early transcript environment. This is characterised by the presence 
of HCMV major IE transcripts, the viral proteins IE1 and IE2, and the host cell SC35 
domains, which are the sites of splicesome factor SC35 localisation. It has been established 
that HCMV DNA associates first with ND10 at the sites where ND10 are found juxtaposed 
to SC35 domains. Nascent IE transcripts and proteins localise to SC35 domains where 
HCMV IE transcription continues (Ishov et al, 1997).  
 
1.5.2.2 Relationships of other viruses with ND10 
In addition to the current viruses of study HSV-1 and HCMV, the genomes of other herpes 
and DNA viruses have been implicated in associating with ND10. In VZV infected cells, 
for example, PML re-distributes upon the expression of its ICP0 homologue ORF61p. 
Although PML is not degraded, knock-down of PML expression in cells results in a 
substantial increase of VZV replication (Kyratsous & Silverstein, 2009). During the 
infection with the gammaherpesvirus EBV, ND10 are disrupted by the actions of EBV IE 
gene product BZLF1 (Adamson & Kenney, 2001). This process occurs sequentially, such 
that Sp100, hDaxx and NDP55 (another ND10 marker protein) are dispersed first followed 
by a delayed dispersal of PML. Unlike in HSV-1 and HCMV, however, complete   45
disintegration of ND10 was not observed until the initiation of Early gene expression (Bell 
et al, 2000). Adenoviral protein E4ORF3 is also capable of ND10 disruption (Carvalho et 
al, 1995). Similarly, in the case of adenovirus, redistribution of Sp100 and NDP55 is seen 
first, before any effect on PML (Doucas et al, 1996). These data indicate that complete 
disintegration of ND10 is not a pre-requisite for initiation of gene expression in some of 
these viruses, where association with ND10 is observed. In addition, PML has been 
demonstrated to act as a restriction factor in vesicular stomatitis virus (VSV) and influenza 
virus infections (Chelbi-Alix et al, 1998), which is indicative of ND10 functions targeted 
against RNA viruses.  
 
Association between viral DNA and ND10 have sparked substantial interest in their roles 
as domains with anti-viral properties in an attempt to explain the mechanism, reasons and 
consequences of this association. A separate section (1.9.2) of this Chapter and Chapters 4 
and 5 (4.1 and 5.1 respectively) are specifically dedicated to the discussion of these aspects. 
 
1.6  Immediate Early gene expression  
Transcription of viral genes initiates following the release of viral DNA into the cell 
nucleus. As mentioned earlier in the Chapter (Section 1.4.1.2) Immediate Early genes are 
the first genes to be transcribed. The products of the IE genes play essential roles in the 
regulation of Early and Late genes, and hence viral particle formation and replication. The 
processes associated with the regulation of IE gene expression have therefore received 
extensive attention in herpesvirus research.  
 
1.6.1  Regulation of HSV-1 Immediate Early gene expression 
Since IE genes do not require de novo protein synthesis for expression, their regulation 
must involve activation of IE promoters by pre-existing factors. In HSV-1 such control is 
provided by the complex formed between viral tegument factor VP16, and host cell 
proteins Oct-1 and HCF (reviewed in Weir, 2001). The mechanism of regulation by VP16-
Oct-1-HCF complex is not entirely understood. Existing data suggests that HCF assists 
nuclear import of VP16, since VP16 itself does not contain a nuclear localisation signal 
(La Boissiere et al, 1999). It is also thought that HCF bound to VP16 induces a 
conformational change allowing binding of Oct-1, and therefore serves as auxiliary protein 
for the activation of transcription by VP16 and Oct-1 (Flint & Shenk, 1997). Mutational   46
analysis of VP16 has revealed that specific mutations in VP16 that abolish interactions 
with Oct-1 and HCF lead to severe impairment of the ability of VP16 to stimulate IE gene 
expression and leads to establishment of quiescent genomes in cell culture (Ace et al, 1989; 
Greaves & O'Hare, 1990). The DNA binding by Oct-1/VP16 is sequence specific and 
targets TAATGARAT sequences within the IE promoters. The hallmark of the Oct-1/VP16 
specific finding to TAATGARAT sequence involves the POU domain of Oct-1 and the 
VP16 N terminus. The C terminus of VP16 possesses an acidic activation domain, which 
confers its ability to stimulate transcription and is proposed to bind to transcription 
initiation factors (Flint & Shenk, 1997). VP16-Oct-1-HCF binding to consensus sequences 
on HSV-1 IE promoters triggers the cascade of IE gene expression. 
 
1.6.2  HSV-1 Immediate Early proteins 
Of the five IE proteins, two (ICP4 and ICP27) are essential for viral replication, while 
ICP22 and ICP0 play critical roles in the regulation of HSV gene expression, and the fifth 
member ICP47 is a virulence factor (Weir, 2001; Whitley et al, 1998). ICP0 is an IE 
protein of a particular relevance to the present investigation and is a promiscuous activator 
of the expression of all the classes of viral genes, which will be discussed in more detail 
later due to its direct relevance to the present investigation (see Section 1.6.3).  
 
1.6.2.1 ICP4 
ICP4 is the product of the gene RS1, which encodes a phosphoprotein of about 175 kDa. 
The protein has been shown to be essential for the transcriptional activation of the Early 
and Late classes of viral genes, using ICP4 temperature sensitive mutant tsK (Watson & 
Clements, 1980). Activation of transcription is allowed by the ability of ICP4 to bind 
directly to the specific sequences on IE, Early and Late promoter sites (Kuddus & DeLuca, 
2007; Sampath & Deluca, 2008), as well as to associate with the proteins of the host 
transcription machinery such as TFIID and TATA-binding proteins (Smith et al, 1993). 
ICP4 has also been found to repress VP16-mediated activation of IE promoters in certain 
assays (Gu et al, 1995).  
1.6.2.2 ICP27 
ICP27 is another essential protein in viral replication, and is 63 kDa in size. Functions 
assigned to ICP27 include inhibition of pre-mRNA splicing, and regulation of viral 
nucleocytoplamic RNA transport during Early and Late gene expression. Therefore its 
principal roles are through post-transcriptional mechanisms (reviewed in Smith et al, 2005).    47
Thus, ICP27 contributes to the regulation of Late gene expression by facilitating the export 
of late RNAs (Soliman et al, 1997). Inhibition of host mRNA splicing by ICP27 has been 
shown to contribute to viral-induced host cell shutoff resulting in the block of cellular 
protein expression (Hardwicke & Sandri-Goldin, 1994).  
1.6.2.3 ICP22 
ICP22, although non-essential for viral replication in many cell types, is required for the 
normal transcriptional programme and has a role in gene expression by negatively 
regulating the expression of IE genes thus avoiding their over-production. It is 
phosphorylated by viral kinase UL13, which is proposed to contribute to ICP22-mediated 
modification of the cellular RNA polymerase II (Long et al, 1999; Rice et al, 1995).  
1.6.2.4 ICP47 
The fifth member of IE gene products,  ICP47, contributes to the mechanism of 
neurovirulence of HSV-1 by inhibiting presentation of peptides derived from viral antigens 
on the cell surface, hence blocking T cell responses. Therefore ICP47 constitutes a 
component of immune evasion mechanism of HSV-1 (Goldsmith et al, 1998). 
 
1.6.3  Immediate Early protein ICP0 
ICP0 is one of the most studied HSV-1 proteins, and despite being a non-essential gene for 
replication in cell culture, it induces dramatic effects on the cell during the infection. 
Because of its central role in determining the fate of the virus, i.e. whether the infection 
would proceed as lytic or latent, ICP0 has received a lot of attention from various research 
groups.  
 
1.6.3.1 Overview of the gene and protein structure   
ICP0 protein is encoded by the IE-1 (or α0) gene within the TRL/IRL region of the genome, 
meaning that the gene is present in two copies. The primary transcript contains introns and 
therefore the IE-1 transcript is one of the few of HSV-1 that undergo splicing. The ICP0 
polypeptide is composed of 775 aa (in strain 17 syn+), and has a predicted molecular 
weight of 80 kDa (Perry et al, 1986). Since on polyacrylamide gels it migrates as a band 
corresponding to the size of approximately 110 kDa, in earlier work it has also been widely 
referred to as Vmw110. Although a small amount of the protein is carried within the tegument of the virion and is capsid-associated (Yao & Courtney, 1992), the functions of 
the protein are conferred by the newly synthesised protein.  
 
ICP0 functions have been extensively studied via mutational analysis of the protein, and at 
least five functional domains required for its full transcriptional activation potential have 
been identified (Everett, 1987; Everett, 1988). These domains have now been mapped and 
defined as the following (Figure 1.4): (a) RING finger domain that confers its E3 ligase 
activity; (b) a nuclear localisation signal; (c) a USP7-interaction domain; (d) a region 
required for localisation to ND10; (e) multimerization domain (reviewed in Everett, 2006).   
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Figure 1.4 A schematic diagram showing ICP0 protein structure  
The key structural domains and phosphorylation sites are indicated (adapted from Everett, 2006). 
 
1.6.3.2 Transcriptional activation by ICP0 
One of the earliest indications that ICP0 is essential for HSV-1 full transcriptional 
activation potential was the discovery that ICP0 activates rabbit β-globin promoter and 
enhances transcription activity of ICP4 to a considerable extent in co-transfection assays 
(Everett, 1984). Subsequent studies of various ICP0 mutants have concluded that the 
transcriptional activation activity of ICP0 for viral promoters is associated primarily with 
the N-terminal half of the polypeptide (Cai & Schaffer, 1989; Everett, 1987; Everett, 1988; 
Perry et al, 1986). A specific deletion of the 2 kb region within this region has yielded an 
ICP0-null HSV-1 strain dl1403 unable to express functional ICP0 (Stow & Stow, 1986). 
Despite being a promiscuous activator of gene expression, ICP0 does not directly interact 
with viral DNA (Everett et al, 1993a). This discovery was somewhat unexpected since 
ICP0 was originally thought to contain a zinc finger motif, classes of which are known to 
be involved in DNA binding. Instead, this motif has been identified as RING finger 
domain with E3 ubiquitin ligase activity (Barlow et al, 1994; Boutell et al, 2002; Everett et 
al, 1993a). The RING domain and its enzymatic activity are essential for ICP0 functions as 
a transcriptional regulator. Therefore this domain is discussed in more detail below.   
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1.6.3.3 ICP0 and E3 ubiquitin ligase function 
The ability of ICP0 to degrade cellular proteins has been exclusively assigned to the 
presence of the N-terminal RING finger motif, which is involved in its E3 ubiquitin ligase 
activity (Boutell et al, 2002). Various RING finger-containing proteins with E3 activity 
have also been implicated in diverse cellular functions and processes, such as cell cycle, 
signalling, transcription, DNA repair and apoptosis (Joazeiro & Weissman, 2000), which 
may indicate the potential range of ICP0 cellular functions during the infection that are yet 
to be identified.  
 
In brief, the pathway of proteasomal ubiquitin-dependent degradation is the step-wise 
process of addition of ubiquitin molecule to the substrates, and consists of three very well 
defined steps:  
(1) Activation of monomeric ubiquitin in ATP-dependent reaction involving the formation 
of a high energy covalent thiolester bond between the C-terminal carboxy group of 
ubiquitin and the active site cysteine residue in the E1 activating enzyme; 
(2) Transfer of the ubiquitin to another thiolester bond with the active site cysteine of an 
E2 ubiquitin conjugating enzyme; 
(3) E3 ubiquitin ligase mediated transfer of the ubiquitin to form an isopeptide bond with 
the lysine side chains in the target molecule; 
Addition of more than 4 ubiquitin monomers in a polyubiquitin chain to a substrates results 
in the substrate recognition by the 26S proteasome and degradation. The polyubiquitin 
chains are then removed and ubiquitin monomers are re-generated by ubiquitin-specific 
proteases (USP) (Hershko & Ciechanover, 1998).  
 
The functionality of the RING-finger domain of ICP0 is crucial for its functions, since 
ICP0 RING-finger mutants are unable to complement ICP0-deletion mutants in plaque 
assays (Everett et al, 2009).  Based on several reports, the RING finger has been shown to 
be required for ICP0-mediated transcriptional activation function and efficient viral 
replication (Everett et al, 1995) and to confer ICP0 functions in degrading PML and Sp100, 
(Chelbi-Alix et al, 1998; Everett et al, 1998a; Parkinson & Everett, 2000), centromeric 
proteins CENP-A, -B and -C (Everett et al, 1999a; Everett et al, 1999b; Lomonte & 
Morency, 2007; Lomonte et al, 2001) and proteins involved in DNA damage response 
(Lilley et al, 2009). Identification of the role of RING finger motifs associated with E3 
ubiquitin ligase activities therefore led to the hypothesis that ICP0 may function through 
the cellular ubiquitin proteasome pathway during infection (Everett et al, 1998b). This 
prediction has proven to be correct following observations that the degradation of the   50
above mentioned proteins during HSV-1 infection occurs in a proteasome-dependent 
manner, since the use of ICP0ΔRING mutant virus or the addition of the inhibitor MG132 
(synthetic proteasome inhibitor) blocks this activity (Boutell et al, 2003; Boutell et al, 
2002). In addition, the RING finger function of ICP0 has also been shown to be required 
for ICP0 incorporation into the virion (Delboy et al, 2010). 
 
The E3 ligase function of ICP0 suggests that ICP0 is capable of inducing its own 
degradation, and therefore in order to avoid it there must be a mechanism by which ICP0 
stabilises itself. This property has been assigned to the ability of ICP0 to interact with 
USP7 (also termed HAUSP in some reports for herpes-associated USP). The strong 
interaction has been confirmed by in vitro assays as well as in infected cells, and is 
suggested to play a key role in stabilization of ICP0 (Boutell et al, 2003; Canning et al, 
2004). In cells infected with ICP0 USP7-interaction deficient mutant virus, notable 
decreases in plaque formation efficiencies and the abilities to efficiently degrade PML and 
Sp100 have been reported (Canning et al, 2004; Everett et al, 1999c), probably because the 
mutant ICP0 is unstable and accumulates to lower levels.  
 
1.6.3.4 ICP0 and association with ND10 
As soon as ICP0 becomes detected in the nuclei of the infected cells, it localises to ND10 
(Maul et al, 1993). This association is transient and is followed by rapid disintegration of 
ND10 due to PML being degraded by the E3 ligase activity of ICP0 (Boutell et al, 2003; 
Chelbi-Alix & de The, 1999; Everett et al, 1998a; Parkinson & Everett, 2000). Localisation 
of ICP0 to ND10 does not require its RING-finger domain (Everett & Maul, 1994; Everett 
et al, 2009; Maul & Everett, 1994). Therefore, based on the analyses of RING-finger 
mutants, it appears that the localisation of ICP0 to ND10 is not a pre-requisite for the 
efficient replication of the virus but is highly dependent on its RING finger function (see 
above). 
 
1.6.3.5 ICP0-null mutant phenotype 
In order to study the ICP0 function, various ICP0-mutants of HSV-1 have been generated 
and extensively characterised (Cai & Schaffer, 1989; Chen & Silverstein, 1992; Everett, 
1988; Everett et al, 2004; Sacks & Schaffer, 1987; Stow & Stow, 1986).  The ICP0-null 
mutant dl1403, containing a 2 kb deletion in both copies of the gene within terminal and 
internal repeats (Stow & Stow, 1986), has been used extensively for the present 
investigation (Chapter 5). Interpreting the phenotype of an ICP0-null mutant HSV-1 is not   51
very straightforward, and a number of its features have to be considered when using in 
experimentation.  
 
The first is the multiplicity-dependent phenotype of ICP0-null mutant HSV-1. Strain 
dl1403 has an approximately 1000-fold defect in plaque formation efficiency in human 
fibroblasts, and the viral genomes are sequestered in a quiescent state (Stow & Stow, 1989; 
Stow & Stow, 1986).  However, in the osteosarcoma cell line U2OS, dl1403 is as efficient 
in replication as a wt HSV-1, suggesting that U2OS cells either encode for an activity that 
substitutes for ICP0, or that they lack a cellular mechanism of repression, which is 
counteracted by HSV-1 ICP0 (Yao & Schaffer, 1995). In other cell lines such as Vero and 
HeLa the differences in the infection efficiencies of ICP0-null and wt HSV-1 are relatively 
minor, however these become more pronounced as lower multiplicities of ICP0-null 
mutant virus are used (Chen & Silverstein, 1992; Everett et al, 2004). As MOI of ICP0-null 
mutant virus increases, however, a certain threshold is reached allowing the virus to 
replicate in restrictive cell lines as efficiently as wt HSV-1. For dl1403 infections this 
threshold MOI ranges between 5 and 10 in fibroblasts depending on the viral stock. This 
observation has become a key in the subsequent attempts to characterise ICP0-null mutants 
(Everett et al, 2004).  
 
Linking with the multiplicity-dependence of ICP0-null HSV-1, the second distinguished 
property of this mutant strain is the probability of establishing lytic infection, or what is 
often referred to as the ‘probability phenotype’ (Everett, 2000). Unlike for the wt HSV-1 
virus, in ICP0-null mutant infections the relationship between the number of plaques 
obtained from a given number of viral particles applied to a cell monolayer is not linear. 
This ratio is referred to as the particle to plaque forming unit (PFU) ratio. Whereas in wt 
infections this ratio is around 20-50, depending on the viral stock and the cell line, for 
ICP0-null mutant strains it is highly variable depending on the cell type. Thus, HFFF 
human fibroblasts are restrictive to ICP0-null virus, and it takes up to 1000 times the 
number of ICP0-null particles to produce approximately the same number of PFU as in a 
wild-type virus infection. This defect however is not observed in U2OS cells (Everett et al, 
2004; Yao & Schaffer, 1995), which is the reason why they are widely used for titration of 
wt and ICP0-null mutant stocks. Supplying ICP0 to dl1403-infected restrictive cell lines, 
using an ICP0-inducible system, fully complements ICP0-null mutant dl1403 (Everett et al, 
2009). Thus, the ‘probability phenotype’ of ICP0-null mutant HSV-1 is considered to be a 
measure of probability that a cell receiving a potentially infectious virus particle will 
commit to lytic infection (reviewed in Everett, 2000). It still however remains unclear why   52
upon infection with ICP0-null virus certain cells have a higher probability of establishing 
quiescent infection and some cells manage to initiate lytic replication, hence resulting in 
plaque formation virtually as efficient as that of the wt virus.  
 
1.6.3.6 ICP0 in reactivation from latency 
The data regarding the requirement of ICP0 during reactivation from latency is somewhat 
controversial. Reactivation of ICP0-null mutant or deletion strains from the infected mouse 
neurons is considerably less efficient than that of wt virus (Halford & Schaffer, 2001; 
Thompson & Sawtell, 2006). On the other hand, supplying ICP0 to the cultured infected 
TG mouse neurons in which quiescent genomes have been established, using viruses 
deficient for IE gene expression (Samaniego et al, 1998), results in active replication of 
viral genomes, suggesting the requirement for ICP0 in reactivation (Terry-Allison et al, 
2007). Other studies have confirmed this conclusion using other quiescently infected 
restrictive cell lines of neuronal and fibroblast origin. The efficiency of reactivation is 
dependent on ICP0 RING finger activity (Wilcox et al, 1997).  
 
Although ICP0 transcripts were detected in latently infected mouse neurons extracted from 
different neuronal sites of latency (Maillet et al, 2006; Thompson & Sawtell, 2006), the 
mechanism of ICP0 action in this process has not been identified. Induction of 
hypothermic stress in the latently infected mouse neurons activates splicing of ICP0 
transcripts, which implicates ICP0 function in the efficient reactivation from latency. On 
the other hand however, it became clear that ICP0 was not required for initiation of 
reactivation (at least in terms of detection of viral antigens), hence implicating stress as an 
important factor (Thompson & Sawtell, 2006). Consistent evidence from a number of 
studies suggests that although ICP0 may increase the titres of reactivated virus, it is not 
absolutely necessary for reactivation under the conditions of stress (Bringhurst & Schaffer, 
2006). Accordingly, the use of quiescent infection models in cell culture has also identified 
different stress factors which are sufficient for reactivation of the quiescent HSV-1 
genomes (Preston & Nicholl, 2008). It may therefore be concluded that despite the strong 
evidence supporting the role of ICP0 in reactivation from latency, the different models of 
study may affect the extent to which ICP0 is required for this process. Hence, the precise 
function of ICP0 during the process of reactivation from latency still remains to be 
established.  1.6.4  Regulation of HCMV Immediate Early gene expression  
Regulation of IE gene expression in HCMV relies on the strong promoter/enhancer 
element named the major immediate early promoter (MIEP; see Figure 1.5 for the basic 
outline of the regulation). MIEP serves as a binding site for various cellular transcription 
factors, for which sequence specific binding elements have been identified. Nuclear factor 
kappa-B (NF-kB) and cAMP response element binding (CREB)/activating transcription 
factor 1, for instance, are amongst the cellular transcription factors required for the 
activation of MIEP, and the binding sites for these proteins are conserved in the MIEPs of 
CMVs of other species (reviewed in Stinski & Isomura, 2008). As discussed in more detail 
in the following section, viral tegument protein pp71 (Liu & Stinski, 1992) and major IE 
proteins (Cherrington et al, 1991; Cherrington & Mocarski, 1989; Hermiston et al, 1990) 
play central roles in the MIEP-regulated transcription.  
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Figure 1.5 Overview of the regulation of HCMV Immediate Early transcription 
The key elements required for activation of IE transcription are shown. HCMV tegument protein 
pp71 is required for efficient stimulation of IE transcription through its ability to counteract hDaxx 
mediated repression (see below). IE1 and IE2 result from alternative splicing of the major IE 
transcript. Once expressed, IE proteins IE1 and IE2 induce expression from MIEP positively and 
negatively, respectively.  
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1.6.5  HCMV tegument protein pp71 
Pp71 is the product of the gene UL82 that codes for a 71 kDa phosphoprotein. The protein 
is an abundant component of viral tegument and is expressed with Early-Late kinetics.  It is 
delivered to the nucleus of the infected cell during the initial stages of infection. In latently 
infected cells, however, pp71 remains in the cytoplasm (reviewed in Kalejta, 2008b).  
 
1.6.5.1 Transcriptional activation by pp71 
One of the early reports on the function of pp71 in increasing the infectivity of HCMV was 
based on transfection-based assays of co-transfected HCMV DNA and plasmids encoding 
for different tegument proteins. A dramatic increase of around 200-fold in DNA replication 
was detected in cells transfected with pp71-expressing plasmid, compared to control or any 
other tegument-protein expressing plasmid (Baldick et al, 1997). Construction of an UL82 
deletion mutant of HCMV (ADSubUL82) further confirmed the high requirement for pp71 
for the activation of productive infection by HCMV. According to these studies, inability 
to express pp71 results in failure to initiate productive infection in restrictive cell lines. 
Therefore, pp71-null mutant virus can be efficiently propagated on complementing cells, 
such as life-extended fibroblasts expressing a catalytic subunit of telomerase and the UL82 
gene (Bresnahan et al, 2000; Bresnahan & Shenk, 2000). In addition, pp71 is able to 
induce expression from HSV-1 promoters and partially substitute for the lack of ICP0 
(Homer et al, 1999; Marshall et al, 2002).  
 
1.6.5.2 Interaction with the cellular ND10 protein hDaxx 
A particularly intriguing property of pp71 that has been extensively studied and presents 
significant relevance to the current line of investigation is its ability to associate with the 
cellular transcriptional repressor hDaxx (Section 1.8.2). This interaction will also be 
addressed in more detail in the introductory part to Chapter 4 (Section 4.1). In infected 
cells pp71 localises to ND10, where it interacts with hDaxx and induces its degradation 
(Cantrell & Bresnahan, 2005; Hofmann et al, 2002; Hwang & Kalejta, 2007; Ishov et al, 
2002; Saffert & Kalejta, 2006). Interaction between hDaxx and pp71 was initially detected 
by two independent groups, one using transient overexpression methods and yeast-two-
hybrid screens (Hofmann et al, 2002), and the other using HCMV-infected cells (Cantrell 
& Bresnahan, 2005). The pp71-interaction domain of hDaxx, however, is still an issue of 
controversy. Hofmann et al work delineated the two regions of pp71-interaction within 
hDaxx, the first of which (aa 439-501) has yielded positive interactions in both yeast-two-  55
hybrid and CoIP assays, while the second of weaker strength was only revealed in CoIP 
assays of transfected cell lysates and mapped a larger region between aa 43 and 371 
(Hofmann et al, 2002).  Yet another group did not detect an interaction between the C-
terminal part of hDaxx and pp71, and mapped the pp71-interacting region of hDaxx to aa 
142-290 (Ishov et al, 2002), indicating that this may be the region responsible for the N-
terminal interaction detected by Hofmann et al (2002). The domains of pp71 required for 
hDaxx binding have been mapped to two short aa stretches between pp71 aa 206-213 and 
324-331 (Hofmann et al, 2002). Mutant viruses with lesions in these regions are unable to 
efficiently stimulate viral gene expression, an effect observed at low MOIs (Cantrell & 
Bresnahan, 2005). These findings have triggered further research into the functional 
significance of the pp71-hDaxx interaction for the progression of infection.  
 
Depletion of hDaxx via RNA interference improves replication efficiency of wt virus 
(Tavalai et al, 2008; Woodhall et al, 2006). Conversely, hDaxx overexpression or hDaxx 
stabilization by treatment with lactacystin of the cells results in repression of HCMV 
infectivity (Saffert & Kalejta, 2006; Woodhall et al, 2006). These data correlate with the 
requirement of pp71-hDaxx interaction for the efficient initiation of IE gene expression. 
Interestingly, depletion of hDaxx supports an even further increase in IE gene expression 
and replication of pp71-null mutant HCMV, as noted by several groups (Preston & Nicholl, 
2006; Saffert & Kalejta, 2006; Saffert & Kalejta, 2007; Tavalai et al, 2008). Pp71-
mediated proteasomal degradation of hDaxx during wt HCMV infection may explain the 
increased efficiency of pp71-null mutant virus in the absence of hDaxx (Hwang & Kalejta, 
2007; Saffert & Kalejta, 2006).  These reports have identified hDaxx as a potent mediator 
of cellular anti-viral response to HCMV.  
1.6.5.3 Effects of pp71 on cell cycle proteins 
In addition to the effects on hDaxx, pp71 is able to induce proteasome-dependent 
ubiquitin-independent degradation of Rb family tumour suppressors, which are involved in 
the cell cycle arrest at G1, by directly binding to them (Kalejta et al, 2003; Kalejta & 
Shenk, 2003). This function of pp71 is proposed to be related to the ability of HCMV to 
induce the G1 to S phase transition during the cell cycle. However, the ability of pp71 to 
degrade Rb family proteins does not affect infectivity of the virus (Cantrell & Bresnahan, 
2005; Kalejta et al, 2003; Kalejta & Shenk, 2003), suggesting other viral components may 
be responsible for these functions. Indeed, it has been demonstrated that IE1 can bind and 
phosphorylate Rb family proteins (Poma et al, 1996), while IE2 drives quiescent G0 cells 
into the cell cycle (Castillo & Kowalik, 2002).    56
1.6.6  Immediate Early proteins IE1 and IE2 
1.6.6.1 Structure of the major IE transcript 
Activation of the MIEP by pp71 and cellular factors results in the initiation of transcription 
from the two adjacent genes, namely UL123/122. The first to be transcribed is the product 
of UL123, 1.95 kb mRNA in size and contains exons 1 through to 4 (Figure 1.5) which 
codes for the IE1 protein (also referred to as IE72 according to its molecular weight). Gene 
UL122 yields two transcripts as a result of alternative splicing. The first one is 2.25 kb in 
size and is composed of the first 3 exons shared with IE1 and an additional exon 5, as a 
result of alternative splicing from UL123/122 gene. The 2.25 kb mRNA encodes a 579 aa 
(82–86 kDa) nuclear protein, IE2 (also known as IE86). The second transcript of the 
UL122 gene, of 1.7 kb, encodes a 425 aa (55 kDa) protein, less well characterised in 
literature, known as IE55. IE55 is identical to IE86 except for a 154 aa deletion between 
residues aa 365 and 519 resulting from a splicing event within exon 5. As a result of 
alternative splicing, the three IE products share the same first N-terminal 85 aa of the 
sequence. IE1 and IE2 have received the most attention in research due to their key 
functions in HCMV lytic infection and their properties in the interaction with ND10 
proteins and induction of the cell cycle (reviewed in Castillo & Kowalik, 2002).  
 
1.6.6.2 Disruption of ND10 by IE1 
One of the earliest indications of ND10 disruption by HCMV has come from Kelly et al 
(1995) demonstrating complete dispersal of PML foci in cells infected with wt HCMV, 
which was observed in a high proportion of cells at the early hours post infection. This 
disruption requires the initiation of IE gene expression since UV-inactivated virus fails to 
perform this function (Kelly et al, 1995). With the initiation of IE1 production, other ND10 
proteins such as Sp100 and NDP52 also become dispersed (Korioth et al, 1996). IE2 is 
found juxtaposed to ND10 with the start of infection, consistent with the development of 
what has been termed the IE transcript environment (Ishov et al, 1997). The role in 
disruption of ND10, however, has been assigned to IE1, rather than IE2, based on transient 
transfection methods (Ahn & Hayward, 1997; Korioth et al, 1996) and studying IE1-
deletion HCMV mutants (Ahn et al, 1998). Attempts to map the domain of IE1 responsible 
for ND10 disruption have concluded that most of the protein sequence is required for 
efficient ND10 disruption, except for the C-terminal acidic domain (aa 347-491) (Ahn et al, 
1998; Wilkinson et al, 1998). The regions that are considered particularly important for 
this function, although not sufficient, were mapped to exons 2 and 3, which encode the 
putative leucine zipper and zinc-finger domains (Wilkinson et al, 1998). The function of   57
the IE1 acidic domain, on the other hand, is associated with binding to the transcriptional 
activator STAT2, a protein involved in IFN-signalling. Disruption of this interaction has 
been shown to be detrimental to virus growth (Huh et al, 2008). IE1-mediated disruption of 
ND10 correlates with the efficient initiation of viral replication. This has been concluded 
from analogous approaches to those used to study the role of hDaxx in the repression of 
HCMV genomes. Thus, targeted knock-down of PML and the use of IE1-deficient mutant 
virus have identified PML as a component of cellular anti-viral defence (Tavalai et al, 
2006). These issues will be addressed further in the Section “Intrinsic Immunity” and in 
Chapter 4 (4.1). 
 
The mechanism utilised by IE1 to disrupt ND10, although still not entirely clear, involves 
interaction with PML, as discovered using yeast-two-hybrid screens. The PML-interaction 
region of IE1 has been mapped aa 1-346 (Ahn et al, 1998). Unlike HSV-1 ICP0, IE1 does 
not cause degradation of PML, although it is capable of abrogating SUMO-modification of 
both PML and Sp100 (Lee et al, 2004; Muller & Dejean, 1999). These studies therefore 
suggest related pathways for inhibiting cell-mediated anti-viral response by the two 
different herpesvirus IE proteins, ICP0 and IE1, and implicate SUMO modification as an 
important factor in this process.  
 
1.7  Chromatin control of herpesvirus infection 
In addition to the control of herpesvirus infection by ND10 components, as discussed 
above, chromatin-associated mechanisms of regulation of viral infection have also received 
significant attention in research. It is generally considered that the cellular response to the 
intrusion of foreign DNA into the cell nucleus would involve the assembly of repressed 
chromatin structure. Hence, numerous studies have been conducted aimed to investigate 
the roles of chromatin modifications and the changes in chromatin dynamics during viral 
lytic and latent infection and reactivation from latency. Because of the dynamic nature of 
nuclear subcompartments, there is a constant exchange between ND10 proteins and 
chromatin. The chromatin-associated proteins that localise to ND10 are therefore of 
particular interest for the study of herpesvirus infection. Therefore, the following part of 
this Chapter is of special relevance to the present line of investigation. Before going into 
the discussion on the current understanding of the role chromatin state and the function of 
chromatin-associated proteins in viral infection, a few paragraphs must address the basic 
characteristics of chromatin organisation and regulation within the cell.  
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1.7.1  Chromatin organisation and structure 
1.7.1.1 The nucleosome: The structural unit of chromatin 
Chromatin constitutes a sub-nuclear compartment. So-called chromosome territories are 
occupied by individual chromosomes and they include transcriptionally inactive condensed 
heterochromatin or less condensed transcriptionally active euchromatin (Lamond & 
Sleeman, 2003). The structural subunit of chromatin is the nucleosome. A single 
nucleosome consists of four types of histone molecules – H2A, H2B, H3 and H4, 
represented as dimers within each nucleosome, with approximately two turns of DNA 
wrapped around the octameric core (Figure 1.6). Nucleosomes are spaced at intervals of 
about 200 base pairs in higher eukaryotes along chromosomal DNA. In addition to the core 
histones, linker histones H1 are associated with the exterior of nucleosomes and are 
important for stabilization of the highly condensed state of chromatin fibres (Hayes & 
Hansen, 2001). The amino termini of the core histones protrude outside the nucleosomal 
core and are post-translationally modified by acetylation, methylation and phosphorylation. 
Thus, active transcription is generally associated with a higher load of acetylated histones, 
whereas the histones of heterochromatin are mostly methylated and hypoacetylated (Figure 
1.6). Exceptions include methylated H3K4 (lysine residue 4 of histone H3), which is a 
marker of active transcription, and acetylated H3K12, a marker of transcriptional silencing 
(Grant, 2001). 
 
1.7.1.2 Chromatin regulation by histone acetylation, deacetylation and methylation 
Histone acetylation or methylation at ε-amino groups of lysine side chains determines the 
status of transcriptional activity. The most abundant and conserved sites targeted for 
acetylation/deacetylation are the lysine residues of histones H3 (K9, -14, 18 and 23) and 
H4 (H4K5, -8, -12 and 16). Acetylated H3K9 is a common marker for determining active 
transcription. In contrast, methylation of histone H3 residues K9 and K27 and of histone 
H4K20 is associated with repressed chromatin. In humans, histone methyltransferase 
(HMT) activity can be provided by the enzyme SUV39H1, which targets H3K9 for 
methylation (reviewed in Grant, 2001; Grunstein, 1997). Methylated H3K9 then attracts 
binding of heterochromatin protein 1 (HP1), serving as another marker for heterochromatin 
formation (Bannister et al, 2001). The processes of histone modification are dynamic and 
implicate many nuclear factors, the list of which has been rapidly expanding.  The enzyme 
families of histone deacetylases and histone acetyltransferases, directly involved in 
modification of histone tails, are briefly described in the next paragraphs.   
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Figure 1.6 Basic organisation of a nucleosome  
Core histones with free N-terminal ends are shown in yellow. DNA wrapped around the 
nucleosome is shown in blue. Post-translational modifications of core histones are marked as Ac 
(acetylated; green) and Me (methylated; red), indicative of active or repressed transcription. 
 
 
Histone Deacetylases 
The mode of histone deacetylase (HDAC) action, as the name implies, involves removal of 
acetyl group from the lysine of the acetylated histone protein, thereby restoring the positive 
charge and allowing the condensation of nucleosomes. The HDAC family is large and 
comprised of two major classes according to their structural characteristics. Twelve 
HDACs have been identified so far and all share a homologous catalytic domain. Members 
of Class I HDACs, HDAC1 and -2 are highly similar with sequence identity of 
approximately 85%. Cellular proteins interact with HDACs and form repressive complexes 
on heterochromatin (reviewed in de Ruijter et al, 2003; Marks et al, 2000). Various 
protein-protein interactions are involved in regulating HDAC function by binding directly 
to HDACs and recruiting co-repressor complexes (Sengupta & Seto, 2004). Interaction 
between ND10 protein hDaxx and HDACs (Hollenbach et al, 2002; Lin et al, 2006) is 
particularly intriguing in the context of the present investigation, hence will be addressed 
in relevant sections of this thesis. To study the properties of HDAC function in cell culture, 
HDAC inhibitors such as trichostatin A (TSA) and other compounds are used. These act by 
targeting enzymatic activity of HDACs thereby relieving repression. Such methods for 
HDAC inhibition have become widely used for determining the nature (HDAC-dependent 
or not) of transcriptional repression (Marks et al, 2000).  
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Histone Acetyltransferases 
Histone acetyltransferases (HATs) are the enzymes that, in reverse to HDAC action, 
transfer the acetyl group to the ε-amino group of the internal lysine residue of a histone tail 
in a reaction that can be reversed by HDACs. Two representatives of HATs are p300 and 
CBP (CREB-binding protein), often referred to as p300/CBP due to their high similarities. 
They target histones H3 and H4 for acetylation, and to a lesser extent H2A and H2B (Kuo 
& Allis, 1998).  
 
Histone Methyltransferases  
One of the representative and best characterised HMTs is SUV39H1. It can interact with 
HP1, and presumably recruit it to methylated H3K9 residues, thereby contributing to the 
formation of heterochromatin (reviewed in Shinkai, 2007).  
 
1.7.1.3 Chromatin regulation by DNA methylation 
Methylation of DNA in addition to histone deacetylation and recruitment of transcriptional 
repressors, provides another important pathway of transcriptional repression. The process 
of DNA methylation involves the addition of a methyl group to nucleotide bases, most 
commonly cytosine. Cytosine methylation is catalysed by DNA methyltransferases 
(DNMTs). In mammalian cells cytosine methylation occurs almost exclusively at cytosines 
residing 5’ to guanine nucleotides. The short stretches of DNA comprising repeated 
occurrences of these C-G sequences are referred to as CpG (cytosine-phospho-guanine) 
islands, where CpG sequences are clustered within 0.5 to 4 kb lengths of DNA (Siedlecki 
& Zielenkiewicz, 2006). Methylated CpG islands present binding sites for methyl-CpG-
binding proteins (MeCPs). Of these the most studied is MeCP2, which binds CpG sites and 
causes transcriptional repression by recruiting transcriptional repressor complexes, some of 
which include HDACs (Nan et al, 1998). MeCP2 can in turn interact with additional co-
factors and complexes that promote assembly of repressed chromatin structures.  
 
One of the more recently proposed hypotheses states that cytosine methylation within the 
DNA is linked to histone methylation of the adjacent nucleosome. Since methylation of 
H3K9 serves as a docking site for heterochromatin protein HP1 (Bannister et al, 2001) and 
DNMTs (Fuks et al, 2003), HP1 may activate the methyltransferase activity of DNMTs 
and reinforce gene repression (reviewed in Brenner & Fuks, 2007).  
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1.7.1.4 Chromatin remodelling by SWI/SNF family enzymes 
An additional level of transcriptional regulation by modifying chromatin structure is 
provided via the action of SWI/SNF ATPase/helicase chromatin remodelling enzymes. The 
SWI/SNF genes were initially identified in yeast Saccharomyces cerevisiae as activators of 
the HO and SUC2 genes; SWI stands for mating type SWItch and SNF for Sucrose Non-
Fermenting.  Mutations in both of these genes result in reductions in growth rate. SWI/SNF 
complexes cause ATP-dependent disruption of histone-DNA interactions within the 
nucleosome in vitro, possibly by sliding histone octamers to other sites on the same DNA 
molecule. This process is thought to expose transcription sites allowing transcriptional 
factors to bind and activate gene expression. It is also believed that interaction of SWI/SNF 
complex subunits with acetylated histones may contribute to activation of certain gene 
targets (reviewed in Muchardt & Yaniv, 1999; Sudarsanam & Winston, 2000). Apart from 
helicase-related properties in transcriptional activation, repressive functions have also been 
described for ATP-dependent nucleosome remodelling complexes. The existence of 
complexes that contain, in addition to nucleosome remodelling activity, histone 
deacetylase activities have been reported (e.g. NuRD complex; Xue et al, 1998).  
 
Evidently, the different pathways of chromatin regulation do not occur independently of 
one another but are dynamic with exchange of transcriptional repressors and activators. 
The different mechanisms of chromatin regulation cannot be described exhaustively here, 
therefore only those relevant to the further discussion have been addressed in this section. 
 
1.7.2  Chromatin organisation during herpesvirus infection 
It has been discovered some time ago that viral DNA is associated with the markers 
indicative of active or repressed gene transcription depending on the stage of the life cycle. 
A powerful technique that is widely used for analysing the chromatin structure of viral 
genomes is chromatin immunoprecipitation (ChIP) that relies on co-immune precipitation 
of the histone complexes associated with viral DNA, and then PCR amplification of 
selected viral sequences. The current understanding of the chromatin control of viral 
infection is summarised below. These aspects have also been recently reviewed (Knipe & 
Cliffe, 2008; Kutluay & Triezenberg, 2009b; Lu & Triezenberg, 2009; Sinclair, 2008).  
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1.7.2.1 Chromatin during lytic infection 
One of the earliest pieces of evidence demonstrating that HSV-1 DNA in lytic cells is not 
extensively associated with nucleosomes came from micrococcal nuclease (MNase) 
digestion of the DNA extracted from the infected cells (Leinbach & Summers, 1980). 
These data suggest that viral DNA is probably not assembled into a regular chromatin-like 
structure. In contrast to HSV-1, MNase digesting approach used in HCMV infected cells 
has demonstrated that viral DNA during productive HCMV infection is mostly 
nucleosomal, and at later stages of infection the nucleosome load becomes restricted 
towards specific genomic regions (Nitzsche et al, 2008). Therefore, the mechanisms of 
HSV-1 and HCMV gene repression during the lytic stage of infection seem to differ 
significantly.   
 
In HCMV infected cells repression that occurs around the MIEP is HDAC-dependent. A 
high load of histones associated with the MIEP undergoes dynamic acetylation and 
methylation modifications, subject to temporal changes (reviewed in Sinclair, 2008). Thus, 
overexpression of HDAC3 results in substantial decrease in the infectivity by HCMV in 
permissive culture, and conversely, TSA treatment of HCMV-infected non-permissive 
cells increases the efficiency of infection (Murphy et al, 2002). In addition, HCMV MIEP 
also associates with HP1 in latent infection models (Murphy et al, 2002), which further 
confirms heterochromatin structure of latent HCMV genomes.  
 
The evidence concerning the role of HDACs in lytic phase of HSV-1 infection, however, is 
conflicting (reviewed in Kutluay & Triezenberg, 2009b). While some reports have 
suggested that inhibition of HDAC activities by TSA treatment can complement for lack of 
ICP0 in ICP0-null HSV-1 infected cells (Poon et al, 2006; Poon et al, 2003), similar 
studies by other groups did not confirm these observations (Everett et al, 2008). Moreover, 
analysis of ICP0 functions specifically required for efficient plaque formation has also 
indicated that ICP0-HDAC interaction (Lomonte et al, 2004) was not required for efficient 
gene expression and plaque formation (Everett et al, 2009), and that ICP0 does not have a 
TSA-like effect on the levels of histone acetylation (Lomonte et al, 2004). In support of 
heterochromatin-independent repression of the lytically HSV-1 infected cells, a study by 
Herrera and Triezenberg has demonstrated the relatively low histone occupancy on IE gene 
promoters. Interestingly, the same study has demonstrated the association of IE promoters 
with CBP/p300, a protein involved in histone acetyltransferase activities (see above). 
Using VP16-activation domain deficient mutant, it was determined that VP16 recruits not 
only HATs but members of SWI/SNF complex to IE promoters, ensuring active   63
transcription during the lytic infection (Herrera & Triezenberg, 2004). It is intriguing that 
upon infection with a VP16-activation domain mutant, a significant increase in core 
histone occupancy on IE promoters is observed (Kutluay & Triezenberg, 2009a). This 
suggests VP16 counteracts the formation of repressed chromatin structure during lytic 
infection.   
 
1.7.2.2 Chromatin during latent infection 
In contrast to lytic infection, there are more similarities in the mechanism of chromatin 
control of latently HSV-1 and HCMV infected cells and during reactivation, and it most 
certainly involves assembly of latent viral DNA into a heterochromatin structure. Indeed, 
earlier work has shown that latent HSV-1 genomes are associated with nucleosomes 
(Deshmane & Fraser, 1989). Moreover, nucleosomal HSV-1 DNA has also been detected 
in a cell culture model of quiescent infection using IE-gene expression deficient virus 
(Ferenczy & DeLuca, 2009). Specific regions of nucleosome formation that include IE and 
Early gene promoters become enriched with repressed histone markers, notably methylated 
H3K9, in mouse trigeminal neurons (Wang et al, 2005). Systems that have used cell 
culture models of quiescent infections for analysis of chromatin control have produced 
evidence that the ICP0 promoter in these cells is associated with tri-methylated H3K9, 
whereas HSV-2 superinfection results in de-repression and acetylation of ICP0 and gC 
(Early gene) promoters (Coleman et al, 2008). 
 
On the other hand, actively transcribed LAT HSV-1 promoters are heavily acetylated in 
latently infected cells (Kubat et al, 2004a; Kubat et al, 2004b). It is interesting however 
that decreased transcription levels of LAT are not associated with decreased acetylated 
histone levels on the 5’ region of the LAT promoter (Kubat et al, 2004a). Although 
methylation plays an important role in maintaining repressed chromatin structures, 
evidence suggests that there are no methylated DNA markers present on latent HSV-1 
genomes (Kubat et al, 2004b). 
 
The role for HDACs in HSV-1 in the maintenance of repressed chromatin structure has 
been an issue of extensive investigation, particularly in view of the controversy for 
lytically-infected cells. There is, however, more firm data regarding HDAC function on 
quiescent or latent genomes. Thus, TSA treatment of latently HSV-1 infected neuronal 
cultures results in derepression of gene expression (Terry-Allison et al, 2007). However, 
TSA mediated de-repression of quiescent HSV-1 genomes does not occur in fibroblasts   64
(Preston & Nicholl, 2005; Terry-Allison et al, 2007). Repression by HDACs during models 
of HCMV latency in non-permissive cell lines is thought to involve the hDaxx co-repressor 
activities since removal of hDaxx by RNA interference (RNAi) relieves the silencing of IE 
transcription in these cells, in the same manner as treatment with TSA (Saffert & Kalejta, 
2007). According to other studies that used ChIP analyses, hDaxx depletion results in a de-
repressed chromatin structure around HCMV promoters (Woodhall et al, 2006). In addition 
to HDAC activity, it has been shown that in monocytes extracted from healthy HCMV-
positive carriers, but not in differentiated dendritic cells, repressed chromatin marker HP1 
associates with the MIEP. In contrast, reactivation of HCMV following differentiation of 
monocytes into dendritic cells is associated with the enrichment of acetylated H4, 
indicative of active transcription (Reeves et al, 2005).  
 
1.8  The chromatin-associated ND10 Components: ATRX and 
hDaxx 
As discussed above, active or repressed chromatin is subject to the regulation by additional 
cellular factors commonly referred to as transcriptional regulators, co-repressors or co-
activators. The various proteins that are found localised to ND10 include several such 
factors.  The candidate subjects of the present investigation into the role of ND10 proteins 
in herpesvirus infection are ATRX and hDaxx, as both have roles in chromatin remodelling 
and transcriptional regulation. These aspects of their functions in the cell are discussed 
below.  
 
1.8.1  ATRX 
1.8.1.1 The gene and protein structure 
When first discovered, the human ATRX gene was localised to the Xq13.3 region, 
telomerically flanking locus DXS56 of the human X chromosome, and by sequence 
analyses shown to contain domains homologous to helicase-like proteins of SWI/SNF 
family such as Saccharomyces cerevisiae RAD54 and SNF2. The human counterpart of 
RAD54, hRAD54 is highly homologous to the C-terminal portion of ATRX, hence its 
structural and functional characteristics may also provide clues for ATRX function. Hence, 
ATRX since then has been referred to as a member of the family of SWI/SNF chromatin 
modifying complexes and sub-family of SNF2 helicases. The ATRX gene is mutated in α-
thalassaemia mental retardation X-linked (ATR-X) syndrome, a condition that is perhaps   65
caused by aberrant regulation of ATRX target genes (Gibbons et al, 1995; Picketts et al, 
1996; Stayton et al, 1994). ATRX-null mice do not survive past embryogenesis, suggesting 
roles in the regulation of development and differentiation (Berube et al, 2005).  
 
The large ATRX gene is composed of about 11,000 nucleotides, of which the cDNA 
sequence of the major ATRX isoform is approximately 7,500 nucleotides in size. The 
major isoform of the ATRX protein is composed of 2288 amino acids and has a predicted 
molecular weight of 280 kDa (Gibbons et al, 1995; Picketts et al, 1996). When analysed on 
a polyacrylamide gel using an antibody recognising a short N-terminal peptide sequence of 
the protein, two bands of 280 kDa and 180 kDa can be detected. This pattern of migration 
has led to identification of an additional truncated isoform (ATRXt), which is predicted to 
arise from alternative splicing (Garrick et al, 2004). N-terminal structural characteristics of 
ATRX include its well characterised PHD-like zinc finger domain. The typical architecture 
of a PHD finger domain is represented as C4HC3 (four cysteines – one histidine – three 
cysteines) that coordinate two zinc atoms in a cross-brace manner. The unique feature of 
ATRX PHD finger domain is that all coordinating atoms are cysteine residues (Bienz, 
2006). This organisation is also shared by specific DNMTs – namely DNMT3A, -3B and -
3L, which are involved in DNA methylation (as mentioned above). Therefore, the domain 
has been named as the ADD domain (Figure 1.7) and is involved in core histone 
recognition (Argentaro et al, 2007; Ooi et al, 2007; Otani et al, 2009).  
 
1.8.1.2 ATR-X syndrome  
Mutations of ATRX gene that result in the development of ATR-X syndrome are mapped to 
various regions of the protein, mostly the PHD finger domain and some to the SNF2 
homology region. Since the PHD finger is likely to be involved in DNA binding, it is 
thought that mutations in this region cause disruptions in ATRX-mediated chromatin 
remodelling functions. Clinical manifestations of the disease include psychomotor 
abnormalities, facial dysmorphisms, urogenital abnormalities and severe mental retardation 
and learning difficulties (Gibbons, 2006; Gibbons et al, 1997). Patient mutations within the 
SNF2 region disrupt localisation of ATRX to ND10 and are proposed to be involved in 
aberrant regulation of gene expression (Berube et al, 2008). 
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Figure 1.7 The ATRX protein sequence 
Key structural features showing: SNF2 homology region and helicase domains (Garrick et al, 2004; 
Tang et al, 2004); hDaxx interacting domain (aa 1189-1326; Tang et al, 2004); ADD domain 
(Argentaro et al, 2007); HP1 binding region (Le Douarin et al, 1996) and PxVxL sequence (green; 
aa 561-595) (Lechner et al, 2005).  
 
 
1.8.1.3 ATRX functions in chromatin remodelling 
The highest homology of ATRX to the SNF2 subfamily of chromatin remodelling enzymes 
is within its C terminus. This part of the polypeptide is homologous to S. cerevisiae 
RAD54, a protein that functions in nucleosome repositioning within homologous DNA 
target sites and therefore has been demonstrated to be involved in DNA recombination 
(Alexeev et al, 2003). Accordingly, ATRX has been demonstrated to remodel DNA by 
nucleosome repositioning using in vitro assays (Xue et al, 2003). However, a substantial 
portion of the N-terminal part of the protein contains a domain involved in HP1 binding 
(Picketts et al, 1998) and a PHD zinc finger motif (Gibbons et al, 1997), which suggest 
functions in DNA binding and chromatin repression. Hence, a number of ATRX protein 
interactions has been determined, in support of its role in transcriptional repression.  
 
Firstly, the proposed interaction between HP1 and a mouse ATRX homologue HP1-BP38 
has been identified using a yeast two hybrid screen (Le Douarin et al, 1996). It appeared 
that this protein was around 83% identical across the majority of the N terminus of ATRX 
(Picketts et al, 1998). Interestingly, HP1 and ATRX co-localise at condensed chromatin 
during mitosis (Berube et al, 2000), which suggests the functional significance of this 
interaction. In other studies, interaction between the chromoshadow domain of HP1α and a 
common HP1 binding motif of ATRX termed PxVxL has been confirmed using GST pull-
down assays (Lechner et al, 2005), providing so far the most convincing evidence of this 
interaction. ATRX may therefore serve as co-repressor by interacting with HP1. This 
possibility is addressed in Chapter 6.  
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A second piece of evidence in favour of ATRX repressive functions is its association with 
MeCP2. Both proteins co-localise at distinct foci within the nuclei of mouse brain cells, as 
a result of interaction between ATRX C-terminal helicase domains and MeCP2. Loss of 
MeCP2 or expression of aberrant MeCP2 containing mutations that are characteristic of 
patients with mental retardation syndrome lead to a dispersed ATRX distribution pattern.  
It therefore follows that DNA regulation by the MeCP2/ATRX complex is required for 
proper development (Nan et al, 2007).  
 
Thirdly, structural features within the ADD domain of ATRX shared with DNMTs suggest 
a role for ATRX in DNA methylation and thus a function as a transcriptional repressor. For 
example, DNMT3a and DNMT3L has been shown to interact with the core histone H3 via 
their ADD domains (Argentaro et al, 2007; Fuks et al, 2003; Otani et al, 2009). DNMT3L 
binds non-methylated histone H3 but this interaction is abolished by H3K4 methylation 
(Ooi et al, 2007). This may suggest a similar mechanism for ATRX interaction with 
histones. Interestingly, novel evidence demonstrates the interaction between ATRX and a 
histone variant H3.3 via H3.3 lysine 4. This association is proposed to regulate telomere 
replication (Wong et al, 2010).  
 
Additional ATRX roles in chromatin regulation include functions in normal chromosome 
segregation during mitosis (Ritchie et al, 2008) and an HDAC-dependent activity at 
centromeric heterochromatin during meiosis (De La Fuente et al, 2004), supporting the 
requirement of ATRX in cell division. 
 
1.8.2  hDaxx 
The role of the protein hDaxx as an ND10 protein with repressive functions during HCMV 
infection has been discussed (Section 1.6.5.2). HDaxx is the second protein that is being 
researched in the present study, therefore its general functional characteristics and cellular 
roles are described further.  
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1.8.2.1 Structure and functional domains 
Daxx is ubiquitously expressed throughout different tissues (Yang et al, 1997). Mouse (m) 
and human Daxx (hDaxx) aa sequences share 69% identity. The hDaxx protein includes 
740 aa with a molecular weight of 81.3 kDa, and it is predominantly a nuclear protein that 
can be localised to ND10, heterochromatin and the nucleolus (reviewed in Chen et al, 
2009). Cloning of the mDaxx gene has identified 7 exons. Targeted disruption of the gene 
in mice leads to embryonic lethality associated with extensive apoptosis (Michaelson et al, 
1999). At the structural domain level hDaxx is poorly characterised. Amongst the known 
conserved domains are the two paired amphipathic helices domains (PAH1 and -2), which 
are present in other proteins involved in co-repressor functions. Acid-rich and serine-
proline-threonine rich domains are also shown (Figure 1.8; adapted from (Yeung et al, 
2008). Regions of interaction with relevant proteins that are discussed here are mapped 
within Figure 1.8 based on the available evidence from the cited reports.  
 
1.8.2.2 hDaxx in apoptosis 
There is some inconsistency in reports regarding pro-apoptotic and anti-apoptotic roles 
attributed to hDaxx (reviewed in Salomoni & Khelifi, 2006). Daxx was originally 
identified as a protein that interacts with a cell death receptor Fas in both in vitro and in 
vivo assays. This interaction activates the Jun-N-terminal kinase (JNK), which results in 
downstream events leading to apoptosis (Yang et al, 1997). This pathway also involves an 
hDaxx adaptor function via association with apoptosis signal-regulating kinase 1 which has 
a central role in JNK activation (Chang et al, 1998).  
 
On the other hand, anti-apoptotic roles of hDaxx have also been proposed. One group 
observed increased apoptosis incidence in cells devoid of hDaxx expression, using Daxx
-/- 
mouse embryo models and using an RNAi approach for targeted knock-down of Daxx 
expression (Michaelson et al, 1999; Michaelson & Leder, 2003). Another study has 
reported elevated apoptosis incidence in transformed APL cells treated with HDAC 
inhibitors. This coincided with downregulation of hDaxx. The authors therefore suggested 
a function of hDaxx in protecting APL cells from apoptosis in an HDAC-dependent 
manner (Amin et al, 2001). According to these studies, Daxx may function as both anti-
apoptotic and pro-apoptotic factor, depending on the cellular environment.  
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Figure 1.8 The hDaxx protein sequence 
Key structural features showing the characterised protein interaction regions with HDAC1 and 
acetylated histone H4 (Hollenbach et al, 2002), ATRX (Tang et al, 2004), HIPK2 (Hofmann et al, 
2003) and other proteins, as indicated. Predicted nuclear localisation signal (NLS), acidic A/D-rich 
and S/P/T-rich domains, and paired amphipathic helixes (PAH1 and PAH2) are also indicated 
(Yeung et al, 2008).  
 
1.8.2.3 The role of hDaxx phosphorylation in its functions 
Phosphorylation of hDaxx is known to regulate its interaction with protein binding partners 
and nuclear localisation. Thus, CRM1 (chromosomal region maintenance 1) interacts with 
hDaxx when hDaxx is phosphorylated at residue S667 to promote its nuclear export under 
conditions of glucose deprivation (Song & Lee, 2004). Recent evidence also suggests that 
phosphorylation at S178 attracts binding of the enzyme prolyl isomerase Pin1, which is 
overexpressed in tumours. This interaction induces degradation of hDaxx, and is proposed 
to inhibit induction of apoptosis by hDaxx (Ryo et al, 2007). Importantly, phosphorylation 
at S669 of mouse Daxx by direct interaction with homeodomain-interacting protein kinase 
(HIPK) 1 induces displacement of hDaxx from ND10. In cells overexpressing HIPK1, 
notable de-repression in transcriptional activities as determined by luciferase assays was 
observed (Ecsedy et al, 2003). In human cells, hDaxx phosphorylation can be induced by 
HIPK2 expression. Co-expression of both proteins induced the JNK signalling pathway, 
proposing a role of HIPK2 in hDaxx-mediated JNK activation during apoptosis (Hofmann 
et al, 2003). Hence, hDaxx phosphorylation can efficiently modulate hDaxx activities.  
 
1.8.2.4 hDaxx in transcriptional regulation 
One of the earliest pieces of evidence for the transcriptional repression function of hDaxx 
was demonstrated by (Torii et al, 1999) using luciferase reporter assays. Following this 
observation the repressor functions of hDaxx have been subject to extensive research. 
Mutational analysis of hDaxx suggests that multiple domains are required for fully 
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efficient repression. Notably, hDaxx mutants lacking both PAH domains or the C-terminal 
S/P/T region had the lowest ability to repress transcription amongst the different mutants 
tested in the assay (Hollenbach et al, 2002). Interaction of hDaxx with chromatin-
associated proteins such as HDACs, core histones, HP1α and centromeric protein CENP-C 
suggest a mechanism for its possible regulation of gene repression (Hollenbach et al, 2002; 
Ishov et al, 2004; Li et al, 2000; Pluta et al, 1998).  
 
The ability of hDaxx to interact with HDAC1 has been mapped to its C-terminal part that 
spans the S/P/T motif. Due to the high homology between HDACs of class I it is proposed 
that hDaxx can interact with all three members (HDAC 1, -2, and -3). The HDAC/hDaxx 
interaction is essential for hDaxx properties as a transcriptional repressor and suggests the 
two proteins function as a complex that represses transcription from its target genes (Li et 
al, 2000). Consistent with these observations, additional interaction between class II 
HDACs and hDaxx has been demonstrated (Hollenbach et al, 2002).  
 
An important observation that identified a consensus SUMO-interaction motif within the 
last 8 amino acids has become an indication of SUMO-mediated transcriptional repression 
by hDaxx (Ryu et al, 2000). SUMO-specific protease SENP1 releases hDaxx from ND10 
(Ryu et al, 2000), indicating the importance of hDaxx interaction with SUMO-modified 
substrates for its sequestration at ND10. Interactions between SUMO-modified co-
repressors and hDaxx have been shown to be important for hDaxx-mediated transcriptional 
repression (reviewed in Shih et al, 2007). These targets include PML, the glucocorticoid 
receptor, Smad4 and CBP (Holmstrom et al, 2008; Ishov et al, 1999; Kuo et al, 2005; Lin 
et al, 2004; Lin et al, 2006; Meinecke et al, 2007; Zhong et al, 2000a). HDaxx itself has 
been reported to be post-translationally modified by SUMO (Jang et al, 2002), which may 
indicate that hDaxx itself is targeted to SIMs of other proteins, although the precise roles of 
this modification in modulation of its transcriptional activities are yet to be established. 
 
Other transcriptional targets of hDaxx include CAAT/enhancer-binding protein 
β (C/EBPβ), involved in differentiation of APL cells (Wethkamp & Klempnauer, 2009) 
and c-met factor, required for cell growth and differentiation (Morozov et al, 2008). 
According to the first study, hDaxx binds to the transcriptional activator C/EBPβ and 
induces repressed transcription (Wethkamp & Klempnauer, 2009). The latter study was the 
first one to show a different mode of hDaxx-mediated repression, in which hDaxx 
physically associated with the c-met DNA promoter (Morozov et al, 2008). Taken together,   71
these studies describe the importance of hDaxx-dependent transcriptional regulation in cell 
differentiation, tumour suppression and the cell cycle.  
 
1.8.2.5 The ATRX/hDaxx complex 
A particularly intriguing interaction is that between ATRX and hDaxx. Several studies 
have detected an interaction between transiently expressed or endogenous proteins (Ishov 
et al, 2004; Tang et al, 2004; Xue et al, 2003) and have suggested functions of this 
complex in chromatin repression. The ATRX-interaction region of hDaxx has been 
mapped to the PAH1 domain (Tang et al, 2004), which is conserved amongst other 
proteins involved in chromatin regulation. In vitro studies of ATRX chromatin-
remodelling activities have created some controversy regarding the chromatin repressor 
functions of the complex. Whereas one study suggests that hDaxx interferes with ATRX 
repressive functions by sequestering it at ND10 (Tang et al, 2004), the other suggests that 
hDaxx is not required for ATRX actions in nucleosome displacement assays (Xue et al, 
2003). Protein interaction partners of ATRX and hDaxx (discussed above), however, 
strongly suggest the potential involvement of the complex in heterochromatin formation. 
Besides, since ATRX-hDaxx and ATRX-MeCP2 (Nan et al, 2007) interactions occur via 
distinct regions of ATRX, it is possible that ATRX serves as an adaptor that recruits co-
repressor hDaxx to the sites of repressed gene transcription (discussed in Chapter 6). In 
addition to these pieces of evidence, there is an indication the ATRX PHD domain may be 
involved in HDAC interaction (Zhang et al, 1998). Since hDaxx and HDACs also interact 
(Hollenbach et al, 2002; Lin et al, 2006), it is possible that chromatin regulation by ATRX 
and hDaxx involves their incorporation as the subunits of a large chromatin repressor 
complex.  
 
1.9  Immunity to viral infection 
Chromatin assembly around viral genomes and ND10-mediated regulation of viral gene 
expression, as discussed in previous sections of this Chapter, are all linked to anti-viral 
intrinsic cellular responses. These phenomena have formed the basis of the concept of anti-
viral intrinsic immunity, which is central to the present investigation. Prior to discussing 
anti-viral intrinsic immunity, the different pathways of host defences against viral infection 
must be considered. Anti-viral immunity can act on several levels: innate immunity 
provided by pre-existing phagocytic cells and natural killer (NK) cells; adaptive immunity 
provided by B and T lymphocytes; and intrinsic provided by the pre-existing intracellular   72
components. Viruses have co-evolved mechanisms of counteracting and evading immune 
responses of the host on all these levels, therefore understanding of the mechanisms which 
are utilised by viruses to overcome host responses may become crucial in vaccine and 
therapy development. Below the basic features of the anti-viral immune systems are 
described. 
 
1.9.1  Innate and adaptive anti-viral immunity  
1.9.1.1 The functions of anti-viral adaptive immune system 
The adaptive immune system relies on the action of T lymphocytes and B lymphocytes. B 
cells produce antibodies directed against the invading pathogens. They recognise antigens 
via  B cell receptors (BCRs), which are expressed on their surface and termed 
immunoglobulins (IgGs), or antibodies. While memory B cells recognise viral antigens and 
present them on the surface in association with MHC class II molecules, plasma B cells 
produce IgGs in secretory form. Antibodies specific to the infecting virion particles can 
then neutralise them by preventing interaction with host cells or disrupting the viral 
envelope, and therefore inhibit entry into the cell. In addition, many phagocytic cells 
express specific receptors for the constant IgG chain, which are recognised by antibodies 
bound with their variable site of the protein to the antigen. This recognition results in the 
destruction of the pathogen by a phagocytic cell.  
 
T lymphocytes recognise the infected cells and either destroy those (CD8+ T cells) or 
assist B cells in antibody production (CD4+ T cells). T cells express T cell receptors that 
recognise antigens expressed by the infected cells. Within virus-infected cells viral proteins 
are subjected to proteolysis through the proteasome pathway, and the resulting peptide 
remnants are trafficked through the cell eventually to be presented on the cells surface in 
complex with MHC molecules. CD8+ T cells recognise antigens presented in a complex 
with MHC class I surface molecules, while CD4+ T cells recognise antigens presented by 
MHC class II molecules. Importantly, interactions between CD4+ T cells and B cells are 
recognised as a crucial step in the anti-viral immune response, since the B cells act as 
antigen presenting cells in this case. Memory B cells internalise viral antigen via surface 
bound antibodies and present the processed peptides in association with MHC class II 
molecules. Interaction with CD4+ T cells triggers their differentiation into antibody 
secreting plasma cells. Lack of functional B cells results in more aggressive viral spread 
(reviewed in Whitton et al, 2004). For example, in HSV-1 infected mice, antibodies   73
produced by B cells play important roles in suppression of lesions formed after primary 
infection by HSV-1 (Deshpande et al, 2000).  
 
1.9.1.2 The functions of innate anti-viral immune system 
Components of the innate immune systems include phagocytic cells that are capable of 
binding microorganisms, then internalising and destroying them. These cells act as the first 
line of defence against infection with various microbes. Natural killer (NK) cells, however, 
have been identified as one of the key components in a rapid anti-viral response (reviewed 
in Biron et al, 1999). In herpesviruses infections, the NK cell response is associated with 
cytotoxicity and IFN-γ production. IFN-γ produced by the activated NK cells mediate 
potent anti-viral activity via different pathways within the first hours to a few days during 
infection, whilst B and T cell responses may take over a week to develop. Cytotoxicity of 
NK cells is dependent on activation of IFN-α/β responses, which are produced by virally 
infected cells. NK cell depletion in mice renders them substantially more susceptible to 
HSV-1 infection, affecting production of efficient adaptive immune response by CD8+ T 
cells (Nandakumar et al, 2008).  
 
Clearly, components of innate and adaptive immune system present are in constant 
interaction. Thus, phagocytes can act as antigen presenting cells and therefore induce 
development of T cell memory. Interferons produced by a subset of T cells can activate 
NK cells to elicit destruction of the infected cells. Co-evolution of viruses with the host 
cells in many cases impedes an efficient antiviral response. It is therefore necessary to 
understand what subcellular and molecular processes are responsible for development of 
viral countermeasure activities during the infection. This aspect is described further.  
 
1.9.2  Cellular anti-viral intrinsic immunity 
The concept of cellular intrinsic defence or immunity has emerged recently, due to 
expanding research into the cellular proteins involved in inhibition of various stages of 
viral replication on the subcellular and subnuclear levels.  The term is applied to the 
collective set of activities that are potent inhibitors of viral gene expression (Bieniasz, 
2004). This definition encompasses the functions of various nuclear, cytoplasmic and 
transmembrane proteins that fall outside the conventional constituents of host adaptive and 
innate immunity systems. Since provided by the pre-existing components of the cell, 
intrinsic immunity can also be considered as a part of innate anti-viral immunity.    74
 
1.9.2.1 Discovery of anti-retroviral intrinsic immunity: APOBEC and TRIM5α 
Unlike adaptive and innate immune systems of mammals that require in vivo study systems, 
intrinsic immunity can be studied in cell culture. Hence, using cell-based approaches the 
factors that restrict replication by retroviruses have been identified. Of the most intriguing 
proteins shown to restrict HIV replication are APOBEC3G and TRIM5α (reviewed in 
Huthoff & Towers, 2008; Nisole et al, 2005; Sokolskaja et al, 2006). 
 
APOBEC (apolipoprotein B mRNA-editing enzyme catalytic polypeptide) proteins 
constitute a family of cytidine deaminases that act on single stranded DNA or mRNA 
molecules. APOBEC3G specifically deaminates single stranded DNA of the minus strand 
of nascent viral DNA. It is thought that APOBEC3G interferes with reverse transcription in 
HIV-infected cells, although the precise mechanism has not been determined. APOBEC3G 
has been identified as a repressive factor that renders cells non-permissive to a mutant 
HIV-1 infection that does not express HIV virion infectivity factor Vif. Hence Vif serves 
as a strong countermeasure to APOBEC-mediated cellular intrinsic resistance mechanism 
(Huthoff & Towers, 2008).  
 
Certain TRIM (tripartite motif) protein family members have been clearly demonstrated to 
restrict infection by HIV-1. Their structural characteristics include a RING domain within 
the RBCC motif, which is shared with that of TRIM19 also known as PML. TRIM5α is the 
largest isoform of the TRIM5 gene, and it contains a SPRY domain that possesses viral 
restriction specificity (reviewed in Nisole et al, 2005). TRIM5α is a cytoplasmic protein 
that has been shown to contribute to an HIV infectivity block using an RNAi approach, 
since TRIM5α deficient cells are more susceptible to infection (Stremlau et al, 2004). The 
mechanism of TRIM5α action, although yet unidentified, is proposed to involve SPRY-
mediated recognition of the incoming viral particles and the enzymatic activity of the 
RBCC box, thereby inhibiting viral infectivity. Ubiquitin ligase activity provided by the 
RING domain of TRIM5 proteins has provided clues to the mode of TRIM5α-mediated 
viral restriction (reviewed in Huthoff & Towers, 2008; Sokolskaja et al, 2006). The precise 
mechanism of TRIM5α action still remains to be clarified. Hence, further research will 
potentially focus on anti-viral properties of all TRIM family members.  
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1.9.2.2 ND10 proteins as constituents of anti-herpesvirus intrinsic immunity 
With the identification of hDaxx as a potent regulator of repression of the HCMV MIEP 
(see Section 1.6.5.2), the term intrinsic immunity has been increasingly applied to ND10 
protein mediated cellular defences against herpesviruses (Saffert & Kalejta, 2007; 
reviewed in Tavalai et al, 2008). The observations by different groups that upon the 
infection released herpesvirus genomes become associated with ND10, followed by the 
ND10 disruption by viral regulatory proteins, have provided the evidence for anti-viral 
functions of certain ND10 components (as discussed earlier in Section 1.5.2). Indeed, the 
following sets of evidence support this hypothesis: (a) HSV-1 ICP0-mediated degradation 
of PML and Sp100 is functionally significant for efficient productive infection, since 
ICP0-null mutant HSV-1 replicates more efficiently in the absence of either or both PML 
and Sp100 (Everett et al, 2008; Everett et al, 2006); (b) HCMV IE-deficient mutant 
replicates more efficiently in PML-dependent cells, which correlates with IE1-mediated 
abrogation of SUMO-modification of PML and Sp100 (Lee et al, 2004; Muller & Dejean, 
1999; Tavalai et al, 2006; Tavalai et al, 2008); (c) HCMV pp71 is capable of inducing 
proteasomal degradation of hDaxx, which in turn restricts initiation of IE gene expression 
and hence blocks viral replication in pp71-null mutant infections (Hwang & Kalejta, 2007; 
Preston & Nicholl, 2006; Saffert & Kalejta, 2006; Saffert & Kalejta, 2007; Woodhall et al, 
2006).  
 
Interestingly, certain parallels can be drawn regarding the functions of PML and TRIM5α 
in anti-viral immunity, hence supporting the need for investigation and identification of 
novel TRIM family members that may be involved in restricting viral replication. For 
example, adenoviral regulatory protein E4ORF3 has also been shown to reorganise ND10 
structures (Carvalho et al, 1995; Doucas et al, 1996) via an interaction with PML, as well 
as to interact with another TRIM family member, TIF1α motif (Yondola & Hearing, 2007). 
Similarly, both PML- and hDaxx-depletion were able to improve the infectivity of a 
mutant adenovirus deficient in E4ORF4 expression (Ullman & Hearing, 2008). These 
observations provide support for the hypothesis that one function of ND10 is in anti-viral 
defence, particularly in the case of DNA viruses. Further research into the potential 
candidate components within ND10 is required in order to establish the mechanisms of 
viral genome repression and the ways adopted by viruses to counteract them.  
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1.10  Aims and objectives of the study 
The earliest events of host anti-viral defences are exhibited on a subcellular level thereby 
providing intrinsic anti-viral immunity. Repression of gene expression by pre-existing 
cellular proteins hence restricts viral replication, cell-to-cell spread and release of viral 
progeny into the host internal systems. Cellular intrinsic anti-viral immunity is a recently-
emerged concept, although extensive research is being conducted in an attempt to elucidate 
the cellular mechanisms responsible for this process.  
 
The study presented here was stimulated by the following key existing concepts regarding 
the relationships between herpesviruses and functions of ND10 components:  
(1) ND10 are recognised as nuclear domains that include certain proteins with cellular 
intrinsic anti-viral properties;  
(2) In addition to ND10, regulation of herpesvirus on chromatin level has provided potent 
repression mechanisms, especially during establishment of latency and reactivation by the 
two herpesviruses HSV-1 and HCMV; 
(3) The two chromatin associated factors ATRX and hDaxx constitute a complex that 
localises to ND10 and is proposed to function in chromatin repression pathways.  
 
Based on these existing data, investigation into the potential roles of ATRX and hDaxx in 
the context of HSV-1 and HCMV was of great interest. The primary purpose of the present 
study therefore is to identify the roles of ATRX and hDaxx in the regulation of HCMV and 
HSV-1 infection. The presentation of the results is divided into three principal parts, which 
were aimed to: (a) Characterise ATRX and hDaxx in cell lines used for the present study, 
as well as the construction of the various recombinant cell lines utilised as tools in further 
investigations (Chapter 3); (b) Investigate the role of ATRX in the regulation of HCMV 
infection (Chapter 4); and (c) Determine the roles of ATRX/hDaxx complex in regulating 
HSV-1 infection, and identify potential mechanisms how ICP0 counteracts the action of 
this complex. The observations presented in the current study demonstrate evidence for the 
existence of a chromatin-associated complex that contributes to intrinsic cellular defence 
against HSV-1 and HCMV infections. Whether this occurs via direct chromatin-
remodelling of viral genomes is currently unclear.    77
2  Materials and Methods 
2.1  Materials 
2.1.1  Antibodies 
Primary and secondary antibodies used throughout the study and the purpose of their use 
are listed in Tables 2.1 and 2.2, respectively, below.  
 
Table 2.1 Primary antibodies used in the study 
Antibody Type  Target  Dilution 
in WB 
Dilution 
in IF  Source 
AC-40  Mouse 
monoclonal  Actin  1:1000 – 
1:2000  N/A Sigma-Aldrich 
H-300  Rabbit 
polyclonal  ATRX N/A  1:200  Santa-Cruz sc-
15408 
39F  Mouse 
monoclonal  ATRX 1:20  1:20  Richard Gibbons, 
Oxford 
D-19  Goat 
polyclonal  ATRX N/A  1:100  Santa-Cruz sc-
10078 
r1866  hDaxx  N/A  1:1000  (Pluta et al, 1998) 
07-471 hDaxx  N/A  1:100  Upstate 
D7810 
Rabbit 
polyclonal 
hDaxx 1:1000  N/A Sigma-Aldrich 
Ab290  Rabbit 
polyclonal  EYFP 1:2500  N/A  Abcam 
11060  Mouse 
monoclonal  ICP0 1:2000  1:1000  (Everett et al, 
1993b) 
R190  Rabbit 
polyclonal  ICP0  IP only  IP only  (Everett et al, 
1998b) 
58S  Mouse 
monoclonal  ICP4 1:1000  1:100  (Showalter et al, 
1981) 
E13  Mouse 
monoclonal  IE1 and IE2  1:2500  1:500  Serotec 
Laboratories 
5E10  Mouse 
monoclonal  PML 1:20  1:20  (Stuurman et al, 
1992) 
r8  Rabbit 
polyclonal  PML  N/A  1:5000  (Boddy et al, 1996) 
ab2595  Mouse 
monoclonal  pp65 1:1000  N/A  Abcam 
SpGH  Rabbit 
polyclonal  Sp100 1:1000  1:1000  (Sternsdorf et al, 
1995) 
Z1F11  Mouse 
monoclonal  UL42  1:1000  N/A  (Schenk et al, 1988)
BL851  Rabbit 
polyclonal  USP7 1:1000  N/A  Bethyl  Laboratories 
R201  Rabbit 
polyclonal  USP7  IP only  IP only 
(Everett et al, 
1999c; Everett et al, 
1997) 
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Table 2.2 Secondary antibodies used in the study 
 Antibody  Raised  in  Dilution  Source 
FITC-conjugated IgG  Sheep  1:100  Sigma-Aldrich 
F3008 
Alexa Fluor 555 IgG  Donkey  1:5000 
Invitrogen, 
Molecular probes 
A31570 
Cy3-conjugated IgG  Goat  1:2000 
GE Healthcare 
PA43002 
A
n
t
i
-
m
o
u
s
e
 
Anti-mouse IgG Horseradish 
peroxidase conjugate  Sheep 1:1000 
Sigma-Aldrich 
A4416 
Alexa Fluor 555 IgG  Donkey  1:5000 
Invitrogen, 
Molecular probes 
A31572 
Alexa Fluor 647 IgG  Donkey  1:5000 
Invitrogen, 
Molecular probes 
A21432 
Alexa Fluor 488 IgG  Goat  1:5000 
Invitrogen, 
Molecular probes 
A11001 
Cy5-conjugated IgG  Goat  1:2000  GE Healthcare 
PA45004 
Cy3-conjugated IgG  Goat  1:2000  GE Healthcare 
PA43004 
A
n
t
i
-
r
a
b
b
i
t
 
Anti-rabbit IgG Horseradish 
peroxidase conjugate  Sheep 1:20000  Sigma-Aldrich 
A4914 
Anti-
goat  Alexa Fluor 555 IgG  Donkey  1:5000 
Invitrogen, 
Molecular probes 
A21432 
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2.1.2  Plasmids 
The plasmids used in the study that were obtained from commercial sources or elsewhere, 
and the purpose of their use are detailed below. Construction of all other plasmids 
generated during the current study is described in the Section 2.2.  
 
Table 2.3 Plasmids 
Plasmid Source  Purpose 
pEYFP-C1 Clontech  Vector backbone for gene 
insertion 
pLKO1.puro 
  Sigma-Aldrich (Figure 2.1) 
Lentiviral vector backbone 
for selected shRNA 
sequences 
pLKO.shLuci  Constructed from pLKO.1puro  
(Everett et al, 2008) 
Lentiviral vector used as 
shRNA control 
pLKO.neo.gD.EYFP 
(pLNGY) 
Constructed from pLKO1.puro 
(Everett et al, 2008) 
Lentiviral vector backbone 
for gene insertions 
pLKO.ShDaxx2 
Constructed from pLKO1.puro using 
the siRNA sequence described in 
(Michaelson & Leder, 2003) 
Lentiviral vector coding for 
shRNA targeting hDaxx
1 
pcDNA3.hDaxx  A gift from John Sinclair hDaxx-coding  vector 
pCMV.DR.8.91  A gift from D. Trono 
(http://tronolab.epfl.ch) 
Lentivirus helper vector 
pVSV-G BD  biosciences 
For expression of VSV 
envelope protein for 
pseudotyped lentivirus 
production 
 
1 shDaxx2 sequence: 5’-GGAGTTGGATCTCTCAGAA-3’ (Michaelson & Leder, 2003) 
 
2.1.3  Enzymes 
Restriction endonucleases and their respective buffers were purchased from Roche apart 
from Age I and Apa I (New England Biolabs).  
T4 DNA ligase and λ-phosphatase and their buffers were from New England Biolabs.  
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2.1.4  Oligonucleotides 
Oligonucleotides used throughout the study were purchased from Sigma-Aldrich. All 
oligonucleotides were dissolved in water to a concentration of 100 μM by adding as the 
volume specified for each primer by the manufacturer. Their sequences and purpose of use 
are detailed below:  
 
Table 2.4 Oligonucleotides used in cloning procedures and sequencing  
F, forward; R, reverse. 
 
Name  Sequence 5’-3’  Purpose of use 
E-Daxx Age F  AGCTTAACCGGTCGCCACCATGGTGAGC 
Daxx Stop Eco R  GACCTGGAATTCCTAATCAGAGTCTGAGAG 
Daxx Xho F  CTCGAGCCATGGCCACCGCTAACAGC 
Construction of 
pLNGY-hDaxx 
Daxx si-ve F  GAGTTAGATCTGAGCGAATTGGATGACCCA 
Daxx si-ve R  CTGCAGGAAAAGGAGTTAGATCTGAGCGAA 
Introduction of si-ve 
site within hDaxx 
sequence 
Daxx Apa F  GGATTCTGGTGAGGGCCCTAGTGGAATGGC 
Daxx Apa R  GCCATTCCACTAGGGCCCTCACCAGAATCC 
Construction of 
pLNGY-hDaxx 
Daxx dPAH1 F 
TCCTCTGAGCCTCATGGGGCCGCCAAGCTCTATG
TCTAC 
Daxx dPAH1 R  GGCCCCATGAGGCTCAGAGGAGCTAGG 
Deletion of hDaxx 
ATRX-interaction 
domain 
Daxx dSIM R 
TCTCGAGGTCGAGAATTCCTACTCTTCTGGATCG
CATTGTG 
Deletion of hDaxx 
SUMO-interaction 
motif 
Daxx MSIM R 
CGAGGTCGAGAATTCCTAATCAGAGTCTGAGCC
CGCGCCGATCTCTTCTGGATCGC 
Mutation of hDaxx 
SUMO-interaction 
motif 
Daxx1701 F  GTTACAGGAGCGACGTCACC 
Daxx2021 F  CCTCCAGAGCTGAGACAGATG 
Daxx201 F  GCTGTTCGAAGAGTTCCTTG 
Daxx Pst F  GACTCCGCATACCTGCAGGAGGCACGGTTG 
Daxx Pst R  CAACCGTGCCTCCTGCAGGTATGCGGAGTC 
Sequencing of the 
hDaxx-expressing 
plasmids 
LKO F  CGATACAAGGCTGTTAG 
LKO R  GCAAACCCAGGGCTGCCTTG 
Sequencing of 
pLKO-based 
plasmids 
SV40 E  GCTGCAATAAACAAGTT 
GFP-C1  CCTGAGCAAAGACCCCAACG 
Sequencing of 
pEYFP-C1 plasmids 
 
2.1.5  Chemicals and reagents 
All reagents were purchased from Sigma-Aldrich unless specified in the list below or 
elsewhere in the text:  
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5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-gal): Melford Laboratories Ltd 
30% (w/v) Acrylamide :         National Diagnostics 
BenchTop 1 Kb DNA ladder:       Promega 
Ammonium  persulphate:       Bio-Rad  Laboratories  Ltd 
Ampicillin:       Melford  laboratories 
Autoradiography Film:         UV Kodak X-Omat 18x24cm - Kodak 
Caesium  Chloride:        Melford  Laboratories  Ltd 
Chloroform:         VWR  International  Ltd 
Dialysis  tubing:        Medicell  International  Ltd 
Dulbecco’s modified Eagle’s medium:    Invitrogen 
Ethanol:         Fisher  Scientific  UK  Ltd 
Ethylene diamine tetra acetic acid (EDTA):    VWR International Ltd 
Foetal bovine serum gold:        PAA laboratories 
Foetal calf (bovine) (FBS) serum:      Invitrogen 
Giemsa  stain:         VWR  International  Ltd 
Glycerol:         VWR  International  Ltd 
Glycine:       VWR  International  Ltd 
Human  serum:       MP  Biomedicals 
Hybond-ECL nitrocellulose membrane:     Amersham Biosciences 
Isopropanol:       VWR International Ltd 
L-glutamine:         Invitrogen 
Methanol:       VWR  International  Ltd 
NP40  substitute:        EuroClone 
Penicillin/Streptomycin  solution:    Invitrogen 
Protease inhibitor cocktail tablets, EDTA-free:   Roche 
Protein G/salmon sperm DNA:     Upstate  (Millipore) 
Protein Rainbow Marker:         GE Healthcare 
Skimmed  milk  powder:       Marvel 
Sodium  chloride:         VWR International Ltd 
Sodium dodecyl sulphate (SDS):    VWR  International  Ltd 
Spectra multicolour broad range protein ladder:  Fermentas 
Sucrose:       VWR  International  Ltd 
T r i s :           R o c h e  
Williams modified Eagle’s medium:     Invitrogen 
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2.1.6  Solutions 
Immunoprecipitation (IP) lysis buffer:  50 mM HEPES pH 7.4, 150 mM NaCl, 0.1% 
(v/v) NP40, 5% (v/v) glycerol, 1 mM EDTA, 
1 mM EGTA, 2 mM DTT; 1 tablet of protease 
inhibitors dissolved in 1 ml of water, 400 μl 
per 10 ml of buffer used 
Luria-Bertani (LB) broth:  10 g NaCl, 10 g Bactopeptone, 5 g yeast 
extract in 1 L water, pH 7.5 
Phosphate buffered saline (PBS):   170 mM NaCl, 3.4 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.2 
Protein gel running buffer:       0.05 M Tris, 0.05 M glycine, 0.1% SDS  
Resolving gel buffer (RGB):      1.5 M Tris-HCl, 0.4% SDS, pH 8.8 
SDS-PAGE loading buffer:   50 mM Tris-HCl, pH 6.8, 2.24% SDS (w/v), 
11.1% (v/v) glycerol, 666.6 mM β-
mercaptoethanol 
STET:   8% (w/v) sucrose, 5% (v/v) Triton-X 100, 50 
mM EDTA pH 8.0, 50 mM Tris-HCl pH 8.0 
Stacking gel buffer (SGB):       0.5 M Tris-HCl, 0.4% SDS, pH 6.8 
Stripping buffer:   2% SDS, 62.5 mM Tris-HCl, 100 mM β-
mercaptoethanol, pH 6.7 
1×TAE:   40 mM Tris, 1 mM EDTA, 5 mM sodium 
acetate, glacial acetic acid to pH 7.6  
Tris-EDTA (TE):  10 mM Tris-HCl, pH 8.0, 1 mM EDTA 
Transfer buffer (TOWBIN):   20% methanol, 25 mM Tris, 192 mM glycine 
pH 8.3 
Versene:          0.6 mM EDTA in PBS, 0.02% phenol red 
X-gal solution:   5 mM potassium ferrocyanide, 5 mM 
potassium ferricyanide, 2 mM magnesium 
chloride, 0.01% NP 40, in PBS; X-gal in 
DMSO (40 mg/ml) added to a final 
concentration of 2.4 mM   83
YTB medium:  8 g bacto-tryptone, 5 g yeast extract, 2.5 g 
NaCl to 1 L water, pH 5.0 
  
2.1.7  Viruses  
2.1.7.1  HSV-1 virus strains 
All HSV-1 strains were propagated in BHK cells, using Glasgow-modified Eagle’s 
medium, and titrated on U2OS cells by Anne Orr (MRC Virology Unit).  
 
Wild-type HSV-1 strain was 17 syn
+ (also known as Glasgow strain; 17+ for short) and 
was previously described (Brown et al, 1973).  The full sequence of this strain is described 
in McGeoch et al (1988). ICP0-null dl1403 HSV-1 strain was the derivative of the wild-
type strain 17+ (Stow & Stow, 1986). Strains in1863 (wild-type recombinant) and its 
ICP0-null dl1403/CMVlacZ counterpart were produced and kindly provided by Prof. Chris 
Preston (MRC Virology Unit). These strains contained an insertion of Escherichia coli 
gene lacZ coding for β-galactosidase within the tk locus.  
 
HSV-1 temperature-sensitive (ts) strain, tsK, and the mutant derivate strain in1374 were 
kindly provided by Chris Preston. Strain tsK has a lesion in ICP4 gene and was previously 
characterised (Marsden et al, 1976; Preston, 1979). Strain in1374 is a derivative of tsK 
virus, and in addition to a temperature-sensitive lesion in ICP4, also contains a deletion of 
the ICP0 gene, a mutation within the tegument protein VP16 that inactivates its ability to 
stimulate IE gene expression and an insertion of HCMV-IE promoter drive LacZ gene 
within UL43 (Preston & Nicholl, 2005). The HSV-1 mutant in1316 has mutations that 
inactivate the transcriptional activities of VP16, ICP0, and ICP4 and an insertion encoding 
EYFP-tagged pp71, controlled by HCMV MIEP, at the tk locus (Marshall et al, 2002). 
Strain  in1360 was a derivative of the above, containing untagged pp71 (Preston and 
Nicholl, 2005).  
 
2.1.7.2  HCMV virus strains 
The wild-type HCMV strain used was AD169. HCMV mutant strain ADSubUL82 has a 
deletion within the UL82 gene than encodes pp71, and was kindly provided by Thomas 
Shenk (Princeton University).  UV-irradiated strain AD169UV was provided by Chris 
Preston and its preparation is described elsewhere (Lukashchuk et al, 2008).  
   84
2.1.8  Cells 
2.1.8.1  Mammalian cells and culture conditions 
The cells used throughout this study and the purpose of their use are detailed below (in the 
order of relevance). Cells were maintained either in DMEM or WME media (as specified). 
DMEM was supplemented with 10% FBS for all cell manipulations unless specified 
otherwise. WME medium was supplemented with 10% FBS Gold (PAA Laboratories Ltd.), 
2 mM L-glutamine, 5 μg/ml insulin and 0.5 μM hydrocortisone (referred to as complete 
WME medium). All cell growth media were supplemented with 100 units/ml penicillin and 
100  μg/ml streptomycin. Cells transduced with lentiviral stocks were maintained in 
additional antibiotic selection media, generally 0.5 μg/ml puromycin and/or 0.5 mg/ml 
G418/neomycin as specified for each individual cell line in Table 2.6.  
 
HepaRG: Human hepatoma cell line with properties closely related to primary human 
hepatocytes (Gripon et al, 2002) was maintained in complete WME medium. HepaRG 
were the major experimental cell line used.  
HF cells: A primary human fibroblast (HF) cell line isolated from human foreskin tissue, 
obtained from the Department of Urology, University of Erlangen, and grown in DMEM. 
HF cells were the second major experimental cell line.  
HEK-293T cells: Human embryonic kidney cells transformed with adenovirus 5 DNA and 
SV40 Large T antigen. The cells were obtained from BD Biosciences and maintained in 
DMEM. The cells were used for the generation of lentiviral stocks expressing shRNA 
molecules or a protein of interest throughout the study. 
HEp-2 cells: Human epithelial cell line, originally established from human laryngeal 
carcinoma; obtained from the MRC Virology Unit cytology department, and maintained in 
DMEM. The cells were used in a small proportion of experimental manipulations.  
ws-HeLa cells: Epithelial cell line, originally established from human cervical carcinoma 
cells. Obtained from the MRC Virology Unit cytology department and grown in DMEM. 
The cells were used in a small proportion of experimental manipulations. 
U2OS: Human osteosarcoma cell line, obtained from the MRC Virology Unit cytology 
department and grown in DMEM. The cells were used for virus titration and other 
experiments.  
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2.1.8.2 Bacterial cells and culture conditions 
The E. coli strain DH5α chemically-competent cells (Invitrogen) were used in cloning 
procedures and plasmid DNA purification. DH5α were grown in LB-broth or plated out on 
LB agar plates.  LB media was supplied with appropriate antibiotics for transformed 
bacterial cells.  
 
2.2  Molecular biology methods 
2.2.1  Bacterial culture handling 
2.2.1.1 Transformation of competent bacterial cells 
For transforming chemically competent DH5α bacterial cells, 50μl aliquots were thawed 
on ice and mixed gently with appropriate quantity of plasmid DNA. For re-transforming 
plasmid DNA, 5-10 ng of DNA mix was used. For transforming ligation mix (see Section 
2.2.2.5), depending on the number of fragments, 3-5 μl of ethanol-precipitated plasmid 
DNA was used. The mixture was incubated on ice for 30 min, transferred to a 37 °C water 
bath for 1 min heat shock, placed back on ice for 2 min and mixed with 1 ml of YTB broth 
pre-warmed to 37 °C. Bacterial cells were allowed to recover at 37 °C for an 1 hour with 
horizontal shaking, centrifuged in the microfuge at 5,000 rpm for 2 min, resuspended in 
200 μl of YTB broth and plated out on pre-warmed agar plates, supplied with appropriate 
antibiotic (ampicillin or kanamycin as specified). Plates were incubated at the 37 °C 
incubator overnight, or generally for a period of less than 24 hours, and colonies were 
picked the following day for inoculating small scale cultures for plasmid miniprep analysis.  
 
2.2.1.2 Growing bacterial cultures for plasmid DNA preparation 
In order to grow up cultures for small scale DNA preparation (minipreps), an individual 
colony from an LB agar plate was inoculated into 3 ml LB-broth supplied with appropriate 
antibiotic, and cultures were incubated with horizontal shaking at 37 °C overnight.  
 
For large scale DNA preparation (maxipreps), bacterial cultures were set up in a larger 
volume of LB media. A starter culture was first set up by inoculating 10 ml of LB-broth 
with a single bacterial colony, grown over approximately 6-8 hours, and then mixed with 
350 ml LB-broth supplied with antibiotics. The large maxiprep culture was then 
propagated at 37 °C overnight with horizontal shaking.  
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2.2.2  Plasmid DNA extraction and analysis 
2.2.2.1 Small scale (miniprep) plasmid DNA extraction by boiling method 
Bacterial cultures grown overnight in 3 ml LB-broth were transferred to 1.5 ml Eppendorf 
tubes and centrifuged in the microfuge at 13,000 rpm for 1 min. Bacterial pellets were 
resuspended in 200 μl STET buffer, mixed with 5 μl of lysozyme/STET solution (10 
mg/ml) and boiled for 50 sec in the boiling water bath. Lysed bacterial cells were then 
centrifuged at 13,000 rpm for 20 min to spin down cell debris. The supernatant was 
transferred to a fresh Eppendorf tube, and the final volume was adjusted to 160 μl with 
additional STET as required. Supernatants were mixed with 135 μl of isopropanol and 
centrifuged in the microfuge at 13,000 rpm for 2 min. The supernatant was discarded and 
the DNA pellet was washed in 70% ethanol by a short 13,000 rpm spin. The pellets were 
dried at room temperature and resuspended in 30 μl of distilled water. This method for 
plasmid DNA preparation produces impure DNA which can only be used for general 
analysis by restriction digest and agarose gel electrophoresis (as described in section 
2.2.2.4).  
 
2.2.2.2 Large scale (maxiprep) plasmid DNA extraction by CsCl banding method  
Bacteria from the large overnight cultures were centrifuged in GSA tubes (400 ml) using 
the Sorvall GSA rotor in the Beckman GPR free-standing centrifuge at 5 k for 10 min at 
4°C. Pellets were resuspended in 20 ml of STET and transferred to 50 ml beakers. The 
suspension was mixed with 2.5 ml of lysozyme/STET solution (10 mg/ml) and incubated 
for 1 min at room temperature before bringing to the boil over the Bunsen burner and 
finally boiling for 50 sec in the boiling water bath. Lysed bacterial cells were transferred to  
50 ml SS34 tubes and centrifuged using the Sorvall SS34 rotor in the Beckman GPR 
centrifuge at 18,000 rpm for 45 min. Supernatant was then mixed with 0.9 volumes of 
isopropanol in 50 ml Falcon tubes and centrifuged at 3,000 rpm for 5 min at 4 °C to pellet 
DNA. The resulting dense DNA pellet was dissolved by adding 5 ml of 1×TE and 
incubating at 37 °C with horizontal shaking. When the pellet was completely dissolved, the 
obtained DNA solution was made up to a total volume of 6.3 ml with 1×TE and mixed 
with 7 g CsCl and 200 μl EtBr. The mixture was incubated on ice for 20-30 min, 
centrifuged at 3,000 rpm in a benchtop centrifuge (Sorvall RT7) for 10 min at 4 °C in order 
to pellet insoluble debris and carefully transferred into 65V13 tubes for CsCl banding. 
CsCl banding was performed by an overnight spin at 45,000 rpm for 16 hours in the 
Beckman L7-65 ultracentrifuge at 15 
oC using the 65 V13 high speed rotor. After the 
centrifugation the two bands were separated, of which the lower band corresponded to   87
plasmid DNA while the upper was chromosomal and linear DNA. The upper chromosomal 
layer was carefully removed using a needle and a 2 ml syringe; the lower band was then 
isolated and transferred into a 15 ml Falcon tube. In order to remove CsCl, dialysis against 
800 ml of 1×TE for 2 hours at room temperature with light stirring was performed. The 
dialysed plasmid was transferred into a 10 ml Sarstedt tube and treated with 100 μg/ml 
RNase by incubation at 65 °C for 1 hour. The solution was cooled then mixed with 100 
μg/ml proteinase K and 0.1% (w/v) SDS, and incubated at 37 °C for 1 hour. To extract the 
DNA, the solution was mixed with one volume of pre-saturated phenol and centrifuged at 
3,000 rpm for 10 min at 4 °C. The aqueous top layer was mixed with an equal volume of 
chloroform in a fresh Sarstedt tube, centrifuged at 3,000 rpm for 10 min at 4 °C (benchtop 
Sorvall RT7 centrifuge) in order to separate the upper aqueous layer.  This was transferred 
to another fresh Sarstedt tube, mixed with 1/20 volume of 5 M sodium chloride and 2.5 
volumes of 100% ethanol and incubated at -20 °C overnight to precipitate the plasmid 
DNA.  To pellet the DNA, the tubes were centrifuged at 3,000 rpm for 10 min at 4 °C, the 
pellet was dissolved in 400 μl of distilled water and transferred to a 1.5ml Eppendorf tube 
for an additional round of ethanol precipitation on a small scale. The solution was mixed 
with 20 μl (1/20 volumes) of 5 M sodium chloride and 1 ml (2.5 volumes) ethanol, 
incubated on dry ice for 20 min and centrifuged at 13,000 rpm in the microfuge (OLE 
DICH microcentrifuge; Camlab) for 10 min. The resulting DNA pellet was washed with 
80% ethanol by 5 min centrifugation at 13,000 rpm, air-dried at room temperature and 
finally dissolved in 0.1 - 0.3 ml 1×TE depending on the size of the final pellet. DNA 
concentrations of the maxipreps were determined using an Eppendorf BioPhotometer. The 
purified plasmid DNA was stored at 4 °C.  
 
2.2.2.3 Using commercial kits for plasmid DNA extraction and purification 
Due to impurities contained within DNA solution obtained by a boiling miniprep method 
(described in section 2.2.2.1), QIAquick® PCR purification kit (QIAGEN) were used to 
clean up selected miniprep DNAs following the manufacturer’s instructions. The clean 
DNA miniprep was then used for sequencing reactions.  
 
For an alternative method of large scale plasmid DNA extraction, NucleoBond® Xtra 
Maxi Plus kit (Macherey-Nagel) was used according to manufacturer’s instructions, using 
the maxiprep protocol.  
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2.2.2.4 Plasmid DNA analysis by restriction digest and agarose gel electrophoresis 
For a standard restriction digest reaction, the total volume of each reaction was made up to 
20 μl with distilled water. Each reaction contained 10 units (or 1 μl) of restriction enzyme 
and 2 μl of its appropriate 10 x restriction buffer. If digesting PCR reactions, they were 
first purified using QIAquick®  PCR purification kit, and the total volume of the purified 
reaction (30 μl of the column-eluted fragment) was used to set up a restriction digest 
reaction with 10 units of the restriction enzyme and 1 x restriction buffer. Reactions were 
incubated for 2 hours at 37 °C.  
 
For restriction analysis or fragment purification, 1% (w/v) agarose gels were prepared in 
1×TAE buffer. Restriction digest reactions were mixed with 6×DNA loading dye 
(Promega) and DNA fragments produced by restriction enzyme digestions were separated 
by agarose gel electrophoresis at 100 volts. The gel was then stained in ethidium 
bromide/1×TAE solution (approximately 1 μg/ml) for 15 min on a shaker and rinsed with 
water. The DNA was visualised with short wave UV on a U.V. Products Inc 
transilluminator. For fragment preparation, 5-10 μg plasmid DNA was digested, and 
following electrophoresis the DNA bands were visualised under long wave UV and 
appropriate fragments were excised. In order to extract fragment DNA from a gel slice, 
QIAquick® gel extraction kit (QIAGEN) was used according to manufacturer’s 
instructions. Fragments were eluted in 30 μl of QIAGEN Elution Buffer. 
 
2.2.2.5 Ligation of DNA fragments 
Prior to setting up a ligation reaction, DNA fragments were purified from agarose gels as 
described above. If using PCR fragments, they were digested and purified using the 
QIAquick® PCR purification kit. For a standard ligation reaction, 5 μl of each QIAGEN 
column-eluted DNA fragment was mixed with 4 μl of T4 DNA ligase buffer and 1 μl T4 
DNA ligase in a total reaction volume of 20 μl. Reactions were incubated at room 
temperature overnight. The following day each ligation mix was made up to a total volume 
of 200 μl with 1×TE, and DNA was precipitated using 1/20 vol of 5 M NaCl and 2.5 vol 
100% ethanol as described for the final steps of the CsCl banding method (see section 
2.2.2.2). The invisible DNA pellet was resuspended in 10 μl distilled water. Depending on 
the number of fragments used per ligation reaction, 2-5 μl of resulting DNA solution was 
used for transforming competent bacterial cells as described in section 2.2.1.1.  
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2.2.2.6 Sequencing of the purified plasmid DNA  
Prior to sequencing, correct construction of the recombinant plasmid was confirmed by 
appropriate restriction digests and selected miniprep DNA was purified using a QIAGEN 
column and following the PCR purification protocol. Sequencing was performed to ensure 
that no random mutagenesis has occurred throughout bacterial cloning procedures. 
Sequencing reactions were submitted to Claire Addison and Aidan Dolan (MRC Virology 
Unit) as reactions of 6 μl total volume containing 3 nmoles primer and 50-70 ng DNA. In 
brief, DNA/primer solutions were mixed with 0.5 μl Big Dyes (ABI version 3.1), 1.75 μl 
ABI Dilution Buffer and 1.75 μl of distilled water. The sequencing mixes were then 
subject to PCR cycling (PCR systems 9700) and ethanol-precipitated (work done by C. 
Addison and A. Dolan). The pellets of the sequencing reactions were submitted to the 
Glasgow University sequence service. Ready sequences were analysed using VectorNTI 
software. 
 
2.2.3  Recovery of pLKO.puro-shATRX clones   
Plasmid DNA expressing shRNA molecules targeting endogenous cellular ATRX were 
part of MISSION shRNA library (Sigma-Aldrich) and were based on the construct 
pLKO1.puro (Figure 2.1, A). These plasmids were sourced commercially and provided as 
glycerol stocks of transformed bacteria. This vector contained the essential elements for 
lentiviral production, including 5’ and 3’ LTRs, HIV-1 packaging sequence, a gene for 
ampicillin resistance  (AmpR) for selective growth of the transformed bacterial colonies, a 
coding sequence for puromycin resistance for mammalian cell selection.  The bacterial 
stock expressing pLKO-shATRX90 was delivered as transformed bacterial cells, which 
were plated out on agar plates supplied with 100 μg/ml ampicillin. The following day 
colonies were inoculated into LB-broth for small-scale plasmid DNA preparation using the 
boiling method. Minipreps were screened by restriction digest, sequenced and respective 
miniprep cultures were grown for large-scale DNA preparations. Plasmid DNA was 
extracted by the CsCl banding method as described in Section 2.2.2.2. The target sequence 
of ShATRX90 within the ATRX gene is 5’-CGACAGAAACTAACCCTGTAA-3’ and is 
schematically represented on Figure 2.1, B.   
 
 
 pLKO1.puro
7052 bp
AmpR
PuroR
HIV 3' sin LTR
HIV 5' LTR
HIV-1 package seq
RRE
cPPT hPGK
RSV promoter
ATRX NM_000489
10330 bp
ATRX cDNA ShATRX90
A
B
 
 
Figure 2.1 Lentiviral vector pLKO1.puro  
A: Map showing the features of the lentiviral vector. Abbreviations of the features: RRE - rev 
response element, hPGK promoter - human phosphoglycerate kinase promoter, cPPT - polypurine 
tract, LTR - long terminal repeats, sin – self-inactivating, RSV promoter - Rous sarcoma virus 
promoter. The vector also bears a gene for puromycin resistance (PuroR) for mammalian cell 
selection and ampicillin resistance (AmpR) for selective growth of transformed bacterial colonies. 
The site of shRNA sequence insertion is indicated by an arrow. B: The ATRX open reading frame 
demonstrating the position of the target site shATRX90. The ATRX cDNA is marked by a grey 
arrow.  
  902.2.4  Specific cloning strategies 
Specific approaches for cloning the hDaxx native sequence into a pLKO-based vector and 
hDaxx mutagenesis were designed. The resulting constructs were used for generating cell 
lines that were utilized for a significant part of the studies described in Chapters 3 and 5.  
 
2.2.4.1 Polymerase chain reaction  
The following polymerase chain reaction (PCR) conditions were used throughout the 
procedures, according to the Phusion
® High-Fidelity (HF) PCR manual (Finnzymes), with 
minor alterations as indicated in the text:  
 
PCR reaction 
5×  HF  PCR  buffer       10  μl 
Primer  1      0.5  μM 
Primer  2      0.5  μM 
Aliquoted  dNTP  mix     0.1  mM   
Template  DNA    50  ng 
dH2O        t o   4 9   μl 
Phusion
® HF DNA polymerase (2 units/μl)  2 units (1 μl) 
 
Cycling conditions 
Initial denaturation cycle  98 °C        30s   
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Denaturation    98  °C        10s 
Primer annealing    60-65 °C    20s       × 30 cycles 
Extension    72  °C      ≥30s  
Final extension    72 °C      5 min 
H o l d      4   °C         ∞ 
 
Extension time was allowed as at least 30 sec per 1 kb of DNA fragment, hence for 
fragments larger than 1 kb it was increased accordingly as specified. Primer pairs used for 
the strategies described in the current section are listed in the table below. Each primer pair 
introduces a restriction site that is unique for each particular fragment amplified in a PCR.  
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Table 2.5 Primer pairs used in pLNGY-hDaxx vector construction 
Primer pair  Restriction 
sites 
Size of the amplified 
fragment  Purpose 
1  Daxx Xho F  
Daxx si-ve R 
Xho I 
Bgl II  650 bp 
2  Daxx si-ve F  
Daxx Apa R 
Bgl II 
Apa I  625 bp 
3  Daxx Apa F  
Daxx Eco stop R 
Apa I 
EcoR I  969 bp 
hDaxx cloning into 
pLNGY 
4  E-Daxx Age F  
Daxx dPAH R 
Age I 
-  890 bp 
5  Daxx dPAH F 
Daxx Eco stop R 
- 
EcoR I  1,900 bp 
Deletion of ATRX-
interaction region 
6  E-Daxx Age F  
Daxx dSIM R 
Age I 
EcoR I  ~2.9 kb 
Deletion of SUMO-
interaction motif 
7  E-Daxx Age F  
Daxx MSIM R 
Age I 
EcoR I  ~3,000 kb 
Mutagenesis of SUMO-
interaction motif 
 
2.2.4.2 General cloning strategy  
The cloning strategies utilized in construction of the plasmids throughout this section 
consisted of all or in part of the main principal steps: 
1.  PCR using conditions specified above with minor alterations.  
2.  Gel electrophoresis of 5 μl of the PCR product was using 1% agarose gel to 
confirm the correct size of the product. 
3.  Purification of the remaining reaction using QIAquick® PCR purification system; 
eluted in 30 μl of the Elution Buffer (QIAGEN), unless detailed below otherwise. 
4.  Restriction digest of the purified PCR fragment (if specified). 
5.  Purification of the restriction digest reaction using QIAGEN PCR purification 
system. 
6.  Ligation of the resulting fragment containing sticky ends with other fragments. 
7.  Ethanol precipitation of the ligation reaction and transformation of competent 
bacterial cells.  
8.  Small-scale DNA extraction (by boiling method, section 2.2.2.1), analytical 
restriction digestion for screening for correct insertion of the fragments, and 
sequencing.  
9.  Large-scale DNA extraction using transformed bacterial cells from successful DNA 
minipreps.  
 
 
 2.2.4.3 Construction of pLNGY-hDaxx 
The vector backbone for cloning hDaxx sequence was pLKO.neo.gD.EYFP (pLNGY for 
short; Figure 2.2). The vector contained in addition to the elements required for lentivirus 
production, a coding sequence for neomycin resistance (G418/neoR), an HSV-1 
glycoprotein D gene (gD) promoter and the EYFP coding region. Plasmid pcDNA3.hDaxx 
expressing native hDaxx (GenBank accession code NM_001350) was kindly provided by 
John Sinclair (Cambridge).   
 
pLKOneo.gD.EYFP (pLNGY)
8064 bp
G418/neo
EYFP
cPPT
HIV 3' sin LTR
HIV 5' LTR
HIV-1 package seq
RRE
AmpR
gD
hPGK
RSV promoter
pBR322 ori
AgeI (8053)
EcoRI (748)
 
Figure 2.2 pLKOneo.gD.EYFP (pLNGY)  
Backbone lentiviral vector containing neomycin resistance gene for mammalian selection 
(G418/neo), the weak gD promoter and EYFP for N-terminally tagging the insert gene. For all 
other marked features refer to Figure 2.1 A.   
 
The strategy for cloning of hDaxx sequence in pLNGY is depicted in Figure 2.3. In order 
to generate the construct pLNGY-hDaxx, firstly, three hDaxx fragments were amplified in 
separate PCR reactions using pcDNA3.hDaxx plasmid as a template DNA, primer pairs 1-
3 and following the reaction conditions as described above, with the fragment extension 
time 30 sec and primer annealing temperature 60 °C. The forward and reverse primers 
Daxx si- (siRNA negative) introduced a silent mutation into shDaxx2 target site, in 
addition to a Bgl II restriction site. Each purified PCR fragment was digested with 
respective restriction enzymes (Table 2.5, restriction enzymes for primer pairs 1-3; Figure 
2.3) and ligated into the pEYFP-C1 plasmid backbone (digested with Xho I and EcoR I) in 
order to generate the intermediate clone pEYFP-C1.hDaxx. The plasmid was transformed 
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into  E. coli cells and plated out on agar plates supplied with kanamycin (25 μg/ml). 
Individual colonies were grown for small-scale plasmid DNA extraction, extracted plasmid 
DNA preps were screened for correct insertion of the fragments by restriction digests and 
successful minipreps were sequenced. DNA clones containing the correct plasmid pEYFP-
C1.hDaxx were digested with Age I (5’) and EcoR I (3’) and the fragment corresponding to 
EYFP-hDaxx coding region of approximately 3 kb was isolated by gel extraction. In the 
meantime, pLNGY vector was digested with Age I and EcoR I to yield the fragment 
corresponding to pLKOneo.gD. The fragments were ligated together, transformed into 
competent bacterial cells the following day and plated onto agar supplemented with 
ampicillin (150 μg/ml). The obtained colonies were first grown for small-scale DNA 
extraction, and DNA minipreps were further processed as described in the general strategy 
above. Plasmid pLNGY-hDaxx (Figure 2.4) was extracted by the CsCl banding method as 
described in section 2.2.2.2, and the sequence of the entire hDaxx open reading frame was 
authenticated.  
 
2.2.4.4 Deletion of hDaxx ATRX-interacting domain PAH1 
For deletion of hDaxx ATRX-interaction domain PAH1, mutagenesis by the gene splicing 
approach described in (Heckman & Pease, 2007) was performed. In summary, the 
technique involved two rounds of PCR, where round 1 generated overlapping fragments 
comprising the nucleotides upstream and downstream of the region to be deleted, and 
round 2 produced the full length product that lacked the region to be deleted (Figure 2.5).   
 
For the first round PCR reactions, plasmid pLNGY-hDaxx was used as the template DNA. 
In round 1 PCR, primer pairs 4 and 5 (Table 2.5) were used to generate overlapping hDaxx 
DNA fragments. Two reactions were set up with primer pairs 4 and 5 (corresponding to 
primers a+b and c+d in Figure 2.5, respectively) and subjected to 30 PCR cycles, using 
product extension temperature of 1 min. For the second round of PCR, 1 μl of each product 
obtained from the reactions of round 1 were mixed into one PCR reaction containing all 
the essential PCR components as detailed in PCR conditions above, apart from the primers. 
The reaction was initially subjected to 5 PCR cycles using a product extension time of 1 
min 30 sec. This step allows denaturation of the two products from the first round of PCR 
and re-annealing of the strand containing overlapping fragments, which are complementary 
to each other. Next, primers E-Daxx Age F and Daxx Eco stop R were added to the 
reaction, and the reaction was finally subjected to the remaining 25 cycles of PCR, which 
amplified the whole fragment EYFP-hDaxx.ΔPAH. The product was then treated as described above in the general cloning strategy (section 2.2.4.2) and DNA maxipreps were 
prepared according to CsCl banding method. 
 
Xho I Bgl II Apa I EcoR I
Xho I EcoR I
pEYFP-C1
Ligation of 
fragments
pEYFP-C1.hDaxx
Age I EcoR I
EYFP
hDaxx fragments
EcoR I
pLKOneo.gD fragment
Age I
Age I EcoR I
Restriction digest and 
excision of 
pLKOneo.gD fragment
Restriction digest and 
excision of EYFP-hDaxx 
fragment
Ligation of 
fragments
pLNGY-hDaxx
Age I EcoR I
pLKOneo.gD.EYFP
(pLNGY)
EcoR I Age I
 
Figure 2.3 Construction of pLNGY-hDaxx 
hDaxx fragments amplified via three different PCR reactions (see text) and pEYFP-C1 
intermediate vector were digested with the indicated restriction enzymes. Four fragments have been 
ligated together and transformed into bacteria. Purified plasmid pEYFP-C1.hDaxx and vector 
pLKOneo.gD.EYFP (pLNGY) were digested with Age I and EcoR I and fragments corresponding 
to EYFP-hDaxx and pLKOneo.gD, respectively were excised from agarose gel. Final pLNGY-
hDaxx construct was produced by ligation of the two fragments and amplification of the resulting 
DNA via bacterial transformation. 
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Figure 2.4 pLNGY-hDaxx construct 
Schematic representation of wild-type hDaxx insert within pLNGY lentiviral vector.  
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Figure 2.5 PCR-mediated gene splicing mutagenesis 
The region to be deleted is marked with a shaded box. During the first round of PCR, the 
overlapping fragments are generated, where the overlapping regions are complementary to 
downstream and upstream regions to be deleted. During the second round of PCR, denaturation 
step produces single strands, so that the overlapping regions, complementary to each other, anneal 
and extend using dNTPs in the following steps of the reaction. The point of resulting deletion of the 
final PCR product is indicated (adapted from Heckman and Pease, 2007).   
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2.2.4.5 Deletion of hDaxx SUMO-interaction motif 
For the SUMO-interaction motif (SIM) deletion, primer pair 6 (Table 2.5) was used to 
amplify the whole EYFP-hDaxx fragment and introduce a deletion of the last 8 amino 
acids in one PCR step. For PCR, template DNA was pLNGY-hDaxx. Reaction and cycling 
conditions for mutagenesis were the same as described above, product extension time was 
1 min 30 sec and annealing temperature was 65 °C.  The obtained EYFP-hDaxx.ΔSIM 
fragment was purified , treated with restriction enzymes Age I and EcoR I and cloned into 
pLKOneo.gD vector as described in the previous section. After screening and analysing the 
small-scale DNA preps, DNA maxipreps were produced by CsCl method. 
 
2.2.4.6 Mutagenesis of hDaxx SUMO-interaction motif  
In order to mutate the hDaxx SIM, the essential residues for SUMO binding were mutated 
using PCR-based site-directed mutagenesis protocol. For the PCR, pLNGY-hDaxx was the 
template and cycling conditions were as above, with the product extension time 1 min 30 
sec and primer annealing temperature 65 °C. Primer pair 7 was used in the reaction (Table 
2.5). The primer Daxx MSIM R used in the reaction introduced mutations coding for three 
amino-acids which replaced sequence I-V-L of the SIM to G-A-G (as indicated below).  
 
               733   734    735   736   737  738   739   740 
         D     P      E       E      I       I        V       L       S      D      S      D      
GC GAT CCA GAA GAG ATC ATC  GTG CTC  TCA GAC  TCT GAT TAG GAATTCTCGACCTCG 
 
                                                   G       A      G 
GC GAT CCA GAA GAG ATC GGC GCG GGC TCA GAC TCT GAT TAG GAATTCTCGACCTCG 
 
Purified PCR product was digested with Age I and EcoR I, and the further steps were 
followed as described in Section 2.2.4.2.    98
2.3  Cell culture methods 
2.3.1  General cell culture manipulations 
2.3.1.1 Maintenance and passaging of the laboratory cell lines 
All cell lines were maintained in their respective growth media as specified in the Section 
2.1.8.1. Additional antibiotic selection for lentivirus-transduced cell lines was used as 
detailed further in the Section 2.3.3.2 and Table 2.6. All cell lines were maintained in the 
incubator at the temperature 37 °C and 5% CO2 and passaged on a regular basis. All media 
and versene solutions were pre-warmed to 37 °C prior to passaging. To passage the cells, 
media was removed, cells were washed once with versene solution and incubated with 
trypsin/versene solution for 2-5 min to trypsinise the cells from the surface of the tissue 
culture flask. Trypsinised cells were then resuspended in media and transferred to a new 
flask. Depending on the cell type and the confluency of the cells required, cell lines were 
split at a range of ratios between 1/3 to 1/10. 
2.3.1.2 Cell seeding 
For experiments and assays, equal numbers of cells as specified for each experiment were 
seeded into appropriate tissue culture dishes. Cells were counted using the improved 
Neubauer haemocytometer chamber and determined as cells/ml. Generally, cell density of 
1×10
5 cells per well or 13 mm glass coverslip of the 24-well plate was used throughout the 
experiments, unless specified otherwise. For other tissue culture dishes, cells were seeded 
at the density specified individually for each experiment.  
2.3.1.3 Freezing and thawing of the cell stocks 
For storage, cell suspension was centrifuged at 1,500 rpm for 5 minutes (Sorvall RT7) and 
cell pellet was resuspended in cell freezing mix containing appropriate media without 
selective antibiotic, additional 20% foetal bovine serum and 10% (v/v) DMSO. 1 ml of the 
resuspended cell pellet was transferred to 1.5 ml cryo-vials. The vials were wrapped in 
several layers of tissue paper, transferred to -70 °C for overnight storage and then 
transferred to the liquid nitrogen freezer.  
 
For recovery from frozen, cells were thawed at 37 °C and put into media warmed to 37 °C 
containing appropriate antibiotic selection if required. Cells were allowed to attach to the 
tissue culture flask surface for a few hours before changing the medium, in order wash off 
residual DMSO.    99
2.3.2  Confocal immunofluorescence microscopy 
Confocal immunofluorescence microscopy is a method used widely throughout this study 
for analysis of protein localisation within normal or infected cells. Cells seeded onto 13 
mm glass coverslips were fixed with 0.5 ml formaldehyde fix solution [5% (v/v) 
formaldehyde solution, 2% (w/v) sucrose, in PBS] by incubation at room temperature for 
10 min. After removing the fix solution and washing the coverslips twice in PBS, 0.5 ml of 
permeabilisation solution [10% (w/v) sucrose, 0.5% (v/v) NP40, in PBS] was added and 
the cells were incubated at room temperature for 10 min. The cells were then washed three 
times in PBS supplemented with 1% FBS and probed with appropriate antibodies, as 
indicated for each individual experiment. 
 
Generally, incubation times were 1 hour with primary antibodies and 1 hour with 
secondary antibodies, diluted appropriately in PBS/1% FBS (see Table 2.1), with 3 or 4 
washes in PBS/1% FBS solution in between. Each coverslip was incubated with 25 μl of a 
diluted antibody by placing a coverslip onto the 25 μl drop with cell side facing down. 
After antibody staining, coverslips were finally rinsed in distilled water to remove PBS 
salts, air-dried at room temperature and mounted onto glass slides using a drop of about 10 
μl Citifluor AF1 (antifade agent in PBS/glycerol).  The coverslips were analysed 
immediately or stored at 4
oC until further analysis.  
 
Confocal microscopy analysis was carried out using a Zeiss LSM 510 confocal microscope 
with 488-, 543- and 633-nm laser lines, under image capture conditions that eliminated 
channel overlap. Samples were observed with a ×63 or ×40 NA 1.4 objective lens. The 
images were exported as files in a Tif format using the LSM Image Browser and edited 
using Adobe Photoshop. 
 
2.3.3  Lentiviral transduction of cell lines 
Generation of lentiviruses and transduction of cell lines was used for either the production 
of cell lines with stable knock-down of protein expression by RNAi approach (Figures 2.6 
and 2.7), or for re-constitution of the endogenous protein by introducing EYFP-fusion 
proteins. Depletion of endogenous protein expression was based on RNAi-mediated gene 
silencing (for reviews see McManus & Sharp, 2002; Meister & Tuschl, 2004). The 
overview of RNAi pathway is represented on Figure 2.6, demonstrating the key enzymatic 
complexes involved in the process. Utilization of short hairpin RNA (shRNA) molecules, expressed by specially designed lentiviral plasmids, in this pathway is detailed in Figure 
2.7.  
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Figure 2.6 Posttranscriptional processing by RNA interference 
Double stranded RNA (dsRNA) is recognised by the enzyme Dicer, which has a catalytic RNase III 
activity, and is cleaved into short double stranded RNA molecules, called small interfering RNA 
(siRNA) molecules. SiRNA molecules associate with the protein complexes to form the RNA-
induced silencing complex (RISC). Mature RISC contains the antisense single stranded RNA 
molecules (blue) that target the complementary sense sequence of the mRNA molecule (green). 
This results in mRNA cleavage and hence gene silencing (adapted from McManus & Sharp, 2002). 
 
2.3.3.1 Transfection using Lipofectamine 
Transfection procedures utilized throughout the study were aimed at production of the 
lentiviral stocks only.    
 
HEK-293T cells were seeded into a 60 mm tissue culture dish on the day preceding 
transfection procedure at a density of approximately 1.5 to 1.7×10
6 cells per dish. For each 
transfection, 4 μg of each plasmid DNA and DMEM without foetal bovine serum and 
penicillin/streptomycin antibiotic mix (referred to as serum-free DMEM), were used. The 
DNA mix for transfection contained the plasmid DNA of interest and two helper plasmids 
for production of lentiviral particles, pCMV.DR8.91 and pVSV-G. DNA was first mixed 
  100with 250 μl of serum-free DMEM and 8 μl of PLUS reagent, and the mixture was 
incubated for 15 min at room temperature. 250 μl of serum-free DMEM and 12 μl of 
lipofectamine reagent were then added and the whole mixture was incubated at room 
temperature for a further 15 min. Meanwhile, media was removed from HK-293T cells and 
kept at 37 °C (referred to as conditioned media). Cells were washed with serum-free 
DMEM once and 1 ml of serum-free media was then added to the cells. Finally, the 
transfection mixture was added to the cells dropwise, and the plates were incubated for 3 
hours at 37 °C, before overlaying with conditioned media. Cells were allowed to recover 
for additional 2-4 hours and media was changed to fresh DMEM. Lentiviral particles were 
then produced by the cells over the period of 72 hours, before harvesting supernatants.  
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Figure 2.7 Short hairpin RNA in experimental RNAi-mediated gene silencing 
DNA sequence is transcribed from a lentiviral vector to yield shRNA precursor molecules. Hairpin 
loop sequence allows folding through cis-base pairing to form an shRNA molecule that is 
recognised by Dicer which directs it for RISC assembly.  
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2.3.3.2 Transduction of cell lines with lentivirus  
Cells to be transduced were seeded into 60 mm dishes at a density of 0.5×10
6 the day 
before transduction with the lentiviral stocks. After 72 h post transfection, the supernatants 
from HEK-293T cells containing lentiviral particles were harvested and centrifuged (using 
benchtop centrifuge Sorvall RT7) at 1,500 rpm for 10 minutes to remove floating cell debri. 
The cleared supernatant was then filtered using 0.45 μm filter. 1 ml of the supernatant was 
added to the cells to be transduced, together with 5 μg of polybrene to aid adsorption of the 
virus. The lentivirus was allowed to adsorb during 1 hour by 37 °C incubation with gentle 
agitation every 5-10 minutes. After that, the procedure was repeated additional two times 
using fresh lentivirus and polybrene solution each time, and finally the cells were ovelayed 
with fresh media supplemented 5 μg/ml polybrene. Appropriate selection was applied the 
following day. Initial antibiotic selection was applied as 1 μg/ml puromycin or 1 mg/ml 
G418/neomycin, depending on the plasmid, which was subsequently reduced to constant 
selection of 0.5 μg/ml puromycin or 0.5 mg/ml neomycin. The resulting cell lines produced 
are detailed in the Table 2.6. 
 
2.3.3.3 Fluorescence activated cell sorting 
Enrichment of cells expressing EYFP fusion proteins after transduction with lentiviruses 
derived from plasmids of the pLNGY- series was achieved by fluorescence activated cell 
sorting (FACS). The service was kindly provided by Thomas Gilbey (Beatson Institute for 
Cancer Research, Glasgow).  
 
For FACS analysis, negative control cells (HepaRG) and cells expressing EYFP-hDaxx 
fusion proteins (see Table 2.6) were harvested in normal growth media, centrifuged in 15 
ml tubes at 1,500 rpm for 5 min and washed twice in 5 ml media containing 1% FBS and 
200 units/ml penicillin, 200 μg/ml streptomycin (2% penicillin/streptomycin solution). 
Cells were finally resuspended in 1 ml of media with 1% FBS and 2% 
penicillin/streptomycin and transferred to FACS tubes. Tubes were stored on ice for a short 
time before sorting EYFP-positive cells on a Becton Dickinson SORP FACSaria machine. 
After sorting, the total numbers of cells varied between 0.5 to 1×10
6 cells. Cells were 
mixed with normal growth media (10% FBS) without antibiotic selection, centrifuged and 
finally transferred to a 35 mm or 60 mm tissue culture dish, depending on the number of 
cells. Concentration of penicillin/streptomycin solution was maintained at 2 % for 
additional 24 hours, before the media was changed to normal media supplied with 
antibiotic selection.    103
 
Table 2.6 Lentivirus-transduced stable cell lines generated during the study  
Name Phenotype  Resistance 
HF-ShLuci  HF + pLKO.puro.ShLuci   Puromycin 
HF-ShA90  HF + pLKO.puro.ShATRX90  Puromycin 
HALL  HepaRG + pLKO.puro.ShLuci  Puromycin 
HAA90  HepaRG + pLKO.puro.ShATRX90  Puromycin 
HALD2  HepaRG + pLKO.puro.ShDaxx2  Puromycin 
HL-E  HepaRG + pLKO.puro.ShLuci + pLNGY Puromycin/neomycin 
HL-ED  HepaRG + pLKO.puro.ShLuci + 
pLNGY-hDaxx  Puromycin/neomycin 
HD-E  HepaRG + pLKO.puro.ShDaxx2 + 
pLNGY  Puromycin/neomycin 
HD-ED  HepaRG + pLKO.puro.ShDaxx2 + 
pLNGY-hDaxx  Puromycin/neomycin 
HD.ΔPAH  HepaRG + pLKO.puro.ShDaxx2 + 
pLNGY-hDaxxΔPAH1  Puromycin/neomycin 
HD.ΔSIM  HepaRG + pLKO.puro.ShDaxx2 + 
pLNGY-hDaxxΔSIM  Puromycin/neomycin 
HD.MSIM  HepaRG + pLKO.puro.ShDaxx2 + 
pLNGY-hDaxxMSIM  Puromycin/neomycin 
 
2.4  Protein methods 
2.4.1  Detection of protein expression by western blot 
The following sections describe the methods for analysis of the protein expression that 
were utilized consistently throughout the study. Bio-Rad systems were used for resolving 
and transferring proteins onto a nitrocellulose membrane. The buffers used in the various 
steps are detailed in Section 2.1.6. 
 
2.4.1.1 SDS-polyacrylamide gel electrophoresis 
In order to analyse expression of the proteins, protein samples were harvested in SDS-
PAGE loading buffer and subjected to SDS-PAGE, based on the method described in   104
(Laemmli, 1970). Cells in the wells of 24-well plates (1×10
5 cells) were harvested in 70 μl 
of SDS-PAGE loading buffer, boiled for 3 min, then 20 μl of the sample was loaded onto 
polyacrylamide gels and the rest stored at -20 °C. Generally samples were resolved on 
7.5% polyacrylamide gels, although 6 % gels were also commonly used for resolving 
proteins of higher molecular weights or for better separation of high molecular weight 
bands. Gels fully submerged into running buffer (see Section 2.1.6) were run at a voltage 
ranging between 80-110 Volts.  
 
2.4.1.2 Transfer of the proteins to nitrocellulose membrane 
Resolved proteins were transferred onto Hybond nitrocellulose membranes following a 
previously described method (Towbin et al, 1979), at a constant voltage either at 50 mAmp 
overnight at 4 °C or at 250 mAmp at a room temperature for 2.5 hours.  
 
2.4.1.3 Immunodetection of the proteins 
All incubations and washes of the membranes were performed with constant agitation. All 
primary and secondary antibodies were diluted in the blocking buffer and stored at -20 °C. 
Membranes were incubated with the blocking buffer (5% (w/v) Marvel milk powder, 1% 
(v/v) Tween 20 in PBS) by incubating for 1 hour at room temperature or overnight at 4 °C 
and incubated first with primary antibodies. Membranes were incubated at a room 
temperature for 2-2.5 hours with most of the antibodies used throughout the study, 
although certain antibodies (such as anti-Daxx D7810) were used overnight at 4°C. Anti-
HCMV IE1 antibody was always used at 4 °C overnight. After incubation with a primary 
antibody, the membrane was washed three times with PBS/1% (v/v) Tween 20, with each 
wash lasting at least 10 min. Next, the appropriate anti-rabbit or anti-mouse horseradish 
peroxidase-conjugated secondary antibody was added for a 1 hour incubation at room 
temperature. Membranes were then washed with PBS/1% (v/v) Tween 20 three times. The 
protein bands were then visualised by staining the membrane with enhanced 
chemiluminescence system (Perkin-Elmer Life Sciences) according to the manufacturer’s 
manual and exposing the membrane to Kodak X-Omat film for the appropriate length of 
time, depending on the efficiency of the antibody binding.  
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2.4.1.4 Stripping of the nitrocellulose membrane 
In order to re-probe the membrane, it was incubated in stripping buffer (see section 2.1.6) 
at 55 °C for 30-40 min with occasional agitation. The membrane was then washed, blocked 
and re-probed as described above. For re-probing of the membrane, it was only stripped 
once.  
 
2.4.2  Co-Immunoprecipitation 
Co-immunoprecipitation (CoIP) was used for detection of interactions between either 
endogenous or re-introduced proteins. Cell monolayers were seeded into 100 mm tissue 
culture dishes at 4.5 × 10
6 cells per dish, unless specified otherwise. The cells were 
harvested in 3 ml of immunoprecipitation (IP) lysis buffer (50 mM HEPES pH 7.4, 150 
mM NaCl, 0.1% NP40, 5% glycerol, 1 mM EDTA, 1 mM EGTA, 2 mM DTT) 
supplemented with protease inhibitors using the rubber plunger from a 2 ml syringe. Cells 
were incubated on ice for 15 min prior to lysing by bath sonication (2 cycles of 1 min each, 
at 4°C) using Branson digital sonifier. Cell debris were removed by centrifugation at 
25,000 rpm for 30 min at 4°C, and the lysates were pre-cleared by incubating with Protein 
G beads supplemented with salmon sperm DNA (Millipore) for 30 min at 4°C, with 
continuous mixing. After centrifugation at 13,000 rpm for 10 min at 4 °C to remove the 
beads and non-specifically bound proteins, immunoprecipitation was carried out by 
incubating the lysates for 2 hours at 4 °C with 1 μg of rabbit antibodies per 750 μl lysate, 
using no antibody control or irrelevant pre-immune rabbit serum control as indicated per 
each experiment, utilizing continuous mixing. Immune complexes were then captured by 
incubation with Protein G beads for 90 min at 4°C, with continuous mixing.  The beads 
were washed 3 times with 1 ml IP lysis buffer and once with 200 μl IP buffer before 
resuspending in 30 μl SDS-PAGE loading buffer. Samples were boiled for 5 min to 
dissociate complexes from the beads, centrifuged to pellet the beads and processed for 
western blotting by resolving on a 6% polyacrylamide gel as described above. 
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2.5  Virology methods 
2.5.1  General virus handling and infection assays 
2.5.1.1 Propagation and titration of the viral stocks 
All HSV-1 viral stocks were provided by Anne Orr (MRC Virology Unit). Virus was 
propagated on BHK cells and harvested as cell-released or cell-associated virus stocks. 
Viral stocks were titrated on U2OS cells because of their property to complement ICP0-
null mutant HSV-1 (Yao & Schaffer, 1995). For HSV-1 titration, cells were stained for the 
appearance of the plaques with Giemsa stain 48 hours post infection.  
 
All HCMV stocks were propagated and provided by Chris Preston. HCMV strains were 
titrated on human fibroblasts cell line HFFF2. Propagation of ADSubUL82 was previously 
described (Bresnahan & Shenk, 2000).   
 
2.5.1.2 Standard approaches for viral infection assays 
The following method for infection of the cells seeded into appropriate tissue culture 
dishes was used throughout the experiments, unless otherwise specified for particular 
HCMV infection assays.  
 
In order to infect the cells seeded into appropriate volume, firstly the required amount of 
virus to be used was determined according to the required multiplicity of infection (MOI), 
based on the number of cells seeded into the dish on the day prior to infection procedures. 
MOI is specified for each individual experiment. Media was removed from the cells so that 
a small amount of media was left to form a meniscus in the dish when tilted. This was 
conditioned media and was stored at 37 °C until further use. Appropriate amount of virus 
was added onto the cells to fully cover the cell monolayer, virus was allowed to adsorb at 
37 °C for 1 hour with gentle agitation every 5-7 min. After 1 hour of virus adsorption, the 
cells were overlayed with conditioned media with or without 1% human serum, as detailed.  
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2.5.2  Viral experimental assays 
2.5.2.1 Establishing HSV-1 plaque formation efficiency using blue plaque assays 
Cells in 24-well plates were infected with sequential three-fold dilutions of the wt and 
ICP0 null mutant viruses containing a CMVlacZ insertion cassette. Starting dilutions for 
the stocks of in1863 and dl1403/CMVlacZ were 10
-4 and 10
-2, respectively, with the stocks 
having been diluted to titres of approximately 1 x 10
9 pfu/ml as determined on U2OS cells. 
After adsorption of the virus (as described above) and overlay with conditioned media 
supplied with 1% human serum in order to neutralise cell released virus, plaque formation 
by cell-to-cell spread was allowed to proceed over approximately 24-26 hour period. The 
cells were washed once in PBS and fixed in 1% (v/v) glutaraldehyde in PBS solution by 
incubating at room temperature for 20-30 min. Meanwhile, X-gal solution was prepared 
(see Section 2.1.6) and warmed to 37 °C. Fixed cells were washed twice in PBS. Prior to 
adding the solution onto cells, it was filtered, then 0.5 ml of the solution was added onto 
cells and the plates were incubated at 37 °C for at least 1 hour to allow β-galactosidase 
staining to develop. The plates were then washed and dried.  
 
Analysis of the plaque formation efficiency included determining the plaque numbers in 
the control cell line first (such as normal HepaRG or HALL cells) and calculating the 
relative number of plaques obtained with the same dilution of virus in the other cell lines 
tested. The averages were determined based on the different sets of dilutions and generally 
on three to four independent experiments (as specified).  
 
2.5.2.2 Immunofluorescence analysis of developing HSV-1 plaques  
Cells seeded onto coverslips were infected with either 17+ or dl1403 at the indicated MOIs. 
Virus was adsorbed as described and overlayed with conditioned media containing 1% 
human serum, in order to neutralise cell-released virus and to only allow cell-to-cell spread. 
After plaques were allowed to develop over 18-24 hour period (or overnight), cells were 
processed for immunofluorescence as described in section 2.3.2. Cells infected at the edge 
of a developing plaque were analysed for distribution of ND10 components and the viral 
transcription regulator ICP4, which binds to viral genomes (Pizer et al, 1991). 
 
2.5.2.3 Kinetics of HSV-1 protein expression 
For kinetics of viral protein expression, standard infection assays utilized HSV-1 strains 
17+ and dl1403. Cells seeded into the wells of the 24-well plate were infected with the   108
virus at an appropriate MOI, as specified for each individual experiment. Virus was 
allowed to adsorb as described in section 2.5.1.2, and infected cells were overlayed with 
conditioned media. Samples were harvested at the indicated time points after adsorption of 
the virus (referred to as hours post infection) in SDS-PAGE loading buffer. Samples were 
either processed for Western blot analysis as described in section 2.4.1 or stored at -20 °C.  
 
2.5.2.4 Assay of establishment of HSV-1 quiescence 
In order to analyse the efficiency of the establishment of HSV-1 quiescence, virus in1374 
was used. Cells, seeded into 24-well plates, were infected with in1374 at an MOI of 5, 
virus was allowed to adsorb at 37 °C and overlayed with conditioned media. For 
determining the maximum potential of reactivation, cells were also co-infected with tsK 
virus at MOI 1. The cells were then transferred to a non-permissive temperature of 38.5 °C, 
and infection was allowed to proceed for approximately 16-18 hours (or overnight). The 
following day cells were stained for β-galactosidase expression with X-gal solution as 
described for blue plaque assays in section 2.5.2.1. Efficiency of establishment of 
quiescence was determined as the number of cells, expressing the marker gene β-
galactosidase, which appeared blue following X-gal staining.  
 
2.5.2.5 Fluorescence recovery after photobleaching 
Fluorescence recovery after photobleaching (FRAP) analysis was performed on HD-ED 
cells, expressing EYFP-hDaxx fusion protein. In order to set up cells for FRAP analysis, 
cells were seeded at a density 5×10
5 cells per dish into 35 mm dishes with a hole in the 
bottom and a coverslip fixed to cover the hole. The following day cells were infected with 
dl1403 at MOI 1.2 and overlayed with conditioned media containing 1% human serum. 
Cells were washed once with DMEM, free of phenol red (Invitrogen) and kept in phenol 
red free DMEM for the length of the experiment. Dishes were placed into the live cell 
chamber of a Zeiss LSM 510META confocal microscope, with environmental control to 
provide an atmosphere adjusted to 37°C and 5% CO2.  Mock infected and cells 
demonstrating clear redistribution of EYFP-hDaxx to foci associated with HSV-1 genomes 
were selected for analysis. ND10 foci (generally 3 per cell) were photobleached using 15 
re-iterations of the 514 nm laser set at 100%. The region of interest was then scanned 20 
times at 1.5 sec intervals to determine the speed of recovery. Control areas were 
unbleached ND10 dot and unbleached area within the nuclei. Data was calculated as 
percentages of fluorescence recovery using Excel. Data was averaged from two   109
independent experiments, each analysing between 20 and 25 ND10 foci from mock 
infected cells or those associated with incoming dl1403 genomes.  
 
2.5.2.6 Phosphorylation analysis of HSV-1 infected cell lysates 
Cells seeded into 24-well plates were infected the following day with 17+ and dl1403 at 
MOI 5 and 10. Cells were harvested in 70 μl IP lysis buffer, without EDTA, at the 
indicated time points post infection. Lysates were incubated on ice for 15 min and lysed by 
bath sonication as described above.  Reactions were set up using λ-phosphatase (New 
England Biolabs) according to the manufacturer’s instructions. For 20 μl of cell lysate, 400 
units of λ-phosphatase was used. Reactions were supplemented with 1× phosphatase buffer, 
2 mM MnCl2 and made up to the total volume of 30 μl with IP buffer. After incubation 
treatment for 1 hour at 30 °C, samples were mixed with 20 μl of SDS-PAGE loading 
buffer, boiled for 5 min and processed for western blot analysis as described above. 25 μl 
of the reaction was loaded onto a gel and the remaining aliquots stored at -20°C.  
 
2.5.2.7 Analysis of HCMV replication efficiency 
HF cells on 13 mm glass coverslips were infected with AD169 or ADSubUL82 as follows. 
100 μl of the virus dilution was added directly onto a coverslip placed onto a lid of the 24-
well plate, with cell side facing upwards, and virus was adsorbed at 37 °C without shaking. 
Coverslips were then transferred into a well of a 24-well plate filled with 1 ml of medium. 
The infection was allowed to proceed for up to 11 days. Because of the EGFP cassette 
inserted in place of deleted UL82 gene in mutant virus ADSubUL82, the plaques could be 
visualised by green fluorescence using the 488 nm laser. Supernatants of the cell released 
virus were harvested and their titres determined by Chris Preston on HFFF2 human 
fibroblast cells, by infecting the coverslips and processing them for immunofluorescence 
(as described above). Titres were determined as IE1-positive units using anti-IE1 antibody 
staining.      
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3  Characterisation of ATRX and hDaxx in Cell Culture 
3.1  Introduction 
In the main introduction to this thesis (Chapter 1) the topic of anti-viral activities of ND10 
proteins has been discussed. To summarise the key points, during herpesvirus infection, 
viral transcriptional activators such as HCMV tegument protein pp71 and HSV-1 IE 
protein ICP0 localise to ND10 very early after infection which, in the case of ICP0, results 
in disintegration of these structures (Everett & Maul, 1994; Everett & Zafiropoulos, 2004; 
Ishov et al, 2002; Marshall et al, 2002; Maul et al, 1993). In the absence of these viral 
transactivators, replication of both HSV-1 and HCMV is considerably less efficient in 
restrictive cell lines (Bresnahan & Shenk, 2000; Everett et al, 2004).  
 
The general hypothesis that drives the work of this thesis states that ND10 proteins 
contribute to the immediate anti-viral intrinsic cell defence responses, which take place as 
soon as the viral genomes are released into the cell nucleus. Experimental investigation of 
this hypothesis using restrictive cell lines by several research groups, referenced above, 
noted that ICP0 and pp71 counteract these mechanisms.  Based on the available data so far, 
it follows that ND10 protein factors collectively contribute, either separately or as a part of 
a complex, to the repression mechanism that occurs in the absence of the viral 
transcriptional activators. In support of this statement, PML has been identified as the 
component of cellular intrinsic resistance to both HCMV and HSV-1 (Everett et al, 2006; 
Tavalai et al, 2006). In addition, Sp100 and hDaxx have been also found to contribute to 
intrinsic resistance against HSV-1 and HCMV infection, respectively, by independent 
groups (Cantrell & Bresnahan, 2006; Everett et al, 2008; Kyratsous & Silverstein, 2009; 
Preston & Nicholl, 2006; Saffert & Kalejta, 2006; Tavalai et al, 2008). These findings have 
instigated further investigation into ND10-localised regulators of viral infection. The 
considerable evidence of the role of chromatin in the regulation of viral infection has 
stimulated a further interest into investigating chromatin-associated proteins that localise to 
ND10, such as ATRX and hDaxx.  
 
Transcriptional repressor hDaxx binds several transcriptional regulators, thereby 
influencing transcription of its target genes (Chang et al, 2005; Hollenbach et al, 2002; 
Holmstrom et al, 2008; Ishov et al, 1999; Ryo et al, 2007), and in some reports has been 
shown to directly repress gene promoters (Morozov et al, 2008). One of the hDaxx-
interacting partners is ATRX (Ishov et al, 2004; Tang et al, 2004; Xue et al, 2003). The   111
key characteristics of ATRX are that it includes motifs related to chromatin-remodelling 
enzymes of the SWI/SNF family of ATP-dependent helicases, that it localises to ND10 
(Ishov et al, 2004; Tang et al, 2004), and that it interacts with chromatin-associated 
proteins MeCP2 and HP1 (Baumann et al, 2008; De La Fuente et al, 2004; Le Douarin et al, 
1996; Lechner et al, 2005; Nan et al, 2007). Since ATRX and hDaxx constitute a complex 
with chromatin-remodelling activities, which are likely to be repressive (Tang et al, 2004; 
Xue et al, 2003), it was of interest to investigate whether the two proteins contribute to the 
cellular intrinsic defence mechanism against HSV-1 and HCMV infection.    
 
The present chapter summarises the preliminary work conducted for the purpose of: (a) 
analysing ND10 components, with the focus on ATRX and hDaxx in different cell lines; (b) 
generating cell lines depleted of endogenous ATRX and hDaxx, as tools for studying the 
functions of the two proteins, and (c) re-constitution of wild-type or mutant hDaxx 
expression in hDaxx depleted cells in order to study its functions in HSV-1 infection in 
more detail. The cell lines characterised in this Chapter have been used throughout the 
investigation into the roles of ATRX and hDaxx in HSV-1 and HCMV infection, and the 
results are described in Chapters 4 and 5.  
 
3.2  Results  
3.2.1  Characterisation of ND10 protein expression in various cell lines 
3.2.1.1 Analysis of ND10 protein expression in human cell lines by western blot 
Differences in the defect in plaque-forming efficiency of ICP0-null mutant HSV-1 range 
between 1000- to 500-fold in restrictive cell lines such as HFs and HepaRG, respectively, 
to around a 10-fold defect in transformed cell lines such as HeLa. Interestingly, there is no 
such replication defect in U2OS cells that are known to complement ICP0-null mutant 
HSV-1 by a mechanism that remains unidentified (Yao & Schaffer, 1995). It is possible 
that cell type differences in expression or function of ND10-related intrinsic resistance 
proteins may contribute to variations in replication efficiency of the mutant virus. In order 
to test this hypothesis, expression levels of a number of ND10 proteins in different cell 
lines were analysed and compared (Figure 3.1).  
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Figure 3.1 Analysis of endogenous expression of ND10 proteins in cultured cell lines   
Samples of the indicated cells were harvested and whole cells extracts derived from approximately 
3 x 10
4 cells were loaded onto 7.5% or 6% polyacrylamide gels. The antibodies used for western 
blot detection were anti-PML 5E10, anti-ATRX 39F, anti-Daxx D7810, anti-Sp100 SpGH, anti-
actin AC-40, and anti-USP7 BL851. HDaxx blots designated as ‘high’ and ‘low’ represent different 
exposure times of the membrane to photographic film. USP7 and actin were used as loading 
controls for 6% and 7.5% gels, respectively. The differences in USP7 expression were reproducible.  
 
 
Equal numbers of HF, HepaRG, HEp-2, HeLa and U2OS cells were seeded for a western 
blot analysis. The relative abundance of the analysed proteins was different amongst the 
five cell lines (Figure 3.1), although only minor variations in the cell extract amounts were 
seen according to the actin blot, which served as a loading control. Due to the differences 
in cell growth rates between the cell lines, the resulting numbers of cells harvested for 
analysis the day following seeding might be varying. These differences however were 
minor and could not account for differential protein expression in the cell lines analysed 
here. 
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As discussed in the introductory Chapter 1 (Section 1.8.2) hDaxx is a phosphoprotein, and 
its phosphorylation at particular sites can determine the fate of hDaxx in the cell (Ryo et al, 
2007; Song & Lee, 2004). On a western blot, endogenous hDaxx appears as a double band 
corresponding to its phosphorylated forms (Figure 3.1). Expression of hDaxx was fairly 
uniform amongst this set of cells, with higher levels seen in highly transformed cell lines 
such as HeLa, Hep-2 and U2OS. This pattern of hDaxx migration is consistent with 
previous reports (Ecsedy et al, 2003).  However, the detection of the phosphorylated band 
of hDaxx in HepaRG cells was not consistent throughout the experiments. This could be 
due to number of reasons, including cell-cycle dependent variation in phosphorylation 
levels (Ishov et al, 2004) and the efficiency of phospho-band detection by the available 
antibody. hDaxx phosphorylation levels, detected in other assays, were higher. 
Phosphatase treatment assays have confirmed that the slower-migrating hDaxx band was 
indeed due to phosphorylation (see Chapter 5). 
 
ATRX was expressed in HF, HepaRG, HeLa and HEp-2 cells, although in the latter two 
cell lines it was expressed at similarly higher levels than in the former two cell lines. The 
appearance of the two bands corresponding to major ATRX isoforms of approximately 280 
kDa and ATRXt (a truncated ATRX isoform) was consistent with previously published 
work (Berube et al, 2000; Garrick et al, 2004). Strikingly, ATRX was not expressed in 
U2OS cells. This, however, can by no means explain the efficient replication of ICP0-null 
mutant virus replication in U2OS cells, since ATRX is expressed normally in HEp-2 and 
293T cells, in which the ICP0-null mutant defect is also relatively minor; (R.D. Everett 
group, unpublished observations). USP7 was normally used as a loading control for 6% 
polyacrylamide gels, however, its expression pattern was not uniform amongst the cell 
lines. Since this pattern was reproducible, this was not attributed to loading inaccuracies 
and suggested cell-type specific differences in USP7 expression as well.  
 
Both Sp100 and PML were expressed in all of the cell lines tested, demonstrating the 
patterns of migration consistent with previous observations (Condemine et al, 2006; 
Sternsdorf et al, 1999) (Figure 3.1). Both proteins are apparently expressed at higher levels 
in HepaRG and HEp-2 cells, while PML is least well expressed in HeLa and U2OS cells. 
The reduced level of expression of PML in these cells appears to correlate with reduced 
expression and SUMO-modification of Sp100 (Figure 3.1). Interestingly, normal SUMO-
modification of Sp100 is dependent on PML (Everett et al, 2008; Everett et al, 2006). 
These observations imply that cell-type specific differences in the expression of different   114
ND10 proteins may contribute to differences in permissiveness to viral infection amongst 
the different cell types. 
 
3.2.1.2 Analysis of ATRX localisation by immunofluorescence 
Whereas hDaxx is ubiquitously expressed throughout different tissues and is generally 
found at ND10 (Chen et al, 2009), ATRX protein is less studied although its ND10 
residency has been clearly observed in previous studies (Ishov et al, 2004; Tang et al, 2004; 
Xue et al, 2003). As one of the starting points to investigating the role of ATRX in viral 
infection, its nuclear localisation has been compared amongst some of the commonly used 
laboratory cell lines (Figure 3.2). In HF, HEp-2 and HepaRG cells (Figure 3.2, panels A, B 
and C, respectively), as well as in a number of additional cell lines analysed (HeLa and 
293T; data not shown) ATRX showed clear ND10 localisation by co-localising with PML. 
ATRX localisation to heterochromatic foci in mouse cells was previously reported (Ishov 
et al, 2004). Therefore, nuclear diffuse staining pattern that was observed here was likely 
to represent association of ATRX with chromatin. The intensity of nuclear diffuse ATRX 
staining was varied between the cell types and between the cells within the same cell 
monolayer to some extent, suggesting the cell cycle differences in ATRX chromatin 
localisation. Thus, visual scanning of stained coverslips revealed that in HepaRG cells 
ATRX nuclear staining was more diffuse than that in HFs. Consistent with the western blot 
analysis, no ATRX signal was observed in U2OS cells (Figure 3.2, panel D). These 
observations propose a conserved ATRX role amongst the analysed set of cell lines, and 
demonstrate that ATRX is not essential for cell survival in culture.  
 
3.2.2  Generation of ATRX- and hDaxx-depleted cell lines by RNA 
interference  
A common way to analyse the role of a specific protein in viral infection, and an approach 
used by our and other groups, is to use RNAi to generate cell lines depleted of the protein 
of interest (Everett et al, 2008; Everett et al, 2006). Therefore, ATRX and hDaxx depleted 
cell lines have been constructed, where the levels of the individual proteins have been 
severely suppressed by stable expression of shRNA molecules targeting endogenously 
expressed ATRX or hDaxx. The following section describes the construction and analysis 
of the resulting cell lines.  PML ATRX PML               ATRX 
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Figure 3.2 ATRX localisation in different cell lines 
Cells on coverslips were fixed in formaldehyde solution and stained with anti-PML 5E10 and 
anti-ATRX H300 antibodies. Secondary antibodies were anti-mouse FITC-conjugated and anti-
rabbit Cy3-conjugated (panels A, B and D) or anti-rabbit AlexaFluor-conjugated 555 (panel C). 
1153.2.2.1 Characterisation of ATRX-depleted cell lines 
For ATRX depletion, primary HF and HepaRG were the cell lines of choice. In order to 
produce lentiviral stocks, HK-293T cells were transfected with plasmid pLKO-ShATRX90 
together with plasmids encoding for lentivirus components, as described in Chapter 2, 
Section 2.3.3. At 72 hours post transfection, the supernatants were harvested and used to 
transduce monolayers of HF or HepaRG cells. Cells were expanded after selecting with 
puromycin-containing media and maintained in this selection (see Chapter 2, Section 
2.3.3.2). These cells were named HF-ShATRX and HAA respectively. In order to 
determine the efficiency of ATRX protein knock-down in HFs, 1×10
5 cells were seeded 
into a 24-well plate, transduced with the lentiviral stocks expressing shATRX90, then 
wells were harvested for analysis by western blotting at increasing times after selection had 
been applied (Figure 3.3). ATRX expression levels were analysed in HF-ShATRX cells in 
comparison to a control cell line (HF-ShGFP) that expresses an shRNA against EGFP. 
According to the data presented in Figure 3.3, successful ATRX depletion in HF-ShATRX 
cells was observed from day 2 after applying lentiviral stocks, with subsequent reduction 
of ATRX to virtually undetectable levels by day 7. USP7 was used as a loading control, 
and as expected, its levels were slightly increased throughout the 7-day experiment.  
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Figure 3.3 Efficiency of ATRX depletion in human fibroblasts  
Cells were seeded into a 24-well plate at a density of 1 x 10
5 cells per well and transduced with 
lentiviral stocks expressing either shGFP or shATRX the following day. On day 1 post transduction, 
puromycin selection of 2 μg/ml was added, which was reduced to 1 μg/ml on day 2. Samples were 
harvested in SDS-PAGE loading buffer every 24 hours between days 2 and 7 post transduction. 
Samples were resolved on a 6% gel and membrane was probed with anti-ATRX H300 antibody. 
USP7 (BL851) was a loading control. 
 
 
 
 
 
  116The levels of ATRX depletion in HF-ShATRX and HAA cells, produced on a larger scale, 
were confirmed by a western blot (Figure 3.4, A and B, respectively). Notably, stable 
ATRX knock-down was never achieved in either of the cell lines, because ATRX 
expression had a tendency to recover after a certain number of cell passes, and therefore 
ATRX depleted cells had to be re-generated on a regular basis.  
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Figure 3.4 Levels of ATRX depletion in cell lines 
HF (A) and HepaRG (B) were transduced with either ShLuci- or ShATRX90-expressing lentiviral 
stocks. Knock-down of protein expression in the resulting cell lines was confirmed by western blot, 
(A) in HF-ShATRX and (B) HAA cells. ATRX was detected with the indicated antibodies. USP7 
was detected with BL851. Knock-down of major and truncated ATRX isoforms was achieved 
successfully in these cell lines. 
 
 
Confocal immunofluorescence analysis of the ATRX-depleted cell lines was performed in 
order to confirm the efficiency of a knock-down and to analyse localisation of other ND10 
proteins, such as the major ND10 component PML and the ATRX-interacting protein 
hDaxx. Figures 3.5 and 3.6 demonstrate that removal of ATRX from cells has not affected 
PML or hDaxx localisation significantly in either HF or HepaRG cells, respectively. 
However, depletion of ATRX in HepaRG cells (HAA) resulted in hDaxx being more 
nuclear diffuse in a higher proportion of cells than in control HALL cells (Figure 3.7), an 
effect not seen in HF-ShATRX  cells (data not shown). Overall, ATRX depletion did not 
result in significant effects on the localisation patterns of either hDaxx or PML.  
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Figure 3.5 The effects of depleting ATRX on the localization of ND10 proteins in human 
fibroblasts 
Control (HF-ShLuci) and ATRX-depleted (HF-ShATRX) cell cultures were analyzed by confocal 
immunofluorescence, using antibodies specific for PML (panels A and C - 5E10), ATRX (panels A 
and C - H300; panels B and D - 39F) or hDaxx (panels B and D - r1866). Secondary antibodies 
were anti-rabbit FITC-conjugated and anti-mouse Cy3-conjugated. 
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Figure 3.6 The effects of depleting ATRX on the localisation of ND10 proteins in HepaRG cells
Control (HALL; panels A-B) and ATRX-depleted (HAA; panels C-D) cell cultures were analysed 
by  confocal  immunofluorescence,  using  antibodies  specific  for  PML  (panels A  and  C  -  5E10), 
ATRX (panels A and C - H300; panels B and D - 39F) or hDaxx (panels B and D - 07-471). 
Secondary antibodies were anti-mouse FITC-conjugated and anti-rabbit AlexaFluor-conjugated 555. 
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Figure 3.7 Wide-field view of ATRX and hDaxx localisation in ATRX-depleted HepaRG cells 
HALL and HAA cells were seeded onto coverslips and processed for analysis by 
immunofluorescence. Fixed cells were probed with anti-ATRX (39F) and anti-hDaxx (07-471) 
antibodies. 
 
3.2.2.2 Characterisation of hDaxx-depleted cell lines 
The approach for generating hDaxx-depleted cells was essentially the same as described 
above for ATRX-depleted cells. The following two figures summarise data obtained from 
immunofluorescence analysis of hDaxx-depleted HFs (Figure 3.8) and HepaRG cells 
(Figure 3.9). As evident from Figure 3.8 (HF-ShDaxx, panels C-D) and Figure 3.9 
(HALD2, panel B), hDaxx depletion resulted in ATRX dispersal, whereas PML remained 
in punctate foci. This observation was consistent with previous reports (Ishov et al, 2004) 
and confirms the absolute requirement of wt hDaxx expression in ATRX targeting to 
ND10. Visual scan of the fixed cells using the confocal microscope revealed that the 
proportion of cells with undetectable levels of hDaxx was close to 100%, which indicated 
higher efficiency of depletion than of ATRX in ATRX-knock down cells (data not shown).  
 
HF-ShDaxx cells were not used in further studies, therefore no further data with these cells 
will be presented. Figure 3.9 C shows levels of hDaxx knock-down in HALD2 determined 
by a western blot analysis. Stable knock-down of hDaxx in these cells was achieved to 
undetectable levels, as compared to endogenous hDaxx expression by naïve HepaRG and 
control HALL cells.  
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Figure 3.8 hDaxx depletion in human fibroblasts 
HF-ShGFP  and  HF-ShDaxx  cells  were  probed  with  anti-PML  (5E10),  anti-ATRX  (panels A-B 
H300; panels C-D 39F) and anti-hDaxx (r1866) antibodies.  
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Figure 3.9 ATRX is dispersed in hDaxx-depleted HepaRG cells 
A-B: Confocal immunofluorescence images demonstrating simultaneous detection by triple staining 
of hDaxx, ATRX and PML in HALL (A) and HALD2 (B) cells, using rabbit anti-Daxx (07-471), 
mouse anti-PML (5E10) and goat anti-ATRX (D19) antibodies. Secondary antibodies were anti-
mouse FITC-conjugated, AlexaFluor-conjugated anti-rabbit 647 and anti-goat 555. C: Western blot 
analysis  of  hDaxx  depletion  in  HepaRG  cells.  Cell  extracts  harvested  from  normal  HepaRG, 
shLuci-expressing  HALL  and  shDaxx-expressing  HALD2  cells  were  resolved  on  a  7.5% 
polyacrylamide gel, and hDaxx expression was detected using D7810 antibody. Actin was a loading 
control. 
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3.2.3  Reconstitution of hDaxx expression in hDaxx-depleted cells 
Given that hDaxx is required for ATRX targeting to ND10 but not vice versa (Figure 3.9), 
it is possible that hDaxx is required for ATRX functions at its target genes, and particularly 
at the viral genomes. Therefore, the interaction between ATRX and hDaxx was studied in 
more detail. Consistent with previously published reports that ATRX and hDaxx co-exist 
and function as a complex (Ishov et al, 2004; Tang et al, 2004; Xue et al, 2003), it was 
hypothesized that ATRX and hDaxx also may act as a complex on viral genomes. In order 
to investigate this issue, an approach for analysis of a specific protein function has been 
developed, whereby either the wild-type or mutant protein of interest is re-introduced back 
into depleted cells, using a lentiviral vector. Application of such an approach for studying 
hDaxx function is described below.  
 
3.2.3.1 Re-introduction of wild-type hDaxx into hDaxx-depleted cells 
Construction of the pLNGY-hDaxx vector utilised for re-introduction of wt EYFP-hDaxx 
fusion protein back into hDaxx-depleted HepaRG cells is described in Chapter 2 (Section 
2.2.4.3). In brief, hDaxx-depleted HepaRG cells HALD2 were transduced with lentiviral 
stocks derived from pLNGY-hDaxx. The resulting cell lines were maintained in media 
supplied with double antibiotic selection of 0.5 μg/ml puromycin and 0.5 mg/ml neomycin. 
The hDaxx cDNA within the pLNGY-hDaxx vector had been designed to contain silent 
mutations that conferred resistance to anti-hDaxx shRNA molecules expressed by the 
HALD2 cell line. The other key feature of this vector system is the use of a weak promoter 
(that of the HSV-1 glycoprotein gD gene) to avoid excessive expression of the 
reintroduced protein. The names of the various cell lines relevant to these experiments are 
presented in Table 2.6. 
 
Control cell lines expressing EYFP only (using plasmid pLNGY) were also produced to 
account for any effects of EYFP expression in the subsequent assays. After expanding the 
HD-ED cell line along with the additional control cell lines (see Table 2.6) enrichment of 
EYFP-hDaxx positive cells was performed by FACS, allowing the isolation of cell 
populations in which close to 100% of the cells expressed the re-introduced proteins. The 
effect of re-introduction of EYFP-hDaxx fusion protein in these cell lines was confirmed 
by western blot and confocal immunofluorescence (Figures 3.10 and 3.11, respectively). 
Western blot analysis of the resulting cell lines using antibodies against hDaxx and EGFP 
indicated that the re-introduced hDaxx fusion protein was expressed at close to endogenous 
levels, with the EYFP-hDaxx band (approximately 140 kDa) corresponding to the size of endogenous hDaxx plus the EYFP tag of approximately 25 kDa (Figure 3.10). Cell line 
HL-ED expressed both endogenous hDaxx and re-introduced EYFP-hDaxx, but was not 
used in any further experiments. Cell line HD-E (HepaRG cells expressing shDaxx2 and 
EYFP) was used here and in subsequent experiments as a control for the hDaxx knock-
down phenotype. 
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Figure 3.10 Western blot analysis of hDaxx expression in cell lines expressing re-introduced 
EYFP-hDaxx 
Reintroduced fusion protein EYFP-hDaxx in HD-ED cells is indicated by arrow heads on the right. 
Antibodies used for detection of the proteins are indicated on the left: hDaxx and EYFP expression 
levels were detected by anti-hDaxx antibody (D7810) and anti-GFP antibody (ab290), respectively. 
The positions of relevant size markers are indicated. 
 
 
Localisation of ND10 proteins in HD-ED cells was compared to that of naïve HepaRG and 
hDaxx-depleted EYFP-expressing HD-E cells, using essentially the same set of antibodies 
and image acquisition settings between the three cell lines to account for any background 
that may have resulted from the expression of EYFP tag (Figure 3.11). Panels A and D 
show representative images of naive HepaRG cells, using the same set of antibodies. 
Analysis of HD-E cells revealed that the localisation patterns of PML and notably ATRX 
were consistent with those in HALD2 cells (Figure 3.9), indicating that EYFP expression 
alone did not affect these patterns (Figure 3.11, panels B and E). Analysis of HD-ED cells 
demonstrated that re-introduced wt EYFP-hDaxx co-localises with PML at ND10 (Figure 
3.11, panel F). More importantly, the re-introduced EYFP-hDaxx relocates ATRX back 
into these structures (Figure 3.11, panel C), suggesting that the interaction between EYFP-
hDaxx and ATRX was likely to occur in the same way as in non-transduced HepaRG cells 
between endogenous hDaxx and ATRX. Cells were also stained with anti-hDaxx antibody 
to confirm depletion of endogenous hDaxx and expression of the re-introduced fusion 
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protein (Figure 3.11, panel F). The intensity of EYFP-hDaxx fluorescence varied amongst 
the cells (Figure 3.11, panel G), and the intensity of ATRX staining in ND10 appeared to 
be proportional to that of the re-introduced EYFP-hDaxx. It is therefore likely that the 
functions of ATRX at ND10 may be regulated by the total amount of hDaxx expressed per 
cell. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________________ 
Figure 3.11 Re-introduced hDaxx targets ATRX back to ND10 
Immunofluorescence analysis of PML, ATRX and hDaxx distribution in HepaRG (panels A and D), 
hDaxx-depleted HD-E (panels B and E) and EYFP-hDaxx re-introduced HD-ED (panels C and F) 
cells.  Cells on coverslips were co-stained for PML (r8) and ATRX (39F) (A-C) or PML (5E10) 
and hDaxx (07-471) (D-F). Secondary antibodies were anti-rabbit Cy5 (blue) and anti-mouse Alexa 
555 (red).  Panel G: Cells were stained with anti-ATRX antibody (H300) only and the distribution 
of EYFP-hDaxx positive cells and ATRX localisation was assessed by taking a wide-field image. 
Green fluorescence resulted from autofluorescence of the EYFP tag.  
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Figure 3.11 - Legend on the previous page.  126
3.2.3.2 Deletion of the hDaxx ATRX-interacting region and disruption of the 
ATRX/hDaxx complex 
Based on the system described in the previous section, it was convenient to introduce a 
deletion of ATRX-interacting domain PAH1 into hDaxx. The intention was to disrupt 
ATRX/hDaxx complex and analyse the consequence of this on HSV-1 infection (see 
Chapter 5). Hence, generation of the cell line expressing EYFP-hDaxxΔPAH is described 
further.  
 
Two PAH domains are adjacent to each other within the N-terminal portion of hDaxx, of 
which the first one is essential for interaction with ATRX (Tang et al, 2004); and Figure 
3.12, A). PAH1 spans amino acids 66 to 108 of hDaxx protein sequence, a region encoded 
by 129 bp within the 5’ region of the coding sequence. Using a PCR-mediated splicing 
mutagenesis approach, a region of 219 bp and a total of 73 amino acids that includes the 
PAH1 domain were deleted from the hDaxx coding sequence within the pLNGY-hDaxx 
lentiviral vector construct, as described in Chapter 2 (Section 2.2.4.4) and using the 
approach schematically represented in Figure 2.5. The resulting cell line, referred to as 
HD.ΔPAH, was produced using lentiviral transduction. The EYFP-hDaxxΔPAH1 insert, 
which was cloned into a pLKO backbone vector, is illustrated on Figure 3.12 A, in 
comparison with the wt hDaxx and EYFP-hDaxx constructs. Having established the cell 
line after initial transduction with lentiviruses made from pLNGY-hDaxxΔPAH, 
enrichment of EYFP-hDaxx.ΔPAH expressing cells was achieved by FACS, and the cell 
line was maintained in media supplemented with appropriate concentrations of puromycin 
and neomycin.  
 
Expression of the EYFP-hDaxxΔPAH in the resulting cell line was confirmed by western 
blotting (Figure 3.12, B), in comparison to non-transduced HepaRG, control HALL, 
hDaxx-depleted HD-E and wt hDaxx re-introduced HD-ED cells. Again, levels of EYFP-
hDaxxΔPAH were close to endogenous and similar to those obtained in cells with the re-
introduced wt EYFP-hDaxx fusion protein. The band corresponding to EYFP-
hDaxxΔPAH migrated faster than that of EYFP-hDaxx, confirming the deletion of the 
fragment (73 amino acids) from the protein sequence.  
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Figure 3.12 Deletion of the ATRX interaction domain of hDaxx 
A: Schematic representation of wt hDaxx (adapted from (Yeung et al, 2008), the EYFP-hDaxx 
construct and the EYFP-DaxxΔPAH mutant, from which amino acids 48-120 spanning the ATRX 
interacting domain PAH1 were removed by PCR-based splicing mutagenesis. PAH, paired 
amphipatic helices; D/E, Asp/Glu-rich motif; S/P/T, Ser/Pro/Thr-rich domain. B: Western blot 
analysis of expression of hDaxx proteins in HepaRG, HALL, HD-E, HD-ED and HD.ΔPAH cells. 
The membrane was probed with the indicated antibodies. Samples were resolved on a 7.5% 
polyacrylamide gel. C: Immunoprecipitation analysis of ATRX and hDaxx interaction in HD-ED 
cells and HD.ΔPAH cells. Lanes 1 and 6 represent 2.5% input of the total extract sample incubated 
in each immunoprecipitation reaction. HD-ED and HD.ΔPAH cells extracts were 
immunoprecipitated with either anti-ATRX (antibody H300, lanes 4 and 9), anti-hDaxx (antibody 
07-471, lanes 5 and 10), control rabbit serum 201 raised against USP7 (lanes 3 and 8) or no 
antibody (lanes 2 and 7). Samples were analysed on a 6% polyacrylamide gel and probed with anti-
ATRX 39F and anti-hDaxx D7810 antibodies.  
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In order to confirm that the interaction between ATRX and hDaxx had indeed been 
eliminated, co-immunoprecipitation (CoIP) assays were performed in HD-ED and 
HD.ΔPAH cells (Figure 3.12, C). Prior to the experiment, the solubility of the two proteins 
was confirmed by testing the appropriate buffers in non-transduced HepaRG cells (data not 
shown). The buffer conditions were designed on the basis of previously published work 
(Tang et al, 2004), with some modifications. As evident from Figure 3.12 C, bands 
corresponding to both ATRX and hDaxx were detected in immune precipitates prepared 
from extracts of HD-ED cells using either anti-ATRX or anti-Daxx antibodies, respectively 
(Figure 3.12 C, lanes 4 and 5), confirming the interaction between the two proteins. The 
anti-Daxx antibody failed to work under present immunoprecipitation conditions as 
efficiently as the anti-ATRX antibody. The relatively low level intensity of the ATRX 
band in the anti-Daxx IP lane (Figure 3.12 C, lane 5) was consistent between independent 
experiments. The reciprocal co-immune precipitation was not observed when extracts from 
HD.ΔPAH were used, although both proteins were precipitated independently by their 
respective antibodies (Figure 3.12 C, lanes 9 and 10). This result was reproducible and 
indicates that the interaction between ATRX and hDaxx has been abolished in HD.ΔPAH 
cells. An anti-USP7 rabbit serum was used as an irrelevant antibody control in CoIP 
reactions (lanes 3 and 8). An interaction between hDaxx and USP7 reported previously 
(Tang et al, 2006) was not detected in these CoIP assays, possibly due to different cell lysis 
conditions.  
 
Immunofluorescence analysis of HD.ΔPAH cells (Figure 3.13, panels A-C) revealed that 
the ATRX interaction domain of hDaxx is required for ATRX localisation to ND10 
consistent with previous reports, in which deletions within the N-terminal portion of 
hDaxx were conducted (Ishov et al, 2004; Tang et al, 2004). In cells expressing the highest 
levels of hDaxx.ΔPAH, however, weak localisation of ATRX in ND10 was noted 
(compare panels A and B of Figure 3.13). This could occur due to residual interaction of 
ATRX via PAH2, which was proposed (Tang et al, 2004). The possibility of signal overlap 
was eliminated by carefully adjusting image capture settings prior to taking an image. 
Interestingly, EYFP-hDaxxΔPAH was still co-localised with PML at ND10 (Figure 3.13 
C), most likely due to its C-terminal SUMO-interaction domain responsible for its 
interaction with SUMO-modified PML (Ishov et al, 1999). These observations confirmed 
that the interaction between ATRX and hDaxx is not essential for the ability of hDaxx to 
localise to ND10, but it is required for ATRX targeting to ND10.  
  
EYFP-hDaxxΔPAH
HD.ΔPAH
ATRX
PML
HD.ΔPAH
HD.ΔPAH
ATRX
A
B
C
hDaxxΔPAH
hDaxxΔPAH
ATRX
ATRX
PML
ATRX
EYFP-hDaxxΔPAH
EYFP-hDaxxΔPAH
EYFP-hDaxxΔPAH
hDaxxΔPAH
hDaxxΔPAH
ATRX
EYFP-hDaxxΔPAH
EYFP-hDaxxΔPAH  
 
Figure 3.13 The requirement of hDaxx ATRX-interaction domain for ATRX targeting to 
ND10 
Panels A-B: Cells fixed on coverslips were stained with anti-ATRX (39F) and anti-Daxx (07-471) 
antibodies.  Representative cells with higher (A) and lower (B) EYFP-hDaxxΔPAH expression are 
shown.  Panel C:  Cells were stained with anti-ATRX (H300) and anti-PML (5E10) antibodies.  
Secondary antibodies were anti-mouse AlexaFluor-conjugated 555 and anti-rabbit Cy5 conjugated. 
EYFP signal resulted from autofluorescence. hDaxxΔPAH indicates re-introduced EYFP-
hDaxxΔPAH detected with the anti-hDaxx antibody 07-471. 
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3.2.3.3 Mutagenesis of hDaxx SUMO-interaction motif  
The ability of hDaxx to interact with the SUMO-modified proteins via its SUMO-
interaction motif (SIM) is important for repressor activities on its target genes (Ishov et al, 
1999; Lin et al, 2006; Shih et al, 2007). HDaxx interacts with PML also via its SIM, and 
this interaction is required for hDaxx localisation to ND10 (Ishov et al, 1999). In order to 
assess the requirement of hDaxx to interact with PML as well as with other SUMO-
modified proteins during viral infection (see Chapter 5), the hDaxx SIM was mutated so 
that the amino-acid residues known to be conserved amongst other SIMs (Song et al, 2004) 
were changed (as described in Chapter 2, Section 2.2.4.6). PCR was performed in order to 
introduce mutations at several codons by site-directed mutagenesis, and the final pLNGY-
hDaxxMSIM construct was produced using the same cloning procedures as for pLNGY-
hDaxx. The cell lines transduced with lentiviral stocks expressing EYFP-hDaxxMSIM 
were sorted by FACS. The resulting cell line, referred to as HD.MSIM, was analysed by 
western blotting and immunofluorescence (Figure 3.14). As with the other hDaxx proteins, 
the EYFP-hDaxxMSIM fusion protein was expressed at close to endogenous levels, when 
compared to control HALL cells and HD-ED cells (Figure 3.14, A). Immunofluorescence 
images (Figure 3.14 panels B and C) demonstrate that EYFP-hDaxxMSIM does not co-
localise with PML and remains dispersed within the nucleoplasm. Based on the previous 
data (Ishov et al, 1999), the interaction between PML and EYFP-hDaxxMSIM has been 
abolished in HD.MSIM cells, however this is based on previous findings and has not been 
confirmed by CoIP assays in the current study. Moreover, in these cells ATRX also fails to 
localise to ND10, although PML is distributed as in normal HepaRG cells, which therefore 
provides an additional support for the importance of hDaxx in targeting ATRX to ND10.  
 
HDaxx knock-down cells were also reconstituted with a SIM deletion mutant of hDaxx 
(EYFP-hDaxxΔSIM) to generate cell line HD.ΔSIM (see Table 2.6). Deletion of the entire 
hDaxx SIM (IIVLSDSD motif) resulted in the same hDaxx localisation phenotype as that 
of EYFP-hDaxxMSIM, however the protein appeared to be unstable or toxic as the cells 
rapidly lost expression of the mutant protein (data not shown). In summary, the interaction 
between ATRX and hDaxx is not sufficient for localisation of the ATRX/hDaxx complex 
to ND10 but requires the ability of hDaxx to interact with SUMO.  
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Figure 3.14 hDaxx SUMO-interaction motif is required for hDaxx localisation to ND10 
A: Expression EYFP-hDaxxMSIM determined by western blot and compared to that of 
endogenous hDaxx in HALL cells, depleted hDaxx in HD-E and re-introduced wt EYFP-hDaxx in 
HD-ED cells. hDaxx and EYFP signal were detected using anti-Daxx D7810 and anti-GFP ab290 
antibodies respectively. Actin (AC-40) was a loading control. B-C: HD.MSIM cells on coverslips 
were fixed for analysis by immunofluorescence and co-stained for ATRX and hDaxx (panel B) or 
ATRX and PML (panel C), using anti-PML 5E10, anti-ATRX H300 and anti-Daxx 07-471 
antibodies. Secondary antibodies were anti-mouse AlexaFluor 555-conjugated and anti-rabbit Cy5-
conjugated. EYFP signal resulted from autofluorescence. hDaxxMSIM indicates re-introduced 
EYFP-hDaxxMSIM detected with the anti-hDaxx antibody 07-471. 
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3.3  Conclusions and discussion 
ATRX and hDaxx are nuclear proteins that interact to form a chromatin-remodelling 
complex that localises to ND10. ND10 localisation of ATRX is dependent on hDaxx 
(Ishov et al, 2004; Tang et al, 2004), whereas that of hDaxx itself requires its interaction 
with SUMO-modified PML via its SIM (Lin et al, 2006).  
 
Whilst hDaxx is a ubiquitously expressed protein, ATRX appears to be expressed in many 
but not all cell types. Analysis of ATRX and hDaxx protein expression levels in different 
commonly used laboratory cell lines (Figure 3.1) has revealed that U2OS cells lack ATRX. 
It is possible that in transformed cells isolated from human tumours compensatory 
mutations may exist that overcome the loss of an important protein. Attempts to 
reconstitute ATRX in these cells by transfection have resulted in very low efficiency of 
ATRX reconstitution, but demonstrated that when expressed at low levels ATRX can 
localise to ND10 structures (data not shown). Further improvements of the transfection 
procedures have been abandoned due to the large size of the ATRX cDNA and the 
difficulty of its use in cloning procedures.  
 
In the present Chapter, for the purposes of the further investigation, cell lines in which 
ATRX or hDaxx expression levels have been severely reduced by RNAi approach and in 
which wt and mutant hDaxx forms have been re-introduced, were described and 
characterised. Consistent with previously published work (Ishov et al, 2004; Tang et al, 
2004), ATRX failed to localise to ND10 upon hDaxx depletion in cells of primary origin. 
ATRX itself, on the contrary, is not required for hDaxx localisation to ND10, suggesting 
that hDaxx serves as the ND10-targeting component within the ATRX/hDaxx complex. In 
addition further analysis of ATRX/hDaxx complex has been restricted to analysing the 
requirement of interaction between the two components of the complex in the localisation 
of either of the proteins to ND10. Thus, the region spanning the ATRX-interaction domain 
of hDaxx PAH1 (Tang et al, 2004) was deleted, and the mutant hDaxx was re-introduced. 
The use of a system that allows reconstitution of hDaxx-depleted cells with wt or mutant 
hDaxx proteins, expressed at close to endogenous levels has become the crucial step in the 
investigation of the roles of ATRX and hDaxx in HSV-1 infection. The key cell lines 
produced in this part of the study were ATRX- and hDaxx-depleted cell lines, using either 
HFs or HepaRG cells, and HepaRG-based cell lines reconstituted with wt or mutant hDaxx.  
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The following conclusions regarding ATRX and hDaxx localisation within the cells can be 
drawn from the analysis of these cell lines: (a) ATRX is dispersed in the absence of hDaxx; 
(b) hDaxx is able to localise to ND10 in the absence of ATRX; (c) ND10 localisation of 
ATRX is restored upon reconstitution of hDaxx-depleted cells with EYFP-hDaxx; (d) 
interaction between ATRX and hDaxx via hDaxx PAH1 domain is necessary for ATRX 
localisation to ND10, and (e) interaction between hDaxx and SUMO-modified proteins is 
required for hDaxx localisation to ND10. These data are summarised in Table 3.1, where + 
or - signifies whether the protein is ND10 localised or not, respectively. No significant 
cytopathology or changes in morphology that could have been adverse for experimental 
procedures were noticed amongst all the produced cell lines. Interestingly, the hDaxx 
localisation pattern in ATRX-depleted HepaRG cells differed to a certain extent from that 
in ATRX-depleted HFs. Whereas in HFs hDaxx was localised to ND10 as in normal cells, 
in ATRX-depleted HepaRG cells hDaxx was more dispersed within a high proportion of 
the nuclei (as depicted on Figure 3.7). Since HepaRG cells go through the cell division 
process in cell culture faster than HFs, it is possible that these difference in hDaxx 
localisation may be related to cell cycle progression differences between the two cell lines, 
implying that a higher proportion of hDaxx may be associated with chromatin in ATRX-
depleted HepaRG at a given time point.  
 
 
Table 3.1 Summary of localisation of PML, hDaxx and ATRX in transduced HepaRG cell 
lines 
ND10 localisation 
Cell line 
PML   ATRX  hDaxx 
HALL  + + + 
HAA  + Depleted + 
HALD2  / HD-E  +  -  Depleted 
HD-ED  + + + 
HD.ΔPAH  + - + 
HD.MSIM +  -  - 
HD.ΔSIM +  -  - 
 
 
Production of stable ATRX depleted cell lines using the methods described above for HFs 
and HepaRG cells was never fully achieved and the cells had to be regenerated on a regular 
basis, in order to perform reproducible assays, which are detailed in Chapters 4 and 5. A 
number of reasons could explain this. Firstly, ATRX plays a role in chromosomal cohesion   134
and segregation during mitosis (Ritchie et al, 2008), which suggests its role in mitosis and 
provide clues as to why ATRX depletion could have been detrimental to cell cycle 
progression. The authors however used ATRX-depleted HeLa cells, which exhibited 
substantial mitotic and growth defects. The use of the primary fibroblasts or hepatoma cell 
line [with the phenotype close to primary hepatocytes (Gripon et al, 2002)], which did not 
show such severe nuclear morphology in the absence of ATRX, may point out the 
differences between the use of primary cell lines and highly transformed ones. Secondly, in 
any cell population generated by shRNA technology there will be a proportion of cells in 
which depletion has occurred to lesser extent than in the majority, or not at all. Outgrowth 
of these cells so that they become the major component after serial passages requires only 
that they have a slight growth advantage over the highly depleted cells.  
 
In contrast to the ATRX knock-down cell lines, those depleted of hDaxx expression 
demonstrated efficient and stable knock down of the protein levels, which allowed re-
introduction of EYFP-tagged wt or mutant hDaxx proteins using the lentiviral vectors, in 
order to study the function of hDaxx in more detail. Therefore, an important issue to be 
addressed is how the introduction of the mutant hDaxx proteins may have affected 
transcriptional regulation of its targets. If the deletion of PAH1 domain in the above assays 
affected the hDaxx interaction with other proteins, it could have resulted in a reduced 
repressive potential of hDaxx as a negative transcriptional regulator. Analysis of the 
previously published work by Hollenbach et al. (2002), in which several hDaxx deletion 
mutants have been generated, revealed that this was unlikely to be the case. Indeed, based 
on their experimental data using transcription reporter assays, it was demonstrated that 
neither the deletion of PAH1 domain nor that of the first 132 aa of hDaxx significantly 
altered transcriptional repression by hDaxx (Hollenbach et al, 2002). Interestingly, this 
domain is also required for hDaxx interaction with acetylated core histone H4 (AcH4), 
complexed with HDAC II (Hollenbach et al, 2002), suggesting possible competitive 
interactions of hDaxx with its partners ATRX, AcH4 and HDACs. Another group has 
identified the first 400 amino acids of hDaxx as the region required for the interaction with 
kinase HIPK2 (Hofmann et al, 2003). HIPK2 interaction with hDaxx promotes its 
phosphorylation, which has a proposed role in the induction of apoptosis. Disruption of the 
HIPK2-hDaxx interaction decreased the total level of hDaxx phosphorylation (Hofmann et 
al, 2003). Based on the data shown on Figure 3.12, the effects of hDaxx PAH1 deletion on 
phosphorylation differences were not significant or difficult to discern on a western blot 
because of the faster migration of the protein due to the deletion of PAH1 domain.  
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HDaxx interacts with SUMO-1 via its C-terminal domain (Lalioti et al, 2002; Ryu et al, 
2000), and the specific SUMO-interaction domain has been mapped to the last 8 amino 
acids of the protein sequence (Lin et al, 2006). The ability of hDaxx to interact with 
SUMO-modified substrates plays a role in transcriptional repression by a number of 
proteins, amongst which are PML, Smad4 (which is involved in tumour growth factor-β 
signalling), and androgen and glucocorticoid receptors (Lin et al, 2004; Lin et al, 2006); 
(Ishov et al, 1999; Li et al, 2000). Figure 3.13 demonstrates that mutagenesis of the hDaxx 
SIM leads to its displacement from ND10, most likely due to inability to interact with PML 
(Ishov et al, 1999), thereby leading to ATRX dispersal. Other protein interactions of hDaxx 
that involve its C-terminal domain, such as those with a centromeric protein CENP-C 
(Pluta et al, 1998) and a protein involved in apoptosis activation Fas (Yang et al, 1997), 
could also have been disrupted. The downstream effects of disruption of these interactions 
will not be considered here. However, based on previous work identifying hDaxx as a 
negative transcriptional regulator it would be expected that depletion of hDaxx or 
mutagenesis of its SIM would lead to enhanced transcription of its target genes, as well as 
to alterations in apoptosis regulation and chromatin remodelling processes.  
 
Within the three different cell lines generated in this part of the study, namely cell lines 
depleted of hDaxx, or expressing hDaxxΔPAH1 or hDaxxMSIM, ATRX had a dispersed 
localisation pattern. Inability of ATRX to localise to ND10 can elicit a number of effects 
on gene expression. Studies of various ATRX mutants, particularly those that fail to 
localise to ND10, including the ones that are commonly seen in ATR-X syndrome, have 
suggested that SNF2 domain of ATRX may be involved in both chromatin remodelling 
and targeting of ATRX to ND10 (Berube et al, 2008). Based on this model, efficient 
association of ATRX with ND10 correlates with its chromatin remodelling functions. In 
addition, this evidence implicates C-terminal SNF2 domain of ATRX in its ND10 
localisation, suggesting that the interaction with hDaxx is essential but not the only 
requirement for ATRX ND10 localisation. Hence, it has been proposed that when ATRX is 
dispersed in the nucleus it is likely to become incapable of its full chromatin remodelling 
potential (Berube et al, 2008). Therefore, dispersed ATRX localisation would be expected 
to result in the inefficient regulation of certain gene targets specific for the ATRX/hDaxx 
complex, which are yet to be identified. This issue needs to be taken into account when 
addressing chromatin repressive properties of the complex in the different cell lines 
utilized throughout the study.  
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As discussed in Chapter 1 and in Section 3.1 of the present Chapter, ND10 components 
constitute a part of cellular intrinsic defence mechanism against both HCMV and HSV-1. 
Generation of the above described cell lines in the present part of the study demonstrates a 
convenient approach for studying functions of other cellular proteins that may be involved 
in this mechanism and therefore is a useful tool in the studies of cell biology mechanisms. 
The use of the cell lines depleted of ATRX or hDaxx, as well as in which ATRX-hDaxx 
interaction had been disrupted, provides the basis of the investigation presented in the next 
two Chapters.    137
4  Regulation of HCMV Infection by ATRX 
4.1  Introduction to cellular intrinsic defence against HCMV 
infection 
In Chapter 1, cellular intrinsic defence against viral infection has been defined as a 
collective set of cellular activities that provides potent protection from viral infection, 
distinct from those provided by adaptive and innate host immunity systems (Bieniasz, 
2004). In the current and subsequent chapters this definition is applied to the set of nuclear 
activities that act to inhibit HCMV and HSV-1 transcription, amongst which are functions 
performed by the components of ND10. In addition to the activities of ND10 proteins, 
histone modifications, being involved in the chromatin state of the viral genomes, are also 
considered to contribute to the efficiency of cellular anti-viral intrinsic immunity. The 
aspects of chromatin structure of HCMV genomes during lytic and latent infectious cycles 
have been addressed in Chapter 1 and previously reviewed (Sinclair, 2009). The following 
account will therefore summarize the data regarding specific ND10 proteins, namely PML 
and hDaxx, which have been shown to contribute to an anti-HCMV intrinsic defence 
mechanism by a number of different studies referenced below.   
 
At the very early stages after the onset of HCMV infection and release of its genome 
together with tegument components into the cell nucleus, the Immediate Early transcript 
environment is formed. This is characterised by the presence of major IE transcripts and 
the spliceosome assembly factor SC35, which become associated with ND10 components 
as IE transcription initiates (Ishov et al, 1997). The two crucial events that are 
distinguished at this stage of the infection are (a) the association of HCMV tegument 
protein pp71 with ND10 component hDaxx and (b) the association of PML with HCMV 
genomes and the co-localisation of the major Immediate-Early protein IE1 (ie72) with 
PML. As the investigations into the effect of HCMV infection on ND10 have progressed, it 
was discovered that disruption of ND10 via PML re-distribution was a result of IE gene 
expression, and was therefore observed within the first hours of infection (Kelly et al, 
1995). IE1 was found to initially co-localise with ND10 while IE2 (ie86) formed foci 
immediately adjacent to these structures, and subsequently the ND10 components became 
distributed diffusely throughout the nucleus (Ahn & Hayward, 1997; Korioth et al, 1996; 
Wilkinson et al, 1998). This disruption of ND10 is a result of the specific interaction 
between IE1 and the major ND10 component PML, followed by IE1-driven removal of 
PML from ND10 in the infected human fibroblasts (Ahn et al, 1998; Ahn & Hayward,   138
1997).  The mechanism by which this occurs is thought to involve abolition of SUMO-
modification in both PML and Sp100 by IE1, leading to disorganisation of these structures 
(Lee et al, 2004; Muller & Dejean, 1999). The effect of IE1 on Sp100 suggests the 
importance of Sp100 in the intrinsic cellular anti-HCMV response, by analogy with HSV-1 
(Everett et al, 2008; Negorev et al, 2006; Negorev et al, 2009), however this hypothesis has 
not been extended in subsequent research. Interestingly, PML depletion results in greater 
efficiencies of infection of wild-type and, to an even greater extent, IE1-deficient HCMV 
(Tavalai et al, 2006; Tavalai et al, 2008), which demonstrates the functional significance of 
IE1-dependent PML displacement during the wt HCMV infection. These observations 
have suggested that IE1 counteracts the cellular response provided mainly by PML.  
 
In addition to PML, hDaxx has also been shown to have a significant role in HCMV 
infection by a number of reports from independent research groups (Cantrell & Bresnahan, 
2005; Cantrell & Bresnahan, 2006; Groves & Sinclair, 2007; Hofmann et al, 2002; Hwang 
& Kalejta, 2007; Ishov et al, 2002; Preston & Nicholl, 2006; Saffert & Kalejta, 2006; 
Saffert & Kalejta, 2007; Tavalai et al, 2008; Woodhall et al, 2006). The HCMV tegument 
protein pp71 can be detected at ND10 virtually immediately after its release into the cell 
nucleus, where it interacts with hDaxx and subsequently induces its degradation (Hofmann 
et al, 2002; Hwang & Kalejta, 2007; Ishov et al, 2002; Saffert & Kalejta, 2006). The 
interaction between pp71 and hDaxx is required for efficient initiation of IE transcription 
(Cantrell & Bresnahan, 2005; Ishov et al, 2002). Importantly, evidence supporting the 
functional role of hDaxx as a component of cellular intrinsic defence came from the 
observations by independent groups who demonstrated that depletion of hDaxx from cells 
relieves repression of HCMV infection to a significant extent, and to a higher extent for 
pp71-null mutant HCMV infection (Cantrell & Bresnahan, 2006; Preston & Nicholl, 2006; 
Saffert & Kalejta, 2006; Woodhall et al, 2006). In normal fibroblasts HCMV is unable to 
efficiently replicate in the absence of pp71 (Bresnahan et al, 2000). Further work has 
proposed the involvement of hDaxx in a similar pathway of repression in the cell culture 
model of quiescent HCMV infection (Saffert & Kalejta, 2007). Therefore, these studies 
have established that hDaxx-mediated intrinsic defence mechanism is antagonised by 
HCMV tegument protein pp71.  
 
In the search of additional components that contribute to cellular intrinsic defence, the next 
part of the studies described in this thesis focuses on ATRX. Since ATRX localises to 
ND10 and interacts with hDaxx (Tang et al, 2004), it is a suitable and appealing candidate 
for investigation for a potential role in HCMV infection. Hence, the aim of the following   139
part of the study was to analyse whether ATRX, by analogy with hDaxx, contributes to the 
cellular intrinsic defence mechanism against HCMV infection. The next set of data will 
demonstrate how ATRX localisation is affected during HCMV infection and the effect of 
ATRX depletion on replication of pp71-null mutant virus. Due to this work being 
conducted in collaboration with Chris Preston and Steven McFarlane (MRC Virology Unit, 
Glasgow), a significant part of the results is not presented in this chapter since it was not 
performed by the author, and the reader is directed to the original manuscript (Lukashchuk 
et al, 2008).  
 
4.2  Results 
4.2.1  HCMV tegument protein pp71 displaces ATRX from ND10  
The following section summarises the key findings obtained from the work conducted by 
Chris Preston and Steven McFarlane (Lukashchuk et al, 2008). HCMV tegument protein 
pp71 and viral genomes become associated with ND10 as soon as they are released into the 
cell nucleus (Hofmann et al, 2002; Ishov et al, 2002; Marshall et al, 2002; Preston & 
Nicholl, 2005). This localisation depends on pp71 interaction with hDaxx. In light of 
understanding the role of hDaxx-interacting partner ATRX in HCMV infection, the effect 
of pp71 on ATRX localisation has been investigated using a number of different assays, all 
based on confocal immunofluorescence microscopy.  
 
Firstly, recombinant HSV-1 strains in1316 or in1360, expressing either EYFP-tagged or wt 
pp71, respectively, were used to infect human fibroblasts. This virus has mutations that 
inactivate HSV-1 proteins VP16, ICP0 and ICP4, which allow it to infect cells without 
detectable HSV-1 protein synthesis or cytopathology. Secondly, pp71 was expressed alone 
by transfecting an EYFP-pp71 encoding plasmid vector. And thirdly, a cell line expressing 
pp71 constitutively was used. These assays demonstrated that in cells where pp71 was 
expressed in low amounts and localised to ND10, ATRX was dispersed and hDaxx 
remained associated with pp71 foci, suggesting the potential significance of pp71-mediated 
dispersal of ATRX.  
 
Having demonstrated the pp71-dependent dispersal of ATRX via transfection and HSV-1 
recombinant infection assays, the experiments were performed to investigate whether a 
similar effect on ATRX displacement from ND10 results from wt HCMV infection. For 
this purpose, HCMV strain AD169 was used (see Chapter 2, Section 2.1.7). ATRX 
displacement from ND10 occurred in cells infected with AD169 as early as 1 hour post   140
adsorption of the virus, before any effects on hDaxx were observed. The increase in the 
number of cells with dispersed ATRX distribution was dependent on the amount of virus 
used, suggesting multiplicity dependence of this effect. Infection with pp71-null mutant 
HCMV did not result in dispersal of ATRX, and instead ATRX remained associated with 
ND10, confirming the pp71-mediated dispersal of ATRX in wt HCMV infection. No 
detectable changes at the early time points post HCMV infection in the expression levels of 
either hDaxx or ATRX were seen in western blot analyses, and therefore ATRX dispersal 
could not be attributed to changes in protein expression levels. Overall the results 
described in the current section provide evidence that ATRX is displaced from ND10 at the 
very early stages of HCMV infection by pp71, and not by other viral tegument components.  
 
4.2.2  ATRX is not required for pp71 localisation to ND10 
It has previously been shown that hDaxx is required for pp71 targeting to ND10 (Ishov et 
al, 2002). Since pp71 displaces ATRX from ND10, as described above (see Lukashchuk et 
al, 2008), and given the fact that ATRX and hDaxx are present at ND10 as a complex 
(Tang et al, 2004), it was hypothesized that ATRX may also be required for pp71 
localisation to ND10 and possibly for its interaction with hDaxx. To investigate this 
possibility, ATRX-depleted fibroblasts (named HF-ShATRX; see Figure 3.5), were 
infected with HSV-1 recombinant in1316 that expresses EYFPpp71 and processed for 
analysis by immunofluorescence at 4 hours post infection. As evident from Figure 4.1 
(panels A and B), in HF-ShATRX cells, EYFPpp71 co-localised with PML, as in control 
HF-ShLuci cells. Depletion of ATRX did not affect co-localisation between EYFPpp71 
and hDaxx in cells expressing low amounts of the pp71 fusion protein and at this time 
point (Figure 4.1, panels C and D), demonstrating that ATRX is not required for the 
interaction between the two proteins. Staining for ATRX in EYFPpp71 expressing cells 
confirmed that ATRX was dispersed (Figure 4.1, panels E and F), consistent with the 
observations described in the previous section, underlying the importance of pp71-
mediated dispersal of ATRX. Overall, the experiment has provided evidence that ATRX is 
not required for pp71 localisation and interaction with hDaxx at ND10.  HF-ShLuci PML
ATRX
PML
EYFPpp71
HF-ShATRX EYFPpp71
EYFPpp71
EYFPpp71
EYFPpp71
EYFPpp71
HF-ShLuci
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HF-ShLuci
HF-ShATRX
hDaxx
hDaxx
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EYFPpp71 hDaxx
EYFPpp71 ATRX
EYFPpp71 ATRX
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Figure 4.1 ATRX depletion does not affect pp71 localisation 
Control or ATRX-depleted HF seeded onto coverslips were infected with in1316 at MOI 0.3 pfu/cell 
and fixed for immunofluorescence analysis at 4 hours post infection. For protein detection, cells 
were stained with anti-PML (r8; panels A and B), anti-hDaxx (r1866, panels C and D) and anti-
ATRX (H300; panels E and F) antibodies. Secondary antibody was Cy3-conjugated anti-rabbit IgG. 
The EYFPpp71 signal resulted from autofluorescence of the expressed fusion protein. 
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4.2.3  ATRX contributes to the repression of HCMV IE protein 
synthesis in the absence of pp71 
Section 4.2.1 of this Chapter has shown pp71-mediated removal of ATRX from ND10 at 
the very early times after the initiation of wt HCMV infection. If such displacement of 
ATRX was functionally important for the efficiency of HCMV IE gene expression, then by 
analogy with the experiments on hDaxx (Cantrell & Bresnahan, 2006; Preston & Nicholl, 
2006; Saffert & Kalejta, 2006; Woodhall et al, 2006), depletion of ATRX should support 
increased IE protein synthesis by pp71-null mutant HCMV. To investigate whether this 
was the case, the efficiency of IE protein synthesis of pp71-null mutant HCMV was 
analysed in ATRX-depleted HFs (Figure 4.2). HF-ShLuci and HF-ShATRX cells were 
seeded and infected the following day with the indicated HCMV strains (Figure 4.2, A and 
B). Samples were harvested for a western blot analysis at 18 or 2 hours post infection as 
specified within the Figure 4.2. Replication of the pp71-null mutant HCMV strain 
ADSubUL82 is severely reduced in HFs due to its inability to express IE proteins 
efficiently, and therefore, as expected, infection of HF-ShLuci cells resulted in barely 
detectable levels of IE1 production (Figure 4.2 A, lane 3). However, ATRX-depletion 
resulted in a substantial increase of IE1 expression compared to that in HF-ShLuci cells, 
suggesting the requirement of ATRX for fully efficient repression of pp71-null HCMV 
genomes (Figure 4.2 A, lane 4). This increase in IE1 expression levels in ATRX-depleted 
cells was consistent amongst several individual experiments, however variation in the 
extent of such increase depending on the efficiency of ATRX-depletion was noted.  
 
For additional controls, cells were co-infected with ADSubUL82 and AD169UV. 
AD169UV is the wild-type HCMV strain inactivated by UV-radiation and therefore was 
unable to replicate but provided functional pp71, therefore co-infection with the two 
viruses served as a measure of a maximum potential of ADSubUL82 strain to produce IE1. 
AD169 is a common laboratory wt HCMV strain. In cells infected with either AD169 (at 
MOI 0.3) or co-infected with ADSubUL82/AD169UV, IE1 levels of expression were 
essentially equivalent in HF-ShLuci and HF-ShATRX90 cells, suggesting that ATRX 
depletion does not affect the ability of pp71 to transactivate IE gene expression. Infection 
with AD169UV alone was conducted in order to ensure that the virus was unable to 
replicate in either of the two cell lines (Figure 4.2 A, lanes 7 and 8). To confirm the 
efficiency of ATRX depletion in the experiment presented on Figure 4.2 A, the membrane 
was blotted for ATRX, indicating efficient reduction in ATRX levels. Because of the 
known relationships between hDaxx and pp71, hDaxx expression was also analysed in   143
these infected cells. In cells infected with ADSubUL82, hDaxx expression levels were 
equal to those seen in mock-infected cells, consistent with previous observations (Saffert & 
Kalejta, 2006; Tavalai et al, 2008). In the infections including AD169UV, a marginal 
reduction in hDaxx expression was observed (compare lanes 5-8 with 1-4 in Figure 4.2A), 
which partly correlates with the reports on pp71-dependent degradation of hDaxx (Hwang 
& Kalejta, 2007; Saffert & Kalejta, 2006; Tavalai et al, 2008). Infection with AD169 strain 
resulted in a further decrease of hDaxx intensity band when compared to AD169UV alone 
or during co-infection with AD169SubUL82/AD169UV (compare lanes 9 and 10 with 5-8 
in Figure 4.2A).  
 
Inconsistency in the levels of hDaxx degradation was observed throughout a number of 
repeated experiments (and in published papers), and the levels of degradation using the 
indicated MOI of AD169 were never as efficient as in previously published work (Hwang 
& Kalejta, 2007; Saffert & Kalejta, 2006). Figure 4.2 B demonstrates an independent 
experiment where viruses from the same stocks were used at the same MOIs. The 
membrane was blotted for IE protein levels, confirming the data presented in Figure 4.2 A, 
and for hDaxx levels (Figure 4.2 B). Degradation levels of hDaxx seen in lanes 3-5 and 8-
10 were consistent with previously published data (Hwang & Kalejta, 2007; Saffert & 
Kalejta, 2006). 
 
In order to confirm that both control and ATRX-depleted cells received an equivalent 
amount of viral load during the infection with ADSubUL82, separate wells of cells were 
seeded and infected using the same amounts of the indicated viruses in Figure 4.2A, lanes 
3, 4, 5 and 6. Samples were prepared for analysis at 2 hours post infection and tested for 
the presence of pp65, an abundant tegument protein that is normally expressed at late times 
and therefore at early times can be used as a measure of the quantity of input virus particles. 
Equal levels of pp65 were present in HF-ShLuci and HF-ShATRX cells infected with 
ADSubUL82 only, and accordingly, when co-infected with ADSubUL82/AD169UV, the 
levels of pp65 were higher due to double infection.  
 
In summary, ATRX contributes to the repression mechanism of the HCMV IE 
transcription, which occurs in the absence of pp71. IE1
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Figure 4.2 ATRX depletion increases Immediate Early gene expression in cells infected with 
pp71-null mutant HCMV 
Control (HF-ShLuci or HF-ShGFP) and ATRX-depleted (HF-ShATRX) cells were mock infected or 
infected with ADsubUL82 (0.2 infectious units per cell), AD169 (MOI 0.3), AD169UV alone (MOI 
3, based on the original titer), or co-infected with AD169UV and ADSubUL82, and harvested for 
western blot analysis. A: Analysis of IE protein synthesis after infection of ATRX-depleted cultures 
with ADSubUL82. Samples were harvested at 18 (top) or 2 hours post infection (as indicated). The 
membranes  were  probed  with  anti-ATRX  39F,  anti-HCMV  IE  E13  and  anti-hDaxx  D7810 
antibodies, or anti-pp65 ab2595 as indicated. B: An additional analysis of hDaxx degradation was 
performed on an independent experiment. The membrane was probed with anti-hDaxx D7810 and 
anti-HCMV IE E13 antibodies. Actin (AC-40) was a loading control in panels A and B. 
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4.2.4  ATRX depletion results in the increased IE gene expression per 
cell infected with pp71-null mutant HCMV 
The above data demonstrate the increase in the total IE1 protein expression levels of pp71-
null HCMV when ATRX expression was severely suppressed. In order to quantify the 
differences in IE1 expression between control and ATRX-depleted cells, the numbers of 
cells infected with pp71-null mutant HCMV and expressing IE1 were assessed and 
compared in control and ATRX depleted cells. This was achieved by infecting HF-ShLuci 
and HF-ShATRX cells on coverslips with 0.2 infectious units per cell of ADSubUL82 and 
processing for immunofluorescence with anti-IE1 and anti-ATRX antibodies at 12 hours 
post infection. This time point after infection was chosen to be the optimal for scoring and 
assessing the observed differences in IE1 expression between the two cell lines.  
 
Based on the findings obtained by western blot analysis, it was expected that the numbers 
of cell nuclei positive for IE protein expression would be much higher in ATRX-depleted 
cells than those in control HFs. Surprisingly, it was found that the numbers of IE1 positive 
nuclei did not differ much between control and ATRX-depleted cells (9.1% and 14.8% of 
the total cell numbers, respectively; Table 4.1). However, it was the amount of IE1 protein 
expressed per cell that differed significantly. In HF-ShLuci cells the majority of the nuclei 
positive for IE1 demonstrated weak punctate IE1 distribution (Figure 4.3, panel A), 
suggesting lack of pp71 still allowed low levels of IE gene expression, consistent with data 
shown in Figure 4.2. In contrast, in ATRX-depleted cells the majority of IE1-positive 
nuclei showed nuclear dispersed localisation, and the protein was expressed at very high 
levels (Figure 4.3, panel B). The percentage of HF-ShLuci infected cells with bright 
dispersed IE1 signal was 0.6% of the total cell numbers, and that of HF-ShATRX infected 
cells was 10% (see Table 4.1). Panels C and D of the Figure 4.3 depict close-up images of 
typical IE1-positive nuclei of HF-ShLuci and HF-ShATRX cells, respectively. Co-
infection of the two cell lines with ADSubUL82 and AD169UV, or infection with AD169 
strain and analysis of the cells at 12 hours post infection for IE1 expression revealed that 
the majority of cell population expressed high levels of the IE proteins, independently of 
the presence or absence of ATRX. Table 4.1 summarises and compares the numbers 
obtained from scoring these nuclei in two independent experiments, scoring approximately 
300 cells for each experiment from random fields of view. In control HF-ShLuci cells, 
those with punctate IE expression during ADSubUL82 infection correlated with the 
retention of ATRX foci at ND10, but when pp71 was added by co-infecting with 
AD169UV or infecting with AD169, ND10 were disrupted. This was consistent with the   146
findings presented on Figure 4.2, and in addition confirms that pp71 allows increased 
expression of IE proteins in the infected cell nucleus thereby causing disruption of ND10.  
 
Table 4.1 IE protein expression in ATRX-depleted cells
1 
Number of cells
2 
Cells Virus 
High IE  Low IE  Total  IE positive (%) 
HF-ShLuci Sub82  5  66  779  9.1 
HF-ShATRX Sub82  78  36  766  14.8 
HF-ShLuci Sub82+AD169UV  94  6 383  26.1 
HF-ShATRX Sub82+AD169UV  113  9  439  27.8 
HF-ShLuci AD169  69  6  158  47.5 
HF-ShATRX AD169  54  6  169  35.5 
 
1 HF-ShLuci or HF-ShATRX cultures were infected with ADSubUL82 (Sub82; 0.2 infectious 
units/cell), co-infected with ADSubUL82 plus uv-irradiated HCMV (AD169UV; MOI 0.3, based 
on original titer), or with wild type HCMV (AD169; MOI 0.3). At 12 h post infection, coverslips 
were fixed and processed for analysis by immunofluorescence with antibodies specific for HCMV 
IE proteins and ATRX.  
2 IE positive cells were classified as present in low (punctate localisation pattern) or high (dispersed 
localisation pattern) amounts, as shown in Figure 4.3.  
 
According to the results presented on Figures 4.2 and 4.3 and those described in section 
4.2.1, it was concluded that pp71-mediated removal of ATRX from ND10 is required for 
efficient initiation of IE gene expression. It has to be noted however, that careful 
immunofluorescence analysis of the normal HFs expressing endogenous levels of ATRX 
infected with wild-type HCMV revealed that some cells positive for IE1 retained ATRX at 
ND10, suggesting that removal of ATRX is important but not essential for the initiation of 
IE gene expression (Lukashchuk et al, 2008). In summary, this and the previous sections 
have demonstrated that the expression of IE proteins is substantially increased during 
pp71-null HCMV infection of ATRX-depleted cells. Hence, it is concluded that ATRX 
contributes to the efficient repression of pp71-null mutant HCMV IE gene expression.  
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Figure 4.3 ATRX depletion increases IE protein synthesis of the individual cells infected with 
pp71-null mutant HCMV 
Cells were infected with 0.2 infectious units of ADSubUL82 per cell and fixed for analysis by 
immunofluorescence at 12 hours post infection. HF-ShLuci (A and C) and HF-ShATRX (B and D) 
were stained with anti-IE1 ab2595 and anti-ATRX H300 antibodies. Secondary antibodies were 
anti-mouse FITC-conjugated and anti-rabbit Cy3-conjugated. Image capture settings in 488 channel 
(FITC) for HF-ShATRX cells were adjusted so that no over-exposure occurred in cells expressing 
high levels of IE proteins.
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Figure 4.4 ATRX depletion increases replication of pp71-null mutant HCMV 
HF-ShLuci and HF-ShATRX cells on coverslips were infected with ADSubUL82 (0.2 infectious 
units per cell) and incubated at 37  C for 11 days. Replicating virus was detected by the expression 
of enhanced green fluorescent protein (EGFP), encoded by a EGFP gene inserted into the UL82 
coding region. Cells were also stained with propidium iodide (PI) to detect all the cells in the 
sample.
o
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4.2.5  ATRX depletion supports increased replication of pp71-null 
mutant HCMV  
In the results presented above, the role of ATRX in the repression of pp71-null HCMV 
infection was demonstrated from the aspect of initiation of IE gene expression (Figures 4.2 
and 4.3). In normally restrictive HFs, HCMV fails to establish efficient productive 
infection in the absence of its transactivator pp71. Therefore, the next question asked was 
whether the increase in IE gene expression of ADSubUL82 in ATRX-depleted cells was 
sufficient to trigger plaque formation and production of infectious viral progeny. HF-
ShLuci and HF-ShATRX cells on coverslips were infected with ADSubUL82 at a 
multiplicity of 0.2 infectious units per cell and incubated at 37 
oC for up to 11 days. 
Because of an EGFP insertion within the deleted UL82 gene in ADSubUL82, the plaques 
could be detected by fluorescence microscopy. As expected, no plaques were detected on 
HF-ShLuci cells that express endogenous ATRX levels. In HF-ShATRX cells however, 
the numbers of green fluorescent plaques was substantially increased (Figure 4.4) and 
averaged about 20 per coverslip. Viral yields were measured by infecting permissive HFFF 
cells using cell-released virus and determining the numbers of IE1 positive cells after a 24-
hour infection (work performed by Chris Preston). Viral yields obtained on HF-ShATRX 
cultures were between 140 and 560 infectious units per culture, whereas those from HF-
ShLuci cultures between 0 and 5 infectious units (both sets of numbers were based on 5 
determinations). Therefore, the increase in IE gene expression that was determined at the 
earlier stages of infection (Figure 4.2) is sufficient for initiation of productive infection by 
pp71-null mutant HCMV in the absence of ATRX. These data implied that ATRX 
depletion relieves the repression mechanism occurring on pp71-null mutant HCMV 
infection, allowing the virus to replicate in culture more efficiently.  
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4.3  Conclusions and discussion 
Understanding of the events associated with the regulation of the early stages of lytic 
HCMV infection is important for identification of the factors that may contribute to 
repression of viral genomes. The investigation reported in the present chapter has 
identified the chromatin-remodelling enzyme ATRX as the novel component that 
contributes to the intrinsic repression mechanism in HCMV infection, which takes place at 
the early stages of IE transcription and during productive infection. The virus counteracts 
this intrinsic mechanism by displacing ATRX from ND10 at the very early time points 
after the infection, or immediately after the HCMV genomes and tegument components are 
released into the cell nucleus. The specific viral component that induces ATRX removal 
from ND10 before any effects on other ND10 proteins can be discerned is HCMV 
tegument protein pp71. The proof that it was indeed due to the action of pp71 came from a 
number of different assays, which were aimed to assess the effect of the HCMV tegument 
protein pp71 only, without the interference of other viral components (see Lukashchuk et 
al, 2008; attached). The relief of cell-mediated repression of pp71-null mutant HCMV IE 
gene expression and replication was achieved by producing an HF cell line in which 
ATRX expression was severely downregulated by shRNA. Moreover, increased IE gene 
expression in ATRX-depleted cells was sufficient for initiation of productive infection by 
pp71-null HCMV, which is incapable of plaque formation in normal fibroblasts. These 
data suggest the functional importance of pp71-mediated ATRX displacement from ND10, 
which allows successful gene expression and replication of HCMV in culture.  The 
findings reported above have therefore provided the first evidence on the role of ATRX in 
intrinsic cellular defence against viral infection. 
 
The concept of intrinsic resistance to HCMV infection has emerged from a number of 
independent studies, showing the importance of ND10 proteins such as hDaxx and PML in 
this process (reviewed in Tavalai & Stamminger, 2008). Based on results presented in the 
manuscript by Tavalai and colleagues it was concluded that the PML-dependent and 
hDaxx-dependent intrinsic resistance mechanisms preferentially follow different pathways, 
since one is counteracted by IE1 and the other by pp71, respectively (Tavalai et al, 2008). 
Whether ATRX acts independently or in a complex with additional co-factors is still to be 
understood in the context of HCMV infection. However, based on its protein-protein 
interaction properties, the latter option is the more likely. The possibility of its cooperation 
with hDaxx in an anti-viral defence mechanism is discussed further. Whether ATRX acts 
alone or as a subunit of a repressor complex is a subject of discussion in Chapter 6.   150
 
The fact that ATRX and hDaxx constitute a complex with chromatin remodelling activity 
(Ishov et al, 2004; Tang et al, 2004; Xue et al, 2003) suggests that the two proteins may act 
together to promote the assembly of a repressed chromatin structure on the incoming 
HCMV genomes. Since ATRX is capable of nucleosome remodelling in vitro (Xue et al, 
2003), ATRX may function as the chromatin-remodelling subunit of the complex, thereby 
contributing to the repression of HCMV genomes immediately after the association of the 
ATRX/hDaxx complex with the incoming viral genomes in the absence of pp71. Inability 
of ATRX to localise to ND10, as a result of various mutations, leads to inefficient 
chromatin remodelling in ATR-X patients (Berube et al, 2008). In Chapter 3 it has been 
shown that hDaxx depletion results in ATRX dispersal, and it was discussed that in these 
cell lines regulation of chromatin remodelling by ATRX may therefore be ineffective. It is 
therefore feasible that the increase in HCMV IE gene expression in hDaxx-depleted cells 
reported previously can be partially attributed to dispersed localisation of ATRX.  
 
Displacement of ATRX from ND10 by pp71 before any of the effects are seen on hDaxx 
localisation suggests that ATRX is one of the first targets of pp71, which thereby promotes 
disruption of ATRX/hDaxx complex during wt HCMV infection. Therefore the actions of 
pp71 can follow two slightly different paths. One model would state that pp71 first binds 
hDaxx, as previously shown in independent studies (Hofmann et al, 2002; Ishov et al, 2002; 
Saffert & Kalejta, 2006), and therefore alters the conformation of the ATRX/hDaxx 
complex, which results in subsequent ATRX displacement from ND10. Despite having 
shown to be specific using yeast two hybrid and CoIP assays (Hofmann et al, 2002), direct 
interaction between pp71 and hDaxx has not been shown definitively and there is a 
possibility of an intermediate co-factor responsible for the interaction between the two 
proteins. On the other hand, a different model could suggest competitive binding between 
pp71 and ATRX to hDaxx, where either pp71 transiently binds ATRX first, displaces it 
from ND10 and gains access for hDaxx interaction, or more likely competitive binding by 
ATRX and pp71 for the same region of hDaxx. In order for the latter model to be true, 
hDaxx interaction regions for ATRX and pp71 would overlap and span the PAH1 domain, 
which is known to be required for the hDaxx/ATRX interaction. The data investigating the 
pp71-interaction region of hDaxx, however, are controversial. According to Ishov et al 
(2002) the region lies between amino acids 142 and 290, whereas based on a report by 
Hofmann et al. 2002 the two regions responsible for pp71 interaction are those between 
amino acids 43-197 and 439-50 (Hofmann et al, 2002; Ishov et al, 2002). Based on the 
results of Hofmann et al, the involvement of hDaxx PAH1 domain in pp71 binding, which   151
is also required for interaction with ATRX, is likely. Preliminary experiments to 
investigate a possible interaction between pp71 and ATRX by CoIP methods in HCMV 
infected HFs have been conducted, but no interaction between pp71 and ATRX was 
detected (Steven McFarlane, personal communication). This finding however still does not 
rule out the possibility of a very transient interaction between the two proteins. 
 
The functional importance of pp71-mediated displacement of ATRX from ND10 resulted 
from an observation that IE gene expression of pp71-null mutant HCMV is substantially 
increased in ATRX-depleted cells, which implies that endogenous ATRX in normal cells 
contributes to the repression of pp71-null mutant virus. In contrast to analogous hDaxx-
depletion experiments, in which an increase in the numbers of IE1-positive cells was seen 
after wt HCMV infection using strain AD169 (Tavalai et al, 2008), no significant 
differences were detected in IE gene expression in ATRX-depleted cells during wt 
infection, suggesting that ATRX was not required for the ability of pp71 to transactivate 
efficient gene expression. This finding correlates with the results presented on Figure 4.1 
using immunofluorescence, demonstrating that ATRX was not required for pp71 
interaction with hDaxx and hence its full transcriptional activation potential. In the absence 
of pp71, HCMV replicates very inefficiently in culture due to its substantially reduced 
capacity to initiate IE gene expression (Baldick et al, 1997; Bresnahan et al, 2000; 
Bresnahan & Shenk, 2000). Removal of ATRX significantly enhanced the ability of pp71-
null mutant HCMV to replicate and produce infectious viral progeny, suggesting that the 
increase in IE1 expression was sufficient to initiate productive infection.  
 
The strong evidence for the role of hDaxx in HCMV repression has also come from the 
observation that its overexpression reduces the infection efficiency of wt HCMV (Cantrell 
& Bresnahan, 2006; Tavalai et al, 2008; Woodhall et al, 2006). If the same were true in the 
case of ATRX, then by analogy, overexpression of ATRX would result in a similar extent 
of reduction of HCMV gene expression and plaque formation. Due to the size of ATRX, it 
is difficult to design a system in which ATRX could be stably overexpressed. Interestingly 
however, preliminary research from Chris Preston’s group has shown that transfection of 
ATRX into U2OS cells, which do not normally express ATRX (Figure 3.1), resulted a 
decreased number of IE1-positive cells, after being infected with wt or pp71-null mutant 
HCMV for 24 hours (Steven McFarlane, personal communication). Hence, this 
observation provides more evidence for ATRX-mediated repression of HCMV gene 
expression and supports the data presented above for the role of ATRX in pp71-null 
HCMV infection.    152
 
The clue suggesting that the pathways of ATRX and hDaxx-mediated repression may be 
different results from analysing IE1 positive cells infected with pp71-null HCMV. 
Previous reports have demonstrated that in hDaxx-depleted HFs, the numbers of IE1 
positive wt or pp71-null mutant HCMV infected nuclei is substantially increased (Tavalai 
et al, 2008). In ATRX-depleted cells the situation was different. Whereas the numbers of 
cells expressing IE1 did not differ significantly between control or ATRX-depleted cells 
infected with pp71-null virus (see Table 4.1), the amount of IE protein expressed per cell 
was substantially higher in ATRX-depleted cells (see Table 4.1 and Figure 4.3). These 
observations imply that ATRX can block progression of IE transcription in the absence of 
pp71, despite a small amount of IE proteins still being produced (HF-ShLuci cells, Figure 
4.3). Therefore, removal of ATRX by RNAi contributes to relief of this repression 
mechanism within the infected cells. It is however unclear whether ATRX targets HCMV 
genomes directly, particularly during pp71-null mutant HCMV infection. Downregulation 
of hDaxx by siRNA results in loss of a repressive chromatin structure around the HCMV 
MIEP (Woodhall et al, 2006), implying that hDaxx constitutes a part of a chromatin 
repressor complex, which forms around HCMV genomes. It remains to be investigated 
whether a similar mechanism applies in ATRX-depleted cells, although it is likely that 
many more chromatin-associated proteins are involved in this repression. Previous work 
suggests that the repression around HCMV genomes involves the action of HDACs 
(Murphy et al, 2002). The evidence concerning histone deacetylation as mechanism of 
repression in the context of both HCMV and HSV-1 will be discussed in Chapter 6. 
 
In conclusion, ATRX contributes to cellular intrinsic resistance to HCMV infection, 
perhaps less potently than hDaxx. Whether the two proteins are acting as components of a 
complex or independently in order to induce chromatin assembly on the incoming HCMV 
genomes in the absence of pp71 is an issue yet to be investigated.  
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5  Regulation of HSV-1 Infection by ATRX and hDaxx 
5.1  Introduction to cellular intrinsic defence against HSV-1 
infection 
The processes of HSV-1 latency establishment, maintenance and reactivation have been 
subjected to extensive research, but the cellular mechanisms involved remain incompletely 
understood. HSV-1 IE protein ICP0 is a strong transcriptional activator of viral gene 
expression that is required for both efficient lytic infection (reviewed in Everett, 2000; 
Hagglund & Roizman, 2004) and productive reactivation from latency (Everett, 2000; 
Halford & Schaffer, 2001; Harris et al, 1989; Russell et al, 1987; Thompson & Sawtell, 
2006). HSV-1 mutants that fail to express ICP0 are highly sensitive to cell mediated 
repression, especially during low multiplicity infections of restrictive cell lines, such as 
human fibroblasts or hepatocytes. Consequently, these mutant viruses can establish 
quiescent infection that in some respects resembles latency (reviewed in Efstathiou & 
Preston, 2005). Since ICP0 is a non-essential gene, ICP0-null mutants are capable of 
replicating in cell culture when high MOIs are used. However, one has to take into the 
account the probability of initiating productive infection by ICP0-null mutant viruses when 
interpreting ICP0-null mutant HSV-1 phenotype (see Chapter 1, Section 1.6.3.5; reviewed 
in Everett, 2006).  
 
As previously mentioned on several occasions, anti-HSV-1 intrinsic resistance is conferred 
by number of pre-existing cellular proteins, and analogous mechanisms are thought to 
operate during the early stages of HCMV infection (Chapter 4, Section 4.1; and reviewed 
in Saffert & Kalejta, 2008; Tavalai & Stamminger, 2008). ICP0 performs an essential 
function of counteracting cellular intrinsic antiviral resistance, which allows wt HSV-1 
establishing a successful productive infection. However, the mechanisms which are 
utilized by cellular proteins to allow this process are incompletely understood and in some 
cases controversial. Therefore further studies on the proteins that are involved in intrinsic 
cellular defences against HSV-1 infection are required. 
 
ND10 integrity is disrupted at early times after wt HSV-1 infection (Everett & Maul, 1994; 
Everett & Zafiropoulos, 2004; Maul et al, 1993) due to the degradation of the SUMO-
modified forms of Sp100 and PML, which is mediated by E3 ubiquitin ligase activity of 
ICP0 (Boutell et al, 2003; Boutell et al, 2002; Chelbi-Alix & de The, 1999; Everett et al, 
1998a; Everett et al, 1998b). These reports provided evidence on the importance of both   154
PML and Sp100 in cellular anti-HSV-1 defence, which is antagonised by ICP0.  During wt 
HSV-1 infection, PML and Sp100, as well as other ND10 proteins, are re-distributed to the 
sites closely associated with the incoming viral genomes, however this re-distribution is 
very transient and difficult to detect due to the activities of ICP0. In the absence of ICP0, 
these proteins are not degraded but instead are rapidly recruited to sites that are closely 
associated with parental viral genomes and early replication compartments (Everett & 
Murray, 2005), suggesting the potential role of ND10 proteins in the repression of ICP0-
null mutant viral genomes that occurs at low multiplicities of infection. Consistent with 
this hypothesis, the recruitment is extremely rapid, and there is a close correlation between 
the abilities of mutant forms of ICP0 to inhibit this process and to stimulate lytic infection 
(Everett et al, 2007; Everett et al, 2009). This hypothesis was supported by the findings 
that in PML or Sp100 depleted cells ICP0-null mutant HSV-1 gene expression and plaque 
forming efficiencies were significantly increased (Everett et al, 2008; Everett et al, 2006). 
 
In order to identify additional ND10 proteins than may be involved in this repression 
mechanism, the current part of the study has concentrated on the roles of ATRX and 
hDaxx in the context of HSV-1 infection. As previously discussed (Chapter 4), during 
HCMV infection, the viral tegument protein pp71 interacts with hDaxx and promotes its 
degradation, a process which is important for the initiation of efficient HCMV gene 
expression (Cantrell & Bresnahan, 2005; Cantrell & Bresnahan, 2006; Hofmann et al, 2002; 
Hwang & Kalejta, 2007; Ishov et al, 2002; Preston & Nicholl, 2006; Saffert & Kalejta, 
2006; Saffert & Kalejta, 2007). ATRX, on the other hand, is displaced from ND10 by pp71, 
which is functionally significant for the ability of pp71 to stimulate gene expression since 
removal of ATRX supports substantially increased replication of pp71-null mutant HCMV 
(Lukashchuk et al, 2008). Therefore, ATRX and hDaxx have been confirmed as 
components of a cell-mediated intrinsic defence against HCMV infection, which is 
counteracted by pp71 (see Chapter 4). It is therefore possible that similar mechanisms 
apply in HSV-1 infection, assuming that ICP0 acts as a viral countermeasure in the cellular 
defences. This hypothesis has become the basis of the current chapter. 
 
Since intrinsic cellular defences are efficiently overcome by ICP0, ICP0-null mutant HSV-
1 has been utilised in the next set of the experiments in order to determine whether ATRX 
and hDaxx contribute to the cellular repression mechanism that occurs in the absence of 
ICP0. As described in previous chapter, RNA interference approach was used to generate 
ATRX- and hDaxx-depleted cell lines. The results provide the novel evidence for the role   155
of ATRX and hDaxx in cell-mediated anti-HSV response and suggest that the two 
components act as a complex during this process.   
 
5.2  Results 
A general hypothesis underlying the research described in this thesis is that the recruitment 
of the ND10 components (and other proteins) to the sites closely associated with the 
incoming HSV-1 genomes and sites of IE transcription represents a cellular response to 
virus infection that may lead to viral genome repression. The function of ICP0 in 
counteracting the cellular repression mechanism correlates with this recruitment being very 
transient during the wild-type HSV-1 infection. In the absence of ICP0 however this 
recruitment is much more long-lived and can be visualised easily in cells at the edge of 
developing ICP0-null mutant HSV-1 plaques (Everett & Murray, 2005). The more stable 
recruitment in the plaque edge cells, where individual cells are infected at very high 
multiplicities, is not representative of ND10-mediated repression of the viral genomes in 
those cells, since intrinsic defence mechanisms have been saturated. What this 
phenomenon does represent is that at low MOIs of ICP0-null mutant HSV-1infections 
association of the viral genomes and ND10 components subsequently results in silencing 
of the viral genomes and establishment of quiescence. Based on the general assumption 
that viral incoming DNA is repressed in the infected cells, the hypothesis that this may be 
performed, in part, by the chromatin-remodelling complexes such as ATRX and hDaxx 
forms the basis of the present chapter. 
 
 
5.2.1  Analysis of ATRX and hDaxx redistribution in HSV-1 infected 
cells 
5.2.1.1 ATRX and hDaxx are recruited to the sites associated with incoming HSV-1 
genomes 
In order to investigate the distribution of ATRX and hDaxx in HSV-1 infected cells, HF or 
HepaRG cells were infected with wt or ICP0-null mutant HSV-1 and the cells were fixed 
the following day for immunofluorescence analysis.  
 
It was demonstrated earlier that both hDaxx and ATRX co-localise at ND10 with the major 
ND10 component PML (Figure 3.2). During wild-type HSV-1 infection both ATRX and 
hDaxx become rapidly dispersed in the great majority of the infected cells in which ICP4 is   156
expressed at readily detectable levels (Figure 5.1, panels A-B). As in previous studies 
(Everett & Murray, 2005; Everett et al, 2008; Everett et al, 2006), IE protein ICP4 is used 
here as a marker of the initiation of IE transcription and localization of HSV-1 genomes 
through its strong interaction with viral DNA (Pizer et al, 1991). However, in rare cells at 
the edges of developing wt HSV-1 plaques it was possible to detect re-distribution of 
ATRX and hDaxx to asymmetric foci in the apparent absence of ICP4 expression or where 
only very low ICP4 levels were detected (Figure 5.1, panels C-D). Based on the data 
presented in these four panels (Figure 5.1), recruitment of hDaxx and ATRX in these cells, 
before ICP4 has accumulated to detectable levels, emphasises the rapidity of the cellular 
response to the invasion of foreign viral DNA, followed by a viral counteracting response 
mediated by ICP0. In the absence of ICP0, both ATRX and hDaxx re-localise in a far more 
stable manner to the novel sites associated with viral genomes and early replication 
compartments (Figure 5.1, panels E and F).  
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Figure  5.1  ATRX  and  hDaxx  are  recruited  to  the  sites  of  incoming  HSV-1  genomes  in 
HepaRG cells 
Immunofluorescence images of HepaRG cells infected with wt HSV-1 (MOI 0.001; panels A-D) 
and ICP0-null mutant HSV-1 (MOI 0.5; panels E-F) at the edge of a developing plaque. Cells were 
processed for immunofluorescence analysis 24 hours post infection and co-stained for ICP4 (58S) 
and ATRX (39F; panels A and C),  or ICP4 and hDaxx (07-471, panels B and D). In panel F, hDaxx 
was detected with anti-rabbit r1866 serum. Secondary antibodies were anti-mouse FITC-conjugated 
(green, panels A-H), anti-rabbit AlexaFluor-conjugated 555 (red, panels A-D) or anti-rabbit Cy3-
conjugated (red, E-F).  157  158
5.2.1.2 Analysis of hDaxx dynamics at the sites of ICP0-null HSV-1 genomes in 
comparison to normal ND10 
Previous studies established the highly dynamic nature of hDaxx at ND10 in cells 
expressing EYFP-hDaxx using a baculovirus vector (Everett & Murray, 2005). If ATRX 
and hDaxx are more stably present at sites associated with ICP0-null mutant viral genomes 
rather than normal cellular ND10, and if the ATRX/hDaxx complex were to act as a 
repressor during the ICP0-null mutant infection, according to the data presented in Figure 
5.1 (panels E and F), it would be expected that the mobility of the two proteins would be 
reduced at the sites associated with the ICP0-null mutant viral genomes in comparison to 
that at ND10 sites of uninfected cells. Construction of the cell line expressing fluorescent 
EYFP-tagged hDaxx, namely HD-ED, in which the protein has been re-introduced into 
hDaxx-depleted cells (see Figure 3.11) allowed measuring the dynamics of hDaxx foci at 
the sites of the incoming viral genomes and comparing with those at ND10 in mock-
infected cells using FRAP (Figure 5.2). HD-ED cells were infected with dl1403 strain at 
MOI 1.2, infection was allowed to proceed overnight and the cells were processed for 
FRAP analysis, as described in Materials and Methods (Chapter 2, Section 2.5.2.5). Three 
or four dots per cell were chosen for photobleaching, as shown on Figure 5.2 A. Figure 5.2 
B represents the mean values obtained from measuring fluorescence recovery times of a 
total of 43 hDaxx foci taken over the two independent experiments. Since the overall 
purpose of the experiment was to show a general trend and comparison of the recovery 
times, for simplicity error bars were omitted. 
 
The overall decrease of about 20% in the fluorescence recovery values at the end of a scan 
after bleaching each dot was observed in HD-ED cells at the plaque edge compared to that 
in ND10 in uninfected cells. Although hDaxx foci at the sites associated with the incoming 
dl1403 genomes appeared to be highly dynamic, this result supports the hypothesis that 
hDaxx dynamics is reduced at the sites of the incoming ICP0-null mutant viral genomes 
compared to that at ND10 of the uninfected cells, thereby allowing its accumulation at 
these sites in preference to pre-existing ND10.  Start
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Figure 5.2 Dynamics of EYFP-hDaxx foci at ND10 of the mock-infected cells and sites associated with ICP0-null mutant HSV-1 genomes
For fluorescence recovery after photobleaching (FRAP) analysis, cells were seeded into a 35 mm tissue culture dish with a coverslip fixed over a hole into its centre and 
infected  with  dl1403  at  MOI  1.2. A:  Detection  of  the  cells  at  the  edge  of  the  developing  plaque  was  achieved  by  visual  scanning  of  the  cells  with  asymmetric 
redistributions of EYFP-hDaxx foci. Representative cells are shown at various time points after photobleaching. Time 0 and 50 represent the start and the end of the image 
scan, respectively. The representative bleached dots are indicated by an arrow. Note, 3 dots in the mock-infected cells and 4 dots in the dl1403 infected cells were bleached 
(circled). B: The graph shows the mean values of percent recovery of the fluorescence, obtained from a total of approximately 40 foci over the 2 independent experiments.  
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5.2.1.3 ATRX recruitment to the sites associated with the incoming HSV-1 genomes is 
not dependent on PML 
PML, being the major ND10 component, is required for ND10 localisation of Sp100 and 
hDaxx, as previously demonstrated (Everett et al, 2006). However, the recruitment of both 
Sp100 and hDaxx to the sites of the incoming viral genomes in the absence of ICP0 occurs 
independently of PML (Everett et al, 2006), suggesting a different mechanism targeting 
these proteins to HSV-1 genomes. By analogy with these observations, ATRX localisation 
in uninfected or dl1403-infected PML-depleted fibroblasts was analysed. The HF-ShPML 
cells for this experiment were generated by Anne Orr (MRC Virology Unit). As expected, 
in uninfected or mock-infected HF-ShPML cells ATRX was dispersed (Figure 5.3, panels 
A and B), confirming the role of PML in the integrity of ND10 structures. In cells infected 
with the wt virus and analysed at 2 hpi, when IE gene expression had just been initiated, 
ATRX first re-localised to ICP0-associated foci in cells expressing very low levels of the 
viral protein (Figure 5.3, panel C), followed by its displacement from these newly formed 
foci and accumulation of ICP0 at the novel punctate structures (Figure 5.3, panel D). 
Whether this displacement occurs as a result of ICP0-mediated PML degradation or 
through a more direct effect on ATRX causing its displacement from the newly formed 
foci is unclear from this experiment, but this issue is considered later in this chapter. In the 
absence of ICP0 in the infected HF-ShPML cells at the edge of the developing plaque, 
ATRX was recruited to the sites associated with dl1403 genomes and co-localised with 
ICP4 in an asymmetric manner (Figure 5.3, panel E) consistent with data shown in Figure 
5.1, and demonstrating that PML is not required for ATRX recruitment to HSV-1 genome 
associated foci. Taking these data together with previous work (Everett et al, 2006), it is 
concluded that the recruitment of the ATRX/hDaxx complex to the sites associated with 
the incoming HSV-1 genomes is PML-independent.  Figure 5.3 PML is not required for ATRX recruitment to HSV-1 genome foci at the early 
stages of infection
HF-ShPML  cells  were  seeded  onto  coverslips  and  either  left  untreated  (A),  mock-infected  (B), 
infected with 17+ at  MOI 2.0 and fixed at 2 h (C-D), or with dl1403 at MOI 0.5 and fixed the 
following day for the analysis. A: Uninfected cells were co-stained with anti-ATRX H300 and anti-
PML 5E10 antibodies. A PML-positive cell, where ATRX localises to ND10 is indicated by an 
arrowhead, in comparison to a PML-depleted cell, where ATRX is dispersed. B-D: Wt HSV-1-
infected cells were co-stained for ATRX and ICP0 (11060). E: ICP0-null HSV-1-infected cells were 
co-stained for ATRX and ICP4 (58S). The secondary antibody mix contained either anti-mouse 
FITC-conjugated and anti-rabbit Cy3-conjugated antibodies (panels A and E), or anti-mouse Cy3-
conjugated and anti-rabbit AlexaFluor-conjugated 488 antibodies (panels B-D). 
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5.2.1.4 ATRX recruitment to viral genome foci requires its interaction with hDaxx   
The requirement of hDaxx in ATRX targeting to ND10 has been demonstrated in the 
current and previous studies (Ishov et al, 2004; Lukashchuk et al, 2008; Tang et al, 2004 
and Figures 3.8 and 3.9). Hence, it was of interest to analyse the requirement of hDaxx in 
ATRX recruitment to ICP0 null mutant HSV-1 genomes during the early stages of 
infection, as a step towards investigating the role of the complex formed between the two 
proteins in HSV-1 infection.  In order to do this, hDaxx-depleted HALD2 cells (see Figure 
3.9) along with control HALL cells were infected with ICP0-null mutant HSV-1, and the 
cells at the edge of developing plaques were analysed by immunofluorescence (Figure 5.4). 
In uninfected hDaxx-depleted cells, ATRX fails to localise to ND10 and shows a dispersed 
distribution (Figure 3.9). Surprisingly, in ICP0-null mutant HSV-1 infected hDaxx-
depleted cells, ATRX was no longer recruited to ICP4 foci in the absence of hDaxx (Figure 
5.4, panel B) and showed dispersed distribution as in uninfected HALD2 cells, whereas 
PML was recruited normally (Figure 5.4, panel D). These results imply that if the 
recruitment of ATRX to sites associated with viral genomes has functional significance, 
then hDaxx may be an important factor in regulating the functions of ATRX and may serve 
as the essential factor that targets ATRX to viral genomes. This hypothesis was therefore 
investigated in more detail. 
 
Chapter 3 has described the use of a system in which hDaxx is re-introduced at close to 
endogenous levels and is easily detectable by the N-terminal EYFP tag (Figures 3.10 and 
3.11). This system therefore allowed the study of the role of hDaxx in more detail by 
introducing mutations that may affect its function. Using lentiviral vectors expressing the 
wt EYFP-hDaxx fusion protein and a derivative with the deletion of the PAH1 responsible 
for its interaction with ATRX, cell lines reconstituted with wt and mutant hDaxx proteins 
were produced and characterised as described in Chapter 3 (Figures 3.12 and 3.13). In 
summary of the data shown earlier, fusion protein EYFP-hDaxx targets ATRX back to 
ND10 but ATRX-interaction deficient mutant EYFP-hDaxxΔPAH1 does not, although the 
mutant hDaxx protein still localises to ND10. Disruption of the interaction between ATRX 
and hDaxx has been confirmed by CoIP assays (Figure 3.12, C). The current section 
investigates the effect of re-introducing wt EYFP-hDaxx or mutant EYFP-hDaxxΔPAH1 
on ATRX recruitment to the sites associated with the incoming HSV-1 genomes in the 
absence of ICP0.   HALD2
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Figure 5.4 ATRX is not recruited to the sites associated with ICP0-null mutant HSV-1 genomes 
in hDaxx-depleted HepaRG cells 
Immunofluorescence analysis of ATRX localisation in cells at the edge of ICP0-null mutant HSV-1 
plaques in HALL (A and C) and HALD2 (B and D) cells. Cells were infected at MOI 0.5 (HALL) or 
0.1 (HALD2) PFU/cell and co-stained the following day with anti-ATRX H300 and anti-ICP4 58S 
antibodies  (A  and  B),  or  anti-PML  5E10  and  anti-ICP4  58S  antibodies  (C  and  D).  Secondary 
antibodies were anti-rabbit AlexaFluor-conjugated 488 and anti-mouse Cy3-conjugated (A, B and 
D) or anti-rabbit AlexaFluor-conjugated 555 and anti-mouse FITC-conjugated (C). 
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HD-ED (Figure 5.5) or HD.ΔPAH (Figure 5.6) cells, along with control cell lines HepaRG 
and hDaxx-depleted HD-E, were infected with dl1403 at MOI 1 or 0.2, respectively, and 
stained the following day for ND10 and ICP4 protein analysis. The reason for the lower 
MOI used for infection of HD.ΔPAH cells will be evident in later sections of this chapter. 
In the absence of hDaxx, using the hDaxx-depleted cell line HD-E that expressed EYFP, 
ATRX remained dispersed within cells at the periphery of the dl1403 plaques, when ICP4 
foci were readily detectable (Figure 5.5 panel B). This was consistent with the results 
obtained with HALD2 cells, suggesting EYFP expression did not have an effect on this 
recruitment. HD-E will later be used as a control cell line in a number of assays. Upon re-
introduction of EYFP-hDaxx, ATRX was recruited back into the sites of the incoming viral 
genomes (Figure 5.5, panel C), in the same way as in non-transduced HepaRG cells (panel 
A), supporting the evidence for the importance of hDaxx for ATRX recruitment to the viral 
genome foci. EYFP expression in hDaxx-depleted cells HD-E or re-introduction of EYFP-
hDaxx in HD-ED cells did not have any detectable effect on the recruitment of PML 
(panels D-E). Notably, PML recruitment in EYFP-hDaxx expressing cells occurred rapidly, 
even before ICP4 expression could be detected (panel E). Infected HD-ED cells were also 
analysed with an anti-Daxx antibody, showing precise co-localisation with EYFP-hDaxx 
signal (Figure 5.5, panel F).   
 
Consistent with its PAH1 dependent localisation to ND10 in uninfected cells (see Figure 
3.13), ATRX remained dispersed in HD.ΔPAH cells at the edge of a developing ICP0-null 
mutant HSV-1 plaque, even though the mutant hDaxx protein was efficiently recruited to 
sites associated with viral genomes (Figure 5.6, panel A). Recruitment of PML and EYFP-
hDaxxΔPAH1 itself occurred normally in HD.ΔPAH cells (panels B and C). These results 
confirm that the interaction between ATRX and hDaxx is required for ATRX recruitment 
to the viral genome associated sites, and identify the hDaxx ATRX-interaction domain 
PAH1 as being important for this process. Therefore, the possibility that ATRX and hDaxx 
may act as a complex in HSV-1 infection was investigated further.  ICP4 ATRX
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Figure 5.5 EYFP-hDaxx targets ATRX back into foci associated with incoming viral genomes 
during ICP0-null mutant HSV-1 infection 
HepaRG,  HD-E  and  HD-ED  cells  were  infected  with  dl1403  and  cells  processed  for 
immunofluorescence  the  following  day  by  co-staining  for  ICP4  (58S;  panels A-F)  and ATRX 
(H300; panels A-C), PML (r8; panels D-E) or hDaxx (07-471; panel F). Secondary antibodies were 
anti-mouse AlexaFluor  555-conjugated  and  anti-rabbit  Cy5-conjugated.  EYFP  signal  (green) 
resuted from autofluorescence of EYFP alone or EYFP-hDaxx, as indicated.
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Figure  5.6  Interaction  between  hDaxx  and ATRX  is  required  for ATRX  recruitment  to 
incoming viral genomes at the edge of ICP0-null mutant HSV-1 plaque
HD.DPAH cells were infected with dl1403 and processed for immunofluorescence the following 
day by co-staining for ICP4 (58S; panels A-C) and ATRX (H300; panels A), PML (r8; panel B) or 
hDaxx (07-471; panel C). Secondary antibodies were anti-mouse AlexaFluor 555-conjugated and 
anti-rabbit Cy5-conjugated. EYFP signal (green) resuted from autofluorescence.
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5.2.2  The role of ATRX/hDaxx complex in the repression of HSV-1 
infection in the absence of ICP0 
Previous reports have demonstrated that depletion of either PML or Sp100 improves the 
efficiency of ICP0-null mutant HSV-1 infection, and simultaneous depletion of both 
improves infection yet further. Both PML and Sp100 are recruited to sites closely 
associated with ICP0-null mutant HSV-1 genomes at the early stages of infection, so this 
phenomenon correlates well with their role in restricting ICP0-null mutant virus gene 
expression (Everett et al, 2008; Everett et al, 2006). In summary of the data demonstrated 
above, both ATRX and hDaxx are recruited to the sites associated with the HSV-1 
incoming genomes in the absence of ICP0, and recruitment of ATRX requires its 
interaction with hDaxx. By analogy with previously published work (Everett et al, 2008; 
Everett et al, 2006), the hypothesis that recruitment of ATRX and hDaxx may also 
contribute to cell mediated repression of ICP0-null HSV-1 gene expression, particularly 
since ATRX and hDaxx constitute a chromatin-associated complex with repressive 
properties (Tang et al, 2004; Xue et al, 2003), underlies the remainder of the current 
chapter. The data presented below demonstrate the effect of ATRX or hDaxx depletion in 
the efficiency of wt and ICP0-null mutant HSV-1 infection from the perspective of viral 
gene expression and plaque forming efficiencies.    
 
5.2.2.1 Depletion of ATRX supports increased efficiency of ICP0-null mutant HSV-1 
infection 
For the analysis of the effect of ATRX depletion on viral infection, both HF and HepaRG 
cells depleted of ATRX were utilized (described in Chapter 3, Figures 3.5-3.9).  In order to 
assess the effect of ATRX on HSV-1 IE and Early gene expression, the control cells 
expressing shGFP or shLuci and ATRX-depleted cells were infected at MOI of 2 PFU/cell 
and expression of typical IE and Early proteins (ICP4 and UL42, respectively) was 
analysed by western blot at various time points over the course of an 8 hour infection 
(Figure 5.7 A-D). Both ICP4 and UL42 proteins are essential for HSV-1 replication. Due 
to the ability of ICP0 to counteract intrinsic cellular defences, depletion of ATRX in 
different cell types did not affect the expression of ICP4 or UL42 during wt HSV-1 
infection (Figure 5.7, A and B), consistent with previously published work (Everett et al, 
2008; Everett et al, 2006). When cells were infected with ICP0-null mutant HSV-1, 
however, ATRX depletion resulted in a slight but reproducible increase in UL42   168
expression (Figure 5.7, C and D). No differences in ICP4 expression were detected. These 
results suggest that ATRX contributes to the normally efficient repression of ICP0-null 
mutant HSV-1 gene expression. 
 
These observations were extended to analyse the efficiency of plaque formation of both wt 
and ICP0-null mutant HSV-1 in both cell types. To achieve this, recombinant HSV-1 
strains with the insertion of a lacZ marker in place of the tk gene were used.  This insertion 
allows expression of β-galactosidase in the infected cells, hence providing a convenient 
way of determining plaque numbers at 24 hours post infection. Control and ATRX-
depleted cells were infected using sequential dilutions of wt and mutant viruses and 
relative plaque forming efficiencies were determined following three independent 
experiments for each set of cells (Figure 5.7, E-H). No significant differences in the plaque 
numbers between wild-type HSV-1-infected control or ATRX-depleted cells were seen 
(Figure 5.7, panels E and F). During the infection with ICP0-null mutant virus, however, 
averages of a 4-fold increase in HF-ShATRX cells and a 6-fold increase in HAA cells in 
plaque forming efficiencies were observed when compared to control HF-ShGFP or HALL 
cells, respectively (Figure 5.7, G and H). The greater increase observed in HAA cells is 
probably a result of more stable depletion of ATRX in HepaRG cell lines, and could not be 
attributed to control cell lines expressing different shRNAs (shGFP vs shLuci). This data 
provides additional support for the repressive activities of ATRX in ICP0-null mutant 
HSV-1 replication.  
 
 
 
 
________________________________________________________________________ 
Figure 5.7 The effects of ATRX depletion on the infection with wt and ICP0-null mutant 
HSV-1.  A-D: Analysis of viral gene expression. HF or HepaRG cells depleted of ATRX, and 
control cell lines expressing shGFP or shLuci, respectively, were infected with wt HSV-1 17+ (wt; 
A and B) or dl1403 (ICP0-null; C and D) at MOI 2 and samples were harvested for analysis by 
western blot at 0, 4, 6 and 8 hours post infection (hpi). Membranes were probed for ICP4 (58S), 
UL42 (Z1F11) and actin (AL-40; loading control). E-F: Analysis of the plaque forming efficiency. 
ATRX-depleted HF (E and G) or HepaRG (F and H) and respective control cell lines were infected 
with in1863 (E and F) or dl1403/CMVlacZ (G and H) at sequential dilutions. Cells were stained for 
β-galactosidase expression at approximately 24 hours post infection. Relative plaque numbers were 
determined against the numbers obtained on control infected cells. The plots represent mean values 
obtained from three independent experiments. Error bars are standard error values.   
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Figure 5.7 The effects of ATRX depletion on the infection with wt  and ICP0-null mutant 
HSV-1  
Legend on the previous page.  
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5.2.2.2 hDaxx contributes to the repression of ICP0-null mutant HSV-1 infection 
Preliminary work indicated that hDaxx also contributes to the repression of ICP0-null 
mutant genomes in both HF-ShDaxx and HALD2 cells, using the same experimental 
approach as that described in Figure 5.7, A-D (Roger Everett and Anne Orr, personal 
communication). In order to test the optimal MOI for experiments in hDaxx-depleted cells, 
cells were infected with ICP0-null mutant HSV-1 strain dl1403 at decreasing MOIs and 
samples were analysed for the levels of viral gene expression at 8 hours post infection 
(Figure 5.8, A). This analysis revealed that the most obvious differences in UL42 
expression between HALD2 cells and HepaRG or HALL cells at this time of infection 
were at MOI of 2 PFU/cell. This increase in UL42 was more significant than that observed 
in ATRX-depleted cells. In addition, a slight increase in ICP4 expression in the absence of 
hDaxx was also detected in this assay, although this was variable between experiments. 
Based on these data (Figure 5.8, A) an MOI of 2 was chosen as the optimal virus amount to 
be used for further experiments (see below), consistent with the assays performed on 
ATRX-depleted cells (Figure 5.7 B and D).  
 
Immunofluorescence analysis demonstrated that re-introduced EYFP-hDaxx targets ATRX 
back to the sites of the incoming dl1403 genomes in the infected HD-ED cells (Figure 5.5). 
Hence, the use of HD-ED cells allowed investigation of whether re-introduction of hDaxx 
reverses the effect of hDaxx depletion in viral infection assays. Infection of HD-ED cells 
along with hDaxx-depleted HD-E and control cell lines which express endogenous hDaxx 
confirmed that this indeed was the case (Figure 5.8 B-C). Again, no differences in the 
levels of ICP4 and UL42 expression were detected during wt HSV-1 infection. In the 
absence of ICP0, however, there was a significant increase in UL42 production in HD-E 
cells, particularly when compared to transduced control HALL cells. These levels were 
reduced upon re-introduction of wt EYFP-hDaxx. The hDaxx blot provides confirmation 
of hDaxx depletion or re-introduction at the time of the experiment.  
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Figure 5.8 hDaxx contributes to the efficient repression of ICP0-null mutant HSV-1 
A: Analysis of ICP0-null HSV-1 protein synthesis in hDaxx-depleted cells at different MOIs. 
HepaRG, HALL and HALD2 cells were mock-infected or infected with dl1403 at MOI 2, 1 or 0.5 
PFU/cell and samples were harvested for western blot analysis at 8 hpi. B and C: Kinetics of ICP4 
and UL42 synthesis in hDaxx-depleted and hDaxx-reconstituted cells. HepaRG, HALL, HD-E and 
HD-ED cells were infected with 17+ (B) or dl1403 (C) at MOI 2 and samples were harvested for 
western blot analysis at 0, 4, 6 and 8 hours post infection (hpi). In panels A-C membranes were 
probed for ICP4, UL42 and hDaxx using antibodies 58S, Z1F11 and D7810, respectively. Actin 
was a loading control. D and E: Efficiency of plaque formation of HSV-1 in hDaxx-depleted and 
hDaxx-reconstituted cells. Cells seeded into 24-well plates were infected with wt HSV-1 strain 
in1863 (C) or ICP0-null HSV-1 dl1403/CMVlacZ (D) at sequential dilutions and stained for β-
galactosidase expression 24 hours later. The plaque numbers are expressed as fold 
increase/decrease against control cells HepaRG. The plots represent mean values of plaque 
numbers relative to those in HepaRG cells, obtained from 4 independent experiments. Error bars 
represent standard error values.  
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Next, the effect of depletion or re-introduction of hDaxx on HSV-1 plaque formation was 
determined, using the same approach as above for ATRX-depleted cells. Similar to 
previous data, wt HSV-1 plaque formation was equally efficient in this set of cells (Figure 
5.8 D), whereas that of ICP0-null mutant virus was increased approximately 5-fold in 
hDaxx-depleted HD-E cells when compared to naïve HepaRG cells. This equated to 
around a 10-fold increase when compared to control transduced HALL cells (Figure 5.8 E). 
Consistent with the viral protein expression analyses, re-introduction of EYFP-hDaxx 
reversed the effect of hDaxx depletion on plaque formation efficiency of ICP0-null mutant 
HSV-1 (Figure 5.8 E). Similar results to those in HD-E cells were obtained using HALD2 
cells that express shDaxx2 only (data not shown), implying that EYFP expression in HD-E 
cells did not interfere with the assay. Taking all the data together, it is concluded that 
hDaxx contributes to the repression of HSV-1 infection in the absence of ICP0 to a higher 
extent than ATRX. Therefore, hDaxx recruitment to the sites of the incoming ICP0-null 
HSV-1 genomes is likely to be functionally significant for its repressive properties at these 
sites. 
 
5.2.2.3 The ATRX interaction region of hDaxx is required for fully efficient repression 
of ICP0-null mutant HSV-1 infection and gene expression 
The indication that the ATRX/hDaxx complex was responsible for targeting ATRX to the 
sites of the incoming viral genomes came from the observations that ATRX-interaction 
domain of hDaxx is required for ATRX recruitment into these foci. EYFP-hDaxxΔPAH1, 
however, was still recruited to the sites of viral IE replication (see Figure 5.6). Hence, the 
next logical question to ask was whether the specific interaction between ATRX and 
hDaxx is required for the repressive properties of the ATRX/hDaxx complex during ICP0-
null mutant HSV-1 infection.  
 
Consistent with the data obtained with other cell lines during the wt HSV-1 infection, there 
were no differences in the efficiency of the wt virus gene expression or plaque formation 
between the control cell line HALL and HD-E,  HD-ED or HD.ΔPAH cells (Figure 5.9, A 
and C). In the cells infected with ICP0-null mutant HSV-1, deletion of the hDaxx ATRX 
interaction domain resulted in an increase in ICP4 and UL42 production, which was 
comparable to that observed in hDaxx depleted cells (Figure 5.9, B). Moreover, the 
increase in ICP0-null mutant gene expression in HD-E and HD.ΔPAH cells was reflected 
in plaque formation efficiency assays. Whereas the plaque forming efficiency of wt HSV-1 
was not significantly different in these cells (Figure 5.9, C), the increase in ICP0-null mutant plaque formation in hDaxx-depleted HD-E cells could be reversed by 
reintroduction of wt hDaxx in HD-ED cells, but not by introduction of the ATRX-binding 
deficient hDaxx in HD.ΔPAH cells (Figure 5.9, D). It is therefore concluded that a 
functional ATRX/hDaxx complex is required for their role in the repression of ICP0-null 
mutant HSV-1 infection. This requirement is likely to be related to the chromatin-
associated functions of the ATRX/hDaxx complex and identifies ATRX/hDaxx complex as 
a novel component in the regulation of ICP0-null mutant HSV-1 infection during the lytic 
cycle. 
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Figure 5.9 The ATRX interaction region of hDaxx is required for fully efficient repression of 
ICP0-null mutant HSV-1 gene expression and plaque formation 
A and B: Cells were infected with the indicated viruses at MOI 2.0 PFU/cell and samples were 
harvested at the 0, 4, 6 and 8 hours post infection (hpi). Samples were resolved on a 7.5 % 
polyacrylamide gel. Membranes were probed for the expression of ICP4, UL42 and hDaxx using 
antibodies 58S, Z1F11 and D7810, respectively. Actin (AC-40) was a loading control. C and D: 
Cells seeded into 24-well plates were infected with wt HSV-1 strain in1863 (C) or ICP0-null HSV-
1  dl1403/CMVlacZ (D) at sequential dilutions and stained for β-galactosidase activity the 
following day to reveal the plaques. The plots represent mean values of plaque numbers relative to 
those in HepaRG cells, obtained from 3 independent experiments. Error bars represent standard 
error values. 
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5.2.3  The role of the ATRX/hDaxx complex in the establishment of 
HSV-1 quiescence  
A number of reports have demonstrated the importance of ICP0 for reactivation of HSV-1 
genomes in cultured cell models of quiescent infection (Harris et al, 1989; Preston, 2007; 
Preston & Nicholl, 1997; Samaniego et al, 1998; Terry-Allison et al, 2007), hence in the 
absence of ICP0 the virus has a higher probability of establishing a quiescent infection.  
Having demonstrated in the previous section of this manuscript the role of ATRX and 
hDaxx in the repression of ICP0-null HSV-1 infection as a complex, the potential of this 
complex in the repression of viral gene expression during the modelled establishment of 
quiescent viral genomes was also investigated.  
 
In order to achieve this, the indicated cell cultures (Figure 5.10) were either mock-infected 
or infected with virus strain in1374, an ICP0-null mutant HSV-1 with a temperature 
sensitive mutation within ICP4 and a mutation within VP16 that eliminates its ability to 
form the complex that stimulates IE gene transcription. After infection was allowed to 
proceed at 38.5 °C for 18 hours, cells were processed for the analysis of β-galactosidase 
expression. Failure to establish quiescence by in1374 was determined by the appearance of 
blue cells, expressing β-galactosidase. Figure 5.10A shows representative images of blue 
cell distributions in different cell cultures infected with in1374 alone, mock-infected or co-
infected with in1374 plus strain tsK. HSV-1 strain tsK only bears a temperature sensitive 
mutation within ICP4, expresses ICP0 and stimulates the expression of the marker β-
galactosidase gene in all in1374 infected cells (Preston & Nicholl, 2005). Co-infection with 
tsK provided the measure of the maximal number of in1374 infected cells. Figure 5.10A 
bottom right panel shows the representative image of β-galactosidase positive cells 
resulting from such co-infection (here HepaRG cells), and indicates that the majority of 
cells in these populations had been infected with in1374. There were no differences 
between the different cell lines used for this experiment in the proportion of blue cell 
numbers obtained from such co-infections. The representative image of the mock-infected 
sample (Figure 5.10 A, bottom left) indicates there was no background staining during the 
processing of the samples. 
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Figure 5.10 Interaction between ATRX and hDaxx is required for the efficient establishment 
of quiescent infections in cultured cells 
Cells were mock-infected, infected with HSV-1 strain in1374 at MOI 5 or co-infected with in1374 
(MOI 5) and tsK (MOI 1). Infected cells were incubated at restrictive temperature of 38.5 °C 
overnight and processed for b-galactosidase staining the following day. A: Images of HALL (a), 
HD-E (b), HD-ED (c) and HD.ΔPAH (d) cells at 24 h after infection with in1374, or HepaRG 
mock-infected (e) or co-infected with in1374 and tsK (f). B: Relative cell numbers of β-
galactosidase expressing cells in the above cell types compared to those obtained in parallel 
in1374- infected HepaRG cells. The plots represent mean values obtained from 3 independent 
experiments. Error bars are standard error values. 
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Results were quantified by comparing the blue cell numbers amongst this set of cell lines 
(Figure 5.10B). Positive cells were scored firstly in the HepaRG infected samples, and 
relative numbers of cells expressing the marker gene were obtained for each individual cell 
line in each set of independent experiments. Depletion of hDaxx resulted in a substantially 
increased number of β-galactosidase positive cells compared to the cells expressing 
endogenous levels of hDaxx. Re-introduction of the wt EYFP-tagged hDaxx fusion protein 
reversed the increase in the number of cells escaping the establishment of quiescence. 
However, in the cells expressing the EYFP-hDaxx.ΔPAH1 mutant protein, the number of 
β-galactosidase positive cells was significantly higher than that in HALL or HD-ED cells.  
These results indicate that the disrupted interaction between ATRX and hDaxx leads to a 
reduced capacity of the cells to repress in1374 gene expression. This suggests that the 
ATRX/hDaxx complex may have a role in the efficiency of establishment of a quiescent 
HSV-1 infection in a cultured cell model. 
 
5.2.4  The role of hDaxx SUMO-interaction motif in regulating ICP0-null 
mutant HSV-1 infection  
In Chapter 3 the requirement of the hDaxx SIM in the ND10 localisation of itself and its 
interaction partner ATRX was demonstrated (Figure 3.14). Based on these findings and 
previous reports (Jang et al, 2002; Lin et al, 2006), it was concluded that the interaction 
between hDaxx and PML via the hDaxx SIM is essential for hDaxx localisation to ND10. 
The SIM of hDaxx is important for its interaction with other transcriptional repressors and 
hence its abilities to elicit its repressive activities (Holmstrom et al, 2008; Kuo et al, 2005; 
Lin et al, 2006; Meinecke et al, 2007; Shih et al, 2007; Zhong et al, 2000a). This section 
investigates whether the hDaxx SIM is required for recruitment of hDaxx to sites 
associated with HSV-1 genomes and whether it has a role in regulating the efficiency of 
viral gene expression and replication, using the same approaches as described above for 
other cell lines.  
 
Examination of HD.MSIM cells at the edge of a developing dl1403 plaque revealed that 
EYFP-hDaxxMSIM failed to be recruited to the sites associated with ICP0-null HSV-1 
genomes (Figure 5.11) and remained dispersed, as in non-infected cells (see Figure 3.14 in 
Chapter 3). In addition, dispersed hDaxxMSIM failed to target ATRX to the sites of the 
viral genomes (Figure 5.11, panel A). PML recruitment was not affected by the expression 
of EYFP-hDaxxMSIM. These data suggest that the hDaxx SIM is required for the 
recruitment of itself and therefore also ATRX to the sites associated with viral genomes.   
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Figure 5.11 hDaxx SUMO-interaction motif is required for hDaxx and ATRX recruitment to 
the sites associated with the incoming ICP0-null mutant HSV-1 genomes 
HD.MSIM cells were infected with dl1403 at MOI 0.2 and processed for analysis by 
immunofluorescence the following day. Cells on coverslips were stained with anti-ATRX H300, 
anti-PML r8 and anti-ICP4 58S antibodies. Secondary antibodies were anti-mouse AlexaFluor 555-
conjugated and anti-rabbit Cy5-conjugated. EYFP-hDaxxMSIM is autofluorescent and appears in 
EYFP channel. 
 
 
If neither ATRX nor hDaxx are recruited to the viral-induced foci, it is expected that they 
would not be able to repress ICP0-null viral gene expression and plaque formation 
efficiently. Indeed, when HD.MSIM cells and respective control cell lines were infected 
with ICP0-null HSV-1 virus (dl1403 or dl1403/CMVlacZ; Figure 5.12, B and D 
respectively), the increases in ICP4 and UL42 production as well as in plaque formation 
were comparable to those obtained observed in hDaxx-depleted HD-E cells. The efficiency 
of wt HSV-1 infection remained unchanged, as in previous experiments (Figure 5.12, A 
and C). The ability of ATRX and hDaxxMSIM to interact was not tested, but it was 
expected that the complex between the two would not be disrupted since the N-terminal 
portion of hDaxx was sufficient for interaction with ATRX in CoIP assays in other studies 
(Tang et al, 2004). This suggests that interaction between ATRX and hDaxx is important 
for the repressive activities of the complex during ICP0-null mutant HSV-1 infection, but it 
also requires the interaction between hDaxx and SUMO and its SUMO-modified targets. 
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Figure 5.12 The SUMO-interaction motif of hDaxx is required for fully efficient repression of 
ICP0-null mutant HSV-1 infection. 
A and B: Cells were infected with the indicated viruses at MOI 2.0 PFU/cell and samples were 
harvested at the 0, 4, 6 and 8 hours post infection (hpi). After resolving the samples on a 7.5 % 
polyacrylamide gel, membranes were probed for the expression of ICP4, UL42 and hDaxx using 
antibodies 58S, Z1F11 and D7810, respectively. Actin (AC-40) was a loading control. C and D: 
Cells were infected with wt HSV-1 strain in1863 (C) or ICP0-null HSV-1 dl1403/CMVlacZ (D) at 
sequential dilutions and stained for β-galactosidase activity the following day to reveal the plaques. 
The plots represent mean values of plaque numbers relative to those in HepaRG cells, obtained 
from 3 independent experiments. Error bars represent standard error values. 
 
  1785.2.5  Analysis of ATRX and hDaxx modification during HSV-1 infection 
Previously published work has demonstrated that ICP0 stimulates the degradation of both 
PML and SUMO modified forms of Sp100 (Boutell et al, 2003; Boutell et al, 2002; 
Chelbi-Alix & de The, 1999; Everett et al, 1998b), an activity that correlates with its 
functions in counteracting the host intrinsic anti-viral response. The next set of results 
addresses the question whether ATRX and hDaxx expression is affected during HSV-1 
infection. The aim of these analyses was to investigate whether ATRX and hDaxx were 
indeed displaced from the sites associated with viral genomes at the early stages of 
infection with wt HSV-1, rather than being targeted for degradation.  
 
5.2.5.1 ATRX is not degraded during wt HSV-1 infection 
As one of the preliminary steps in these studies, the levels of ATRX expression during the 
course of the infection were examined in infected fibroblasts. HFs were infected with wt or 
ICP0-null mutant HSV-1 at the high MOI of 10 and samples were harvested for analysis 
every two hours during the course of 8 hours post infection (Figure 5.13).  No significant 
changes in the expression of major ATRX isoforms were detected following the infection. 
Slight reduction in the levels of truncated ATRX isoform were noticed in ICP0-null mutant 
infection, although this observation was not subjected to any further investigation. It was 
therefore concluded that dispersal of ATRX, which is observed very soon after the entry of 
wt HSV-1 genomes into the nucleus, was not associated with its degradation.  
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Figure 5.13 Analysis of ATRX expression during infection with HSV-1 
HFs were infected with either wt 17+ strain or ICP0-null dl1403 strain of HSV-1 at MOI 10 and 
samples were harvested for analysis at indicated hours post infection (hpi). ATRX and ICP4 were 
resolved on a 6% polyacrylamide gel, and ICP0 and actin were resolved on a 7.5% gel. Antibodies 
used for western blotting were anti-ATRX 39F, anti-ICP4 58S, anti-ICP0 11060 and anti-actin AC-
40.  
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5.2.5.2 The ATRX/hDaxx complex is neither disrupted during HSV-1 infection nor 
interacts with ICP0  
Previous evidence suggested that ICP0 associates with HDACs as well as with the 
chromatin repressor complex REST/CoREST/HDAC1 (Gu et al, 2005; Lomonte et al, 
2004). Moreover, ICP0 disrupts the REST/CoREST/HDAC1 complex (Gu et al, 2005). 
Therefore, by analogy with these findings, the next experiment rests on the possibility that 
the dispersal of ATRX and hDaxx during the early stages of wt infection may be either a 
direct or an indirect consequence of ICP0-mediated disruption of the ATRX/hDaxx 
complex. CoIP assays were performed using HepaRG cells infected with wt HSV-1 at 
MOI 5, and the samples were harvested for analysis at 4 hours post infection.  The reason 
for the chosen time point was the already observed changes in hDaxx gel mobility which 
seem to occur in ICP0-dependent manner at MOI of 2 Pfu/cell (Figure 5.8). In addition, if 
there was an effect of ICP0 on the integrity of the hDaxx/ATRX complex, it might be 
observed very early after infection (based on the earlier analysis of recruitment of the 
proteins to sites associated with viral genomes, Figure 5.1).  
 
Figure 5.14 demonstrates the results of CoIP assays in which essentially the same buffer 
conditions were used as described in Figure 3.12C. Immunoprecipitation was carried out 
using anti-ICP0, anti-ATRX and anti-hDaxx antibodies (Figure 5.14; lanes 2 and 8; 3 and 9; 
4 and 10, respectively). Controls with no added antibody (lanes 5 and 11) and an anti-
USP7 antibody (lanes 6 and 12) were used as a negative control and a positive control for 
the interaction between USP7 and ICP0 (Everett et al, 1997). The input lane represents 
2.5% of the cell extract used in each IP reaction. Evidently, there were no differences in 
the efficiency of CoIP of the ATRX/hDaxx complex with both anti-ATRX and anti-hDaxx 
antibodies in the mock-infected and wt HSV-1 infected cell extracts (Figure 5.14), 
suggesting unmodified integrity of the complex in the infected cells. IP using the anti-
hDaxx antibody was more efficient in pulling down ATRX in the current assay than that 
presented in Figure 3.12 C, suggesting a certain level of variation in the assay efficiencies 
between the experiments. More importantly, ICP0 was not detected in the immune 
precipitates with either anti-ATRX or anti-hDaxx antibodies (lanes 9 and 10). The weak 
bands in anti-ICP0 blot are indicative of background since the same sized band is present 
in the negative control lane 11. Likewise, neither ATRX nor hDaxx specific bands were 
detected in the immune precipitates with anti-ICP0 antibody (lane 8), although ICP0 was 
clearly detected in the immune precipitates of infected cell extracts. Interaction between 
ICP0 and USP7, on the other hand, was successfully detected in the wt HSV-1 infected 
cells (lane 12) but not in mock-infected cells (lane 6). Based on these data, it is concluded that HSV-1 ICP0 neither interacts with the components of ATRX/hDaxx complex, nor 
disrupts the ATRX/hDaxx complex.  
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Figure 5.14 ICP0 neither interacts with nor disrupts the ATRX/hDaxx complex 
HepaRG cells were either mock-infected or infected with wt HSV-1 at MOI 5 and cells were 
harvested in IP lysis buffer at 4 h post infection. Immunoprecipitation was carried out using no 
antibody or anti-ICP0 190, anti-ATRX H300, anti-Daxx 07-471 and anti-USP7 210 antibodies, as 
indicated. Input lanes contained 2.5% of the sample used for immunoprecipitation. Western blot 
analysis was performed using mouse anti-ATRX 39F, anti-Daxx D7810 and anti-ICP0 11060 
antibodies.  
 
5.2.5.3 hDaxx phosphorylation levels are increased during wild-type HSV-1 infection 
In the course of earlier experiments shown in the current chapter it had been noted that 
hDaxx is subject to modification during wt but not ICP0-null mutant HSV-1 infection of 
HepaRG-based cells (Figure 5.8). Based on previously published work (Ecsedy et al, 2003), 
such a pattern of modification is reminiscent of increased phosphorylation of hDaxx. This 
hypothesis was investigated more thoroughly by analysing the expression pattern of 
endogenous hDaxx in naïve infected HepaRG cells over 10 hours of infection with wt or 
ICP0-null mutant viruses at MOI 5 (Figure 5.15). As the wt virus infection progressed, the 
lower band of the hDaxx doublet decreased in mobility and merged with the higher band 
isoforms (Figure 5.15, A). This shift did not occur in the parallel ICP0-null mutant virus 
infection, even at late times in this experiment when UL42 expression was abundant 
(Figure 5.15, B). During the course of replicate experiments, it was noted that the detail of 
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the hDaxx isoforms varied between gels, implying that the slight mobility shifts observed 
could be affected by minor variations in electrophoresis conditions.  
 
A similar pattern of Daxx migration was observed in previous studies when kinase HIPK1, 
which is responsible for Daxx phosphorylation in mouse cells, was over-expressed (Ecsedy 
et al, 2003). Therefore, it was possible that the hDaxx band shift during wt virus infection 
could be a result of increased phosphorylation levels of hDaxx. To test this hypothesis, 
cells were infected with wt and ICP0-null mutant HSV-1 at MOIs of 5 and 10 and the 
infected samples were harvested in IP lysis buffer without EDTA (which is inhibitory to λ-
phosphatase according to manufacturer’s manual) at 4 and 7 hours post infection. These 
time points were picked based on the data presented in Figure 5.15 A and B. Samples were 
either left untreated or treated with phosphatase for 1 hour at 30 ºC and analysed on 6% 
and 7.5% gels (Figure 5.15, C-D). As shown in this and previous chapters, hDaxx migrates 
as a double band, which is likely to result from varying mobility of phosphorylated and 
non-phosphorylated hDaxx forms. Phosphatase treatment of mock (M) infected samples 
resulted in the loss of the lower mobility bands and an increase in intensity of the highest 
mobility form, indicating that hDaxx phosphorylation was abolished in these cells (Figure 
5.15 C-D). Analysis of the wt HSV-1 infected samples at MOI 5.0 and 10, harvested at 4 
and 7 hours post infection indicated that the infection specific band shift was also due to 
phosphorylation (Figure 5.15) since phosphatase treatment of the infected samples caused 
loss of the lower mobility forms and the appearance of a single, more intense band of 
higher mobility (Figure 5.15, C). The faint appearance of hDaxx bands in untreated, wt 
HSV-1 infected samples was due to the slower migration of different multiply-
phosphorylated hDaxx forms, rather than degradation, since the intensities of phosphatase 
treated bands were indistinguishable between non-infected and wt HSV-1 infected samples. 
In the cell extracts obtained from ICP0-null mutant infected samples interpretation of the 
results was not as straightforward as in the wt HSV-1 infection. Untreated samples from 
the ICP0-null mutant HSV-1 cells infected at MOI of 5 showed no evidence of increased 
phosphorylation at the same time points and were indistinguishable from the mock infected 
samples. At the MOI of 10, however, hDaxx migration pattern produced similar results to 
those observed with wt HSV-1 infection at MOIs 5 and 10 at the same time points. 
Phosphatase treatment of the ICP0-null mutant infected samples, particularly those 
infected at MOI of 10, resulted in disappearance of the higher mobility hDaxx bands 
(Figure 5.15 D), as in the wt infected samples. These observations indicate that the hDaxx 
phosphorylation events that occur during wt HSV-1 infection are not a direct effect of 
ICP0 itself (as might be concluded from the results of infections of MOI 5) but instead are a consequence of high viral load. Despite the phosphorylation of hDaxx in dl1403 infection 
at MOI 10, the process occurs far more readily in wt than ICP0-null mutant infections at 
lower multiplicities. It therefore remains possible that phosphorylation of hDaxx in some 
way reflects the role of ICP0 in overcoming hDaxx mediated repression. 
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Figure 5.15 Phosphorylation of hDaxx during wild-type HSV-1 infection 
A-B: HepaRG cells were seeded into a 24-well plate at a density of 1 x 10
5 cells per well and 
infected with wt (A and C) or ICP0-null HSV-1 (B and D) at the indicated MOIs. Samples were 
harvested at indicated time points (A-B) and resolved on 7.5% gels for ICP4, UL42 and actin, and 
on 6% gels for hDaxx. ‘High’ and ‘low’ marks in hDaxx blots indicate different exposure times. In 
panels C and D, samples were harvested in IP lysis buffer (without EDTA) and mock-treated or 
treated with λ-phosphatase. M, mock; wt, wild-type; MOI, multiplicity of infection. 
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5.3  Conclusions and discussion  
Previous work identified two major ND10 components, PML and Sp100, as factors 
contributing to intrinsic cellular defence against HSV-1 (Everett et al, 2008; Everett et al, 
2006). In accordance with the ongoing investigation into the roles of additional ND10 
components in HSV-1 infection, the results presented in the current chapter provide novel 
evidence for the role of ND10 chromatin-remodelling proteins ATRX and hDaxx in the 
regulation of ICP0-null mutant HSV-1 infection. In summary, it has been demonstrated 
that: (a) hDaxx targets ATRX to the sites associated with the incoming HSV-1 genomes; 
and (b) the interaction between ATRX and hDaxx is required for fully efficient repression 
of ICP0-null mutant viral genomes during the lytic cycle of infection and for the efficient 
establishment of quiescence in cell culture. The effect of viral genome repression by the 
ATRX/hDaxx complex is only evident in the context of ICP0-null mutant HSV-1 infection, 
due to the strong counteracting function of ICP0 in wt HSV-1 infection. The mechanisms 
underlying the chromatin-remodelling functions of ATRX and hDaxx in the infected cells 
and how ICP0 antagonises these mechanisms remains a complex issue. These issues are 
discussed further with regard to the events associated with HSV-1.   
 
5.3.1  Fully efficient repression of the mutant HSV-1 genomes requires the 
ATRX/hDaxx complex 
During ICP0-null mutant HSV-1 infection both ATRX and hDaxx are recruited to and 
retained in association with viral genomes, whereas this recruitment is efficiently inhibited 
by the actions of ICP0 in wt HSV-1 infected cells (Figure 5.1). Hence the question posed 
next was whether the more stable recruitment of the two proteins to the sites of ICP0-null 
mutant genomes functionally correlates with the repression by ATRX/hDaxx complex. A 
number of observations have supported this hypothesis.  
 
Firstly, FRAP analysis of the ICP0-null mutant HSV-1 infected cells expressing EYFP-
tagged hDaxx has demonstrated that the mobility of hDaxx foci associated with viral 
genomes was reduced, in comparison to the dynamics of those at normal ND10 of the 
mock-infected cells (Figure 5.2). Although these cells are infected at very high MOI of 
ICP0-null mutant virus, this observation is another way to represent the requirement of 
ND10 proteins, for example hDaxx, in the repression mechanisms that occur at low MOIs 
of ICP0-null mutant HSV-1. The downsides of this approach however were the general 
difficulties in identifying cells at the edges of plaques, based only on re-distribution pattern   185
and the highly dynamic nature of hDaxx foci. The loss of focus during measurements of 
the fluorescence recovery times was also a problem, and might have contributed to 
inaccuracies. The former issue can be resolved by using the ICP0-null HSV-1 strain where 
ICP4 is tagged with the ECFP fluorescent protein (Sourvinos & Everett, 2002). 
Nevertheless, this evidence is consistent with the general hypothesis that the recruitment of 
ND10 proteins to the sites of the incoming ICP0-null mutant viral genomes correlates with 
their repressive properties. It is important to bear in mind, however, that the individual 
cells infected at the edge of a developing plaque in ICP0-null mutant infections contain a 
high load of viral genomes that saturate cellular intrinsic defences, and therefore these cells 
are productively infected.  
 
Secondly, if stable recruitment of ATRX and hDaxx to ICP0-null mutant genomes at high 
MOIs correlates with the repression of ICP0-null mutant HSV-1 infections that occurs at 
low MOIs, then by analogy with previous findings on PML and Sp100 (Everett et al, 2008; 
Everett et al, 2006) removal of ATRX or hDaxx should support increased levels of gene 
expression and replication of ICP0-null mutant HSV-1. Indeed, in the ICP0-null mutant 
infected cells, depletion of either ATRX or hDaxx contributed to the more efficient 
infectivity by ICP0-null virus (Figures 5.7-5.8). Earlier work however, has demonstrated 
that depletion of PML or Sp100 contributed to a more pronounced increase of ICP0-null 
viral gene expression, which was clearly detected on the levels of both IE and Early protein 
synthesis (Everett et al, 2008; Everett et al, 2006). In contrast to those findings, whereas 
hDaxx depletion in the present study resulted in only a minor increase in ICP4 production 
(Figure 5.8), in ATRX depleted cells infected with ICP0-null mutant HSV-1 there were no 
detectable changes in ICP4 production at all (Figure 5.7). This may reflect the fact that 
ICP0-null mutant HSV-1 levels of ICP4 expression are higher than might be expected on 
the basis of the plaque forming defect of this virus (Cai & Schaffer, 1992; Everett et al, 
2004). In spite of this, these increases in gene expression were sufficient for the detectable 
increases in plaque numbers of ICP0-null mutant virus in the absence of ATRX or hDaxx, 
when compared to cells expressing endogenous levels of both proteins. These data have 
provided evidence for the individual roles of the two proteins in regulation of ICP0-null 
mutant HSV-1 infection.  
 
Thirdly and most importantly, a critical indication that ATRX and hDaxx act as a complex 
in the repression of ICP0-null mutant infection has come from the analysis of infected cells 
expressing ATRX-interaction deficient mutant hDaxx. In these cells the ATRX/hDaxx 
complex has been disrupted, but the mutant hDaxxΔPAH protein was still capable of being   186
recruited to the sites associated with ICP0-null mutant HSV-1 genomes. The efficiency of 
ICP0-null mutant HSV-1 replication, however, was comparable to that observed in hDaxx-
depleted cell lines (Figure 5.9). Therefore, targeting of hDaxx alone in the absence of 
ATRX to the sites associated with the viral genomes was insufficient for its full repressive 
potential. In addition, the data suggest that the increase in replication and plaque forming 
efficiency of ICP0-null mutant virus in the absence of hDaxx as seen on Figure 5.8 is also 
likely to be in part a result of the inability of ATRX to associate with the viral genome foci.  
 
Additional supporting data for the role of the ATRX/hDaxx complex in the repression of 
viral genomes has been obtained in the model of quiescent infection using mutant virus 
in1374 (Figure 5.10). The extent of increases in the relief of repression following removal 
of hDaxx or disruption of ATRX/hDaxx complex in this model correlated with that seen in 
ICP0-null mutant infections using the same cell lines. These data therefore suggest that 
similar repressive activities of ATRX and hDaxx may be responsible for both repression of 
ICP0-null mutant virus at low MOIs and establishment of quiescence by the mutant HSV-1. 
Having demonstrated the requirement of ATRX/hDaxx complex for fully efficient 
repression of mutant HSV-1 genomes, the precise mechanism of action of the 
ATRX/hDaxx complex on HSV-1 genomes still remains to be elucidated. However a 
number of models explaining the counteracting function of ICP0 can be proposed. These 
are addressed in the next paragraphs.  
 
5.3.2  Phosphorylation of hDaxx as an ICP0-mediated response to antiviral 
cellular intrinsic defence  
Both ATRX and hDaxx are rapidly released from ND10 during wt HSV-1 infection. 
Unlike PML (Boutell et al, 2003; Boutell et al, 2002; Everett et al, 1998a), neither ATRX 
nor hDaxx are degraded during wt HSV-1 infection (Figures 5.13 and 5.15). Furthermore, 
ICP0 does not interfere with the integrity of the ATRX/hDaxx complex after infection with 
the wt HSV-1 (Figure 5.14). Hence, displacement of this complex away from the 
replicating viral genomes must occur via a different mechanism.  
 
Whereas ATRX does not seem to undergo evident modification in HSV-1 infected cells, 
the band shift pattern of hDaxx during wt infection was suggestive of increased 
phosphorylation. Since hDaxx is not a direct substrate of ICP0 (Figure 5.14), the effects 
observed on hDaxx modification must be an indirect consequence of ICP0 expression. The 
hypothesis that HSV-1 induces phosphorylation of certain nuclear proteins during infection   187
is consistent with analogous observations on protein modifications in collaborative work 
from different groups (Antrobus et al, 2009; Kyle Grant, personal communication). 
Antrobus et al. have demonstrated a similar modification pattern, in an ICP0 RING-finger 
dependent fashion, of two chromatin associated proteins, HP1-γ and minichromosome 
maintenance protein 4 (MCM4), as well as accumulating levels of phosphorylated histone 
H2AX (γH2AX) during the time course of HSV-1 infection.  
 
Interestingly, phosphatase assays conducted in the present study revealed that hDaxx 
becomes hyperphosphorylated during wt HSV-1 infection at MOI of 5 in an ICP0-
dependent manner (Figure 5.15). The appearance of the smeared slow-migrating hDaxx 
bands is indicative of multiple phosphorylation events. At very high MOIs of ICP0-null 
mutant virus, ICP0 was not required for this phosphorylation. Although the sites of these 
hDaxx phosphorylation events during HSV-1 infection remain to be determined, previous 
work suggests some potential consequences of this activity. Phosphorylation of hDaxx at 
S178 allows binding of the prolyl isomerase Pin1 resulting in subsequent degradation of 
hDaxx (Ryo et al, 2007).  In that hDaxx degradation does not seem to occur in the 
phosphatase assays (compare the bands of phosphatase treated samples in mock-infected 
and infected cells, Figure 5.15), it is unlikely that this mechanism is in operation during 
HSV-1 infection, but may provide some evidence for the regulation of hDaxx protein 
stability. It is interesting that mouse Daxx is a direct substrate for phosphorylation by 
HIPK1 (Ecsedy et al, 2003). Moreover, overexpression of HIPK1 results in Daxx being 
displaced from ND10 which leads to a reduction in its repressive potential (Ecsedy et al, 
2003). Consistent with this finding, overexpression of HIPK2 in human cells results in 
hDaxx phosphorylation and delocalisation from ND10 (Hofmann et al, 2003). Therefore, 
in the context of HSV-1 infection, it is possible that wt HSV-1 acts to promote 
hyperphosphorylation of hDaxx in order to (a) decrease its functions in transcriptional 
repression on viral genomes and (b) displace it from virally induced ND10-like foci that 
form in close association with viral genomes. Based on these data and the results presented 
in Figure 5.15, it is possible that HSV-1 induces phosphorylation of certain proteins in 
order to counteract cellular intrinsic defence mechanism in an ICP0-dependent manner.  
 
 
   188
5.3.3  SUMO-dependent targeting of hDaxx to the sites of the viral genomes 
Another mechanism by which the ATRX/hDaxx complex may be targeted and removed 
from the sites of early viral replication during wt HSV-1 infection may relate to the ability 
of hDaxx to interact with SUMO and SUMO-modified substrates (Li et al, 2000; Lin et al, 
2006). SUMO-modification of hDaxx target proteins is known to be significant in hDaxx-
mediated transcriptional repression (reviewed in Shih et al, 2007). This property correlates 
with the observations that the hDaxx SIM is required for the fully efficient repression of 
ICP0-null mutant HSV-1 genomes during the active replication phase of infection (Figure 
5.12). Consistent with these findings, in cells expressing an hDaxx mutant deficient for the 
interaction with SUMO (hDaxxMSIM), hDaxx fails to get recruited to the sites associated 
with the viral genomes and remains dispersed in the nucleus (Figure 5.11). Dispersal of 
hDaxxMSIM in infected cells and the inability of mutant hDaxx to fully perform its normal 
repressive functions during ICP0-null mutant infection indicate the importance of SUMO-
mediated regulation of HSV-1 infection. The mechanism of this regulation, however, can 
only be a subject of speculation, based on the available evidence, as discussed further.  
 
Mutations within the hDaxx SIM do not affect PML recruitment to viral genomes, and it is 
attractive to suggest that PML targets hDaxx to the sites of the viral genomes via the 
SUMO/SIM association. However, this proposal is not supported by the evidence that both 
hDaxx and ATRX are recruited to the virus-induced foci in the absence of PML (Everett et 
al, 2006; Figure 5.3). Nevertheless, the possibility that the dispersal of both components 
during wt HSV-1 infection can be a result of ICP0-mediated degradation of PML should 
not be excluded due to the ability of ICP0 to preferentially target SUMO-modified PML 
isoforms for degradation and its overall effect on disintegration of ND10 (Boutell et al, 
2003; Boutell et al, 2002; Chelbi-Alix & de The, 1999; Everett et al, 1998a).  
 
If the ATRX/hDaxx-mediated pathway of the antiviral intrinsic defence mechanism were 
to be SUMO-dependent, then ICP0 would target SUMO-modified substrates to induce 
removal of hDaxx from the sites of the HSV-1 genomes by disrupting the SUMO/SIM
hDaxx 
interactions. A number of observations support this hypothesis. Earlier evidence has 
demonstrated that exogenously expressed ICP0 induces removal of SUMO-1 from ND10-
associated foci (Bailey & O'Hare, 2002).  This correlates with the ability of ICP0 to target 
SUMO-modified proteins for degradation (Everett et al, 1998a; Muller & Dejean, 1999); 
Boutell et al. unpublished observations). Similarly, in ICP0-null HSV-1 infection SUMO-
modified proteins are recruited to the viral genome foci in a PML-independent manner 
(Boutell et al, unpublished observations). Based on these findings and the data presented in   189
Figure 5.11, the following model can be proposed: hDaxx removal from the sites of 
incoming viral genomes during wt infection results from ICP0-mediated global 
degradation of SUMO-modified substrates; whereas in ICP0-null mutant infection an 
interaction between hDaxx SIM and SUMO-1 provides a mechanism of retention of the 
ATRX/hDaxx complex at the sites of the viral genomes, thereby contributing to repression 
of viral gene expression.  
 
The investigation presented in the current chapter explored the role of the ATRX/hDaxx 
complex in the intrinsic resistance to HSV-1 infection. In summary, the data suggest that 
ATRX and hDaxx act as a complex in order to contribute to the repression of the incoming 
ICP0-null mutant HSV-1 genomes as well as to the efficient establishment of quiescent 
genomes. This repression is efficiently counteracted by the functions of ICP0. Currently 
proposed models of ICP0 actions include: (i) hyperphosphorylation of hDaxx that results 
indirectly from ICP0 expression and leads to ATRX/hDaxx complex displacement from 
the sites of the genomes; (ii) ICP0-mediated degradation of SUMO-modified proteins 
associated with the early viral genome foci leading to disruption of SUMO/SIM
hDaxx 
interactions. The precise mechanisms underlying both models remain to be clarified. The 
evidence that exists so far may provide important clues in understanding the mode of 
action of ICP0 during the lytic cycle of HSV-1 infection and reactivation.  
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6  Summary, Discussion and Future Prospects 
Members of the virus family Herpesviridae, HSV-1 and HCMV, are important human 
pathogens that actively replicate during lytic stage of the life cycle and persist in the host 
during latency. Ongoing aims of HSV-1 and HCMV research are to identify the processes 
of the cell-virus interactions that are responsible for successful lytic replication, latency 
establishment and maintenance, and reactivation. In Chapter 1, three classes of host 
immunity to the infection have been outlined: innate, adaptive and intrinsic. The recently 
emerged concept of anti-viral intrinsic immunity, or intrinsic defence rests on the fact that 
cells constitutively express a number of proteins that in addition to their functions in 
cellular pathways have properties that inhibit virus infection (reviewed in Bieniasz, 2004). 
The rapid changes in cellular dynamics associated with the intrinsic defence mechanisms 
are therefore observed immediately after the virus invades the subcellular environment. 
Identification of the underlying molecular events and how the virus counteracts them in 
order to achieve successful replication will provide a better understanding of viral life 
cycle and promote the identification of the potential anti-viral drug targets.  
 
6.1  Summary of the data 
One aspect of anti-viral intrinsic resistance against both HSV-1 and HCMV is associated 
with components of the intranuclear dynamic sites known as ND10 (reviewed in Maul, 
1998; Tavalai & Stamminger, 2008). The current study was aimed to explore the 
relationships between ND10, viral genomes and chromatin modifying enzymes, and focus 
on the roles of the two chromatin-associated ND10 proteins ATRX and hDaxx in the 
regulation of HSV-1 and HCMV infection. The key results presented in the previous 
chapters can be summarised as follows:   
(i) During HCMV infection, viral tegument protein pp71 displaces ATRX from ND10. 
This allows efficient stimulation of HCMV IE transcription by pp71, since repression of 
pp71-null mutant virus is relieved to a substantial extent in the absence of ATRX.  
(ii) In ICP0-null mutant HSV-1 infected cells, the complex formed between ATRX and 
hDaxx contributes to the repression of viral gene expression that occurs in the absence of 
ICP0. ICP0 counteracts this repression by promoting displacement of ATRX/hDaxx 
complex from the incoming viral genomes. 
 
These sets of evidence have led to a conclusion that ATRX and hDaxx are components of 
cell-mediated intrinsic immunity against HSV-1 and HCMV. Moreover, in the case of   191
HSV-1, this intrinsic immunity requires the sequences of hDaxx that are responsible for its 
interaction with ATRX. This may indicate that ATRX and hDaxx act as a complex in 
pp71-null mutant HCMV infection as well. Putting these data together with previously 
published work (Cantrell & Bresnahan, 2005; Cantrell & Bresnahan, 2006; Everett et al, 
2008; Everett et al, 2006; Hwang & Kalejta, 2007; Ishov et al, 2002; Preston & Nicholl, 
2006; Saffert & Kalejta, 2006; Tavalai et al, 2006; Tavalai et al, 2008; Woodhall et al, 
2006), it can be concluded that the effects of PML, Sp100, ATRX and hDaxx in anti-viral 
defence mechanisms are cumulative and complementary to each other. This fits into the 
general definition of intrinsic cellular anti-viral defence, as noted above, which suggests a 
collective set of cellular activities that act to repress viral gene expression. It can be 
predicted that simultaneous depletion of more than one ND10 protein should further 
improve the efficiency of viral infection. This implies that the proteins are likely to act in 
unison to accelerate the assembly of repressive chromatin-like structures on viral genomes.  
 
6.2  Evidence for ATRX and hDaxx as the components of a 
multisubunit repressor complex during viral infection 
The aspects of chromatin remodelling have been partially covered in Chapter 1. In brief, 
chromatin repression is associated with the assembly of DNA into compact 
heterochromatin structure, which is generally marked by core nucleosomal histone 
methylation and DNA methylation at CpG islands. Histone H4 methylated at lysine 
position 9 can attract HP1 proteins for establishing a more stably repressed nucleosomal 
structures, while protein MeCP2 can bind CpG islands on DNA to bring about 
transcriptional repression. A specialised class of enzymes DNMTs is involved in directly 
methylating cytosine residues, which serves as a binding site for MeCP2 (Nan et al, 1997; 
Siedlecki & Zielenkiewicz, 2006), as well as in HP1 and Suv39H1 (HMT) binding (Fuks et 
al, 2003). A densely packed heterochromatin structure is proposed to result from the tight 
association of the proteins residing at the sites of methylated DNA and methylated histones 
of the adjacent nucleosomes, according to the model reviewed elsewhere (Brenner & Fuks, 
2007). Analysis of the conserved domains and protein-protein interaction properties within 
different transcriptional co-repressors suggests that formation of such repressed chromatin 
structures can also be induced by recruitment of additional repressor factors and complexes. 
ATRX and hDaxx are both candidates for being components of these complexes, and this 
hypothesis can be supported by a number of observations.  
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Firstly, ATRX interacts with both MeCP2 (Nan et al, 2007) and HP1 (Le Douarin et al, 
1996; Lechner et al, 2005), which indicates a bridging function of ATRX in chromatin 
repression, in a similar model as proposed above. Interestingly, the interaction between 
ATRX and MeCP2 is abolished in patients with ATR-X syndrome, suggesting an 
important role in transcriptional regulation mediated by the MeCP2/ATRX complex (Nan 
et al, 2007). The same group also demonstrated that MeCP2 is a component of multi-
subunit complex that contains Class 1 HDACs and a transcriptional repressor mSin3a (Nan 
et al, 1998).  mSin3a contains a PAH1 domain, related to that in hDaxx required for 
interaction with ATRX (Tang et al, 2004). Therefore, it is possible that mSin3a recruits 
ATRX to this repressor complex via competitive binding with hDaxx, or that ATRX is 
dynamically exchanged between the two co-repressors, depending on the target gene.  
 
Secondly, hDaxx has been shown to interact with HDAC1 and -2 (Hollenbach et al, 2002; 
Li et al, 2000), which suggests that the ATRX/hDaxx complex itself can interact with 
HDACs. Repression mediated by hDaxx is dependent on this interaction, as suggested by 
experiments using TSA treatment (Li et al, 2000). In a different system using cells 
undergoing meiosis, TSA treatment results in disruption ATRX interaction with meiotic 
centromeres, which indicates of HDAC-dependent regulation of ATRX functions (De La 
Fuente et al, 2004). Since the ATRX- and HDAC-interacting regions of hDaxx (the PAH1 
domain and the S/P/T region, respectively; see Figure 1.8) do not overlap, it is possible that 
the interaction between hDaxx and HDACs recruits ATRX to target promoters. On the 
other hand, the PHD-like finger domain of ATRX itself may be involved in an interaction 
with HDAC1 (Figure 1.7) (Gibbons et al, 2000; Zhang et al, 1999). Although the presence 
of HDAC within the ATRX/hDaxx-containing complex is speculative, it can explain the 
mechanism of regulation of transcriptional repression by ATRX and hDaxx. 
 
A third possibility of ATRX and hDaxx being a part of a multisubunit transcriptional 
repressor complex is based on their ability to interact with HDACs, which themselves are 
in a complex consisting of REST, CoREST and HDACs. REST (repressor element-1-
silencing transcription factor) and its co-factor Co-repressor of REST (CoREST) play an 
important role in transcriptional regulation of neuronal gene expression. Both REST and 
CoREST can independently bind additional transcription co-repressors (reviewed in 
Lakowski et al, 2006). The ability of ATRX/hDaxx complex to associate with HDACs, at 
least via hDaxx, makes feasible their presence in this multi-protein repressor complex. 
Based on the substantial evidence that implicates the role of HDACs in the regulation of   193
chromatin state of HSV-1 and HCMV genomes, the issue of whether ATRX and hDaxx 
are components of this repression mechanism is addressed further below. 
 
6.3  The mechanisms of repression by ATRX/hDaxx complex during 
HCMV and HSV-1 infection 
Despite the facts that HSV-1 and HCMV represent viruses of the same virus family, and 
that ND10 proteins such as PML and ATRX are involved in repression of gene expression 
of both viruses (Everett et al, 2006; Tavalai et al, 2006; Figures 4.2 and 5.7 C-D), the 
mechanisms of their action on viral genomes and the ways viruses counteract them appear 
to differ substantially (Figure 6.1). This is true in the context of the role of ATRX/hDaxx 
complex in HSV-1 and HCMV infectivity, based on the results of the Chapters 4 and 5 of 
this thesis. Chapter 4 discusses the possible mechanisms which may be utilised by pp71 to 
counteract repression by ATRX and hDaxx: pp71-induced displacement of ATRX from 
ND10 followed by interaction with hDaxx and its subsequent degradation. Similarly, 
results presented in Chapter 5 suggest at least two mechanisms of how ICP0 may 
counteract ATRX/hDaxx-mediated gene expression, which are not exclusive of each other: 
one suggests increased phosphorylation of hDaxx followed by the removal of the 
ATRX/hDaxx complex from the sites associated with the viral foci; the other indicates on 
ICP0-mediated degradation of SUMO-modified ND10 components, the presence of which 
is required for ATRX/hDaxx targeting to the viral incoming genomes via the hDaxx 
SUMO-interaction motif. The models of ICP0 and pp71 actions on the ATRX/hDaxx 
complex are depicted on Figure 6.1. These results however neither provide evidence for 
the mechanism of action of the ATRX/hDaxx complex, nor suggest that the ATRX/hDaxx 
complex may be directly involved in the assembly of repressed chromatin structures on 
viral genomes. The next two subsections discuss some evidence that may provide clues to: 
(a) whether the pathways of HSV-1 and HCMV gene repression are related; and (b) to the 
mode of action of ATRX and hDaxx as a complex on HSV-1 and HCMV genomes.  
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Figure 6.1 Models of HCMV pp71 and HSV-1 ICP0 counteracting functions on ATRX/hDaxx 
complex during the initial stages of lytic infection 
I. HCMV pp71 counteracts the repressive functions of ATRX/hDaxx (designated as A and D) 
complex by displacing ATRX from ND10, interacting with hDaxx and inducing efficient gene 
expression. hDaxx may be subsequently degraded (crossed circle), although the data is 
controversial. II. (a) ICP0 expressed by HSV-1 can indirectly induce phosphorylation (P) of hDaxx. 
Because hDaxx is the targeting component of the ATRX/hDaxx complex, this causes displacement 
of the entire complex away from the viral genomes (marked in red) and relieves cellular repressive 
mechanism. (b) hDaxx is targeted to the sites associated with the incoming HSV-1 genomes via 
interaction with SUMO-modified proteins. ICP0 targets SUMO-modified substrates for 
degradation, thereby causing displacement of ATRX/hDaxx complex. 
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6.3.1  Evidence that the pathways of ATRX/hDaxx-mediated repression of 
HSV-1 and HCMV infection are distinct 
Pp71 can substitute to some extent for the lack of ICP0 (Preston and Nicholl, 2005), 
suggesting they may be functional analogues. Identification of ATRX and hDaxx in related 
pathways of repression that occurs in the absence of pp71 or ICP0 in HCMV and HSV-1 
infected cells, respectively, may indicate similarities between ATRX/hDaxx-mediated 
processes associated with this repression. But is this really the case?   
 
During HCMV infection the ATRX/hDaxx complex is likely to be efficiently disrupted by 
the action of pp71, since ATRX is displaced from ND10 prior to any effects on hDaxx are 
observed, and indeed before detectable IE gene expression (Lukashchuk et al, 2008). 
Therefore any repression mechanism operating during the very early stages of wt HCMV 
infection may not rely on the function of the actual complex, but rather on ATRX and 
hDaxx acting independently. Furthermore, hDaxx is subsequently degraded by pp71 
according to some reports (Hwang & Kalejta, 2007; Saffert & Kalejta, 2006). Localisation 
of pp71 to ND10 is required for efficient stimulation of IE gene expression and is 
dependent on hDaxx (Ishov et al, 2002), but not ATRX (Figure 4.1). Hence, disruption of 
the ATRX/hDaxx complex by pp71 may be required for pp71 to access hDaxx and 
stimulate induction of the immediate early transcript environment (Ishov et al, 2002). In 
the case of HSV-1 infection, however, the ATRX/hDaxx complex remains intact and 
neither of the components interacts with nor are they degraded by ICP0 (using the assay 
presented in Figure 5.13). These results suggest that in HSV-1 and HCMV infection 
components of ND10 are differentially targeted by viral regulators during the initiation of 
viral gene expression, and indicate of the differences in progression of viral replication 
between the viruses of the same family.  
 
HCMV is a slow-replicating virus and cellular intrinsic defences may be easier to detect 
during infection with this virus. On the other hand, HSV-1 replicates rapidly in cell culture, 
once the genomes have been released, indicating that cellular intrinsic responses have been 
saturated or are overcome very efficiently. This links with the observations that initial 
repression of HCMV genomes during lytic infection is associated with nucleosome 
assembly (Nitzsche et al, 2008), whereas some reports suggest this is not the case for HSV-
1 (Herrera & Triezenberg, 2004; Leinbach & Summers, 1980). The role for histone 
association with HSV-1 genomes, however, remains controversial. Although HSV-1 DNA 
is associated with histones and particularly with active transcription histone markers at 
early times post infection (Cliffe & Knipe, 2008; Herrera & Triezenberg, 2004; Huang et al,   196
2006; Kent et al, 2004), nucleosomes are underrepresented on IE promoters, and the 
histone load is further reduced as infection progresses (Herrera & Triezenberg, 2004; Oh & 
Fraser, 2008). Association of latent and quiescent HSV-1 DNA with nucleosomes appears 
to be more likely, according to several reports (Deshmane & Fraser, 1989; Ferenczy & 
DeLuca, 2009).  
 
How does this evidence correlate with ATRX- and hDaxx-driven repression of HSV-1 and 
HCMV genomes? If ATRX and hDaxx associate with additional repressive chromatin 
markers such as MeCP2, HP1 and HDACs (see above in Section 6.2), it is attractive to 
suggest that they enhance assembly of heterochromatin on viral genomes. It appears that 
these mechanisms differ in efficiency during infection with wt and pp71-null mutant 
HCMV, based on the ability of pp71 to disrupt the ATRX/hDaxx complex. Assuming that 
heterochromatin assembly during HSV-1 infection is more likely to occur during latency 
and quiescence, it is possible that in ICP0-null mutant infections at low MOIs, and in 
quiescent infection models using viral strains such as in1374 and d109 that are unable to 
initiate IE gene expression (Preston & Nicholl, 2005; Samaniego et al, 1998), related 
pathways operate whereby ATRX and hDaxx are involved in inducing the formation of 
repressed chromatin on viral genomes. This would therefore correlate with the data 
presented in Chapter 5, which demonstrate that depletion of either ATRX or hDaxx 
increases the proportion of cells that escape repression and do not enter quiescence.  
 
Another mechanism of regulation may rely on the proposed role of ATRX in histone 
deposition. Interestingly, novel evidence suggests incorporation of histone variants H3.1 
and H3.3 on HSV-1 promoters during the early hours post infection (Placek et al, 2009). 
Incorporation of H3.3 is associated with active transcription, although deposition of H3.3 
at heterochromatic sites also occurs (reviewed in Elsaesser et al, 2010). This is intriguing 
since ATRX has been recently shown to interact with H3.3 (Goldberg et al, 2010; Wong et 
al, 2010), which correlates with its previously published function in histone H3 binding 
(Otani et al, 2009). This evidence may therefore indicate additional pathways of ATRX-
mediated regulation of chromatin assembly and modification during viral infection. In 
summary, it can be concluded that ATRX and hDaxx may assist in the assembly of 
repressed chromatin at different stages of the viral life cycle. The subsequent section 
therefore presents a more detailed discussion regarding repressed chromatin markers, with 
the focus on the role of HDACs in HCMV and HSV-1 infection.  
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6.3.2  Regulation of the chromatin state of HSV-1 and HCMV genomes: the 
role of histone deacetylases 
Since hDaxx interacts with HDAC1 and is known to repress transcription in some assays 
through this activity (Hollenbach et al, 2002; Li et al, 2000), it is attractive to suggest that 
hDaxx influences the efficiency of transcription from parental viral genomes via HDAC-
dependent chromatin remodelling. Whether that is the case during HSV-1 and HCMV 
infection in both latency and lytic cycle is therefore an issue that has been subjected to 
extensive investigation.   
 
With regard to HSV-1 infection, a lot of research has primarily concentrated on the role of 
viral transcriptional activators in counteracting chromatin assembly on viral genomes. One 
group has shown that ICP0 interacts with the REST/CoREST/HDAC complex, and causes 
HDAC1 dissociation from the complex (Gu et al, 2005; Gu & Roizman, 2007). These data 
correlated with the findings that TSA treatment of certain cell lines partially compensates 
for the lack of ICP0 during ICP0-null mutant replication. Based on these data, it was 
concluded that ICP0 acts to inhibit the action of HDACs (Poon et al, 2006; Poon et al, 
2003). A number of other observations, however, contradict this conclusion. Firstly, 
despite an independent report showing the interaction between ICP0 and class II HDACs, 
ICP0 expression does not increase levels of acetylated histone H4, unlike TSA (Lomonte et 
al, 2004). Furthermore, in many restrictive cells lines, TSA treatment does not increase the 
plaque forming efficiency of ICP0-null HSV-1 (Everett et al, 2008). Secondly, ICP0 
interaction with the CoREST complex is not essential for ICP0 function in HSV-1 lytic and 
de-repression assays, and depletion of CoREST does not improve ICP0-null mutant 
replication, assessed by gene expression and virus yield assays (Everett, 2010; Everett et al, 
2009). Therefore these latter observations are inconsistent with the hypothesis that the 
interaction of ICP0 with the REST/CoREST/HDAC is a core requirement for ICP0 
function. Since ICP0 does not co-immunoprecipitate with either hDaxx or ATRX 
according to the findings of this investigation (Figure 5.14), the overall evidence is not 
strong enough to speculate that ICP0 directly causes disruption of the ATRX/hDaxx 
chromatin-repressor activity assembled around incoming HSV-1 genomes during the early 
stages of the lytic phase of infection. It is plausible however that ICP0 does so indirectly 
by recruiting additional factors or via its E3 ligase activity on other protein components.  
 
If one excludes HDAC-dependent repression mechanisms being essential for repression of 
HSV-1 genomes (based on the results of HDAC inhibition cited above), histone deposition 
on HSV-1 promoters reported elsewhere (Cliffe & Knipe, 2008; Herrera & Triezenberg,   198
2004; Huang et al, 2006; Kent et al, 2004; Oh & Fraser, 2008) may therefore represent the 
earliest cellular responses to the intrusion of foreign viral DNA. This is also true of the 
cells infected with high MOIs of ICP0-null mutant virus at the edge of a developing plaque, 
where cells show more stable recruitment of both ATRX and hDaxx to the sites associated 
with the incoming viral genomes. In these cells repression does not occur because of the 
multiplicity dependence of the ICP0-mutant virus phenotype, which reflects saturation of 
the intrinsic resistance due to high genome numbers. It is assumed that the more stable 
recruitment at high MOI is indicative of similar events, which occur at low MOI and 
reflect the repression mechanisms that act on ICP0-null mutant virus. Although limited 
histone assembly on viral genomes occurs during high MOI infections, these genomes are 
unlikely to be repressed by nucleosomes and heterochromatin formation due to the 
saturation of cellular intrinsic defences.  
 
A different scenario can be proposed for HCMV infection. The means by which the virus 
successfully achieves initiation of lytic infection, allowing the expression of its IE proteins, 
involves the functions of the tegument protein pp71 and IE product IE1. These aspects of 
HCMV infection have been addressed in Chapters 1 and 4. The model suggested by the 
findings presented in this study illustrates that HCMV tegument protein pp71 displaces 
ATRX from ND10 (see Chapter 4 and (Lukashchuk et al, 2008), and interacts with and 
subsequently leads to degradation of hDaxx  (Cantrell & Bresnahan, 2005; Hwang & 
Kalejta, 2007; Saffert & Kalejta, 2006). Removal of either ATRX or hDaxx contributes to 
a substantially increased efficiency of infectivity of pp71-null mutant virus (Preston & 
Nicholl, 2006; Saffert & Kalejta, 2006; Tavalai et al, 2008); Figures 4.2 and 4.3). It is 
therefore possible that ATRX and hDaxx act through mechanisms that involve assembly of 
heterochromatin in HCMV infected cells. A few reports have directly implicated hDaxx in 
this aspect: (a) downregulation of hDaxx increases the load of acetylated nucleosomal 
histone markers on HCMV promoters (Woodhall et al, 2006); and (b) TSA treatment 
together with stabilization of hDaxx allows increased IE1 production (Saffert & Kalejta, 
2006). The observation that HCMV DNA is associated with nucleosomes (Nitzsche et al, 
2008) is consistent with a role for both ATRX- and hDaxx-mediated repression 
mechanisms, according to the potential models that involve multi-protein chromatin 
modification repressor complexes as discussed above. Whether ATRX performs an 
HDAC-dependent role in this repression mechanism, by analogy with hDaxx, is currently 
unclear, however one can assume that interactions of the ATRX/hDaxx complex with 
additional co-repressors may contribute to heterochromatin assembly on HCMV genomes.  
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Based on the role of hDaxx in ATRX targeting to ND10 and viral nucleoprotein complexes, 
it is possible that hDaxx may be required for ATRX functions at HCMV genome 
promoters. This hypothesis would therefore correlate with the fact that depletion of hDaxx 
affects not only gene expression of pp71-null mutant virus but also that of wt virus 
(Tavalai et al, 2008). Whereas the role of the interaction between ATRX and hDaxx has 
been subject to a detailed investigation in the context of HSV-1 infection in the present 
study, further investigations could address the same issues in HCMV infection.  This 
evidence provides further support that the chromatin repression mechanisms during the 
early lytic phase of HSV-1 and HCMV infection are distinct.  
 
Mechanisms regulating the latent and quiescent states of HSV-1 and HCMV genomes may 
be more related than during lytic infection. Thus, it appears that in models of both HSV-1 
(Figure 5.10) and HCMV (Saffert & Kalejta, 2007) quiescent infection hDaxx contributes 
to the normally efficient repression of the viral genomes. Whether this reflects the 
requirement of hDaxx in biological latency, however, is an issue of further complexity and 
controversy. In HCMV-based studies, hDaxx has been shown to be important for 
maintenance of repression of HCMV genomes in latent systems, using undifferentiated 
quiescently HCMV-infected cells (Saffert & Kalejta, 2007). Consistent with the situation 
in lytic infection, hDaxx appears to function through the activity of HDACs, since (a) TSA 
treatment of normally non-permissive to HCMV cells reverses the cell phenotype to 
permissive, followed by association with the increase in acetylated histone levels; and (b) 
overexpression of HDAC3 reduced permissiveness to HCMV infection in differentiated 
cells (Murphy et al, 2002). In the situation when pp71-null mutant genomes are repressed 
(as presented in Chapter 4, 4.2), it is possible that the mechanisms operating during this 
repression are related to some extent to the latency systems demonstrated in these reports. 
This therefore would explain the increased gene expression of pp71-null mutant virus once 
hDaxx or ATRX are removed. Taking into account the role of HDACs in maintaining 
nucleosome structure by catalysing removal of acetyl groups on histones, this indicates a 
role for nucleosome assembly during repression in HCMV infected cells. Hence, this 
discussion links HDAC-dependent heterochromatin formation on viral genomes to the 
functions of hDaxx and ATRX. 
 
When analysing data concerning the mechanisms of chromatin-regulated latency and 
reactivation in HSV-1 infected cells, consideration of the different systems must be taken 
into account. According to several reports reactivation from quiescence in infected 
neuronal cell cultures can occur via supplying ICP0, VP16, ICP4, as well as by treating   200
with TSA and other HDAC inhibitors or inducing stress (Arthur et al, 2001; Danaher et al, 
2005; Halford et al, 2001; Miller et al, 2006; Terry-Allison et al, 2007). These data indicate 
that the functions of viral transcriptional activators can be compensated by the inhibition of 
HDAC activities. In non-neuronal restrictive cell cultures however such as fibroblasts, 
establishment of quiescently infected cell lines corresponds to the formation of very tight 
repression mechanisms that are reactivated by ICP0 and not by TSA (Everett et al, 2008; 
Preston & Nicholl, 2005; Terry-Allison et al, 2007). These studies therefore indicate either 
HDAC-independent repression mechanisms or much more densely arranged 
heterochromatin-like structures than those observed in quiescently infected cell lines of 
neuronal origin. An exception is in Vero cells in which the defect in ICP0-null plaque 
formation is significantly lower than in fibroblasts, and TSA treatment result in some level 
of derepression of quiescent HSV-1 genomes (Terry-Allison et al, 2007). Taking into 
account the differences in experimental systems used in these studies, the importance of a 
cell type when interpreting the involvement of heterochromatin-mediated repression 
mechanisms occurring on viral genomes cannot be underestimated.  
 
6.4  Future directions in anti-viral cellular intrinsic immunity  
In the present investigation, ATRX and hDaxx have been identified as components of 
cellular anti-viral intrinsic resistance mechanisms. Although the analysis of the precise 
mechanisms of their action is beyond the scope of the present investigation, evidence 
suggests that chromatin has a large part to play. In the summary of the results presented in 
this thesis, and the evidence discussed above, it is proposed that ATRX and hDaxx 
constitute components of multi-subunit chromatin repressor complexes that assemble on 
viral DNA and that recruit additional co-factors involved in histone modification and 
repression. Further investigation into the roles of histone and nucleosome association on 
viral promoters may reveal the cellular response mechanisms of the early stages of 
infection as well as the mode of chromatin-mediated regulation of quiescent herpesvirus 
genomes. So far, the evidence that both HCMV and HSV-1 latent DNA is associated with 
nucleosomes (Deshmane & Fraser, 1989; Ferenczy & DeLuca, 2009; Nitzsche et al, 2008) 
suggests that the ATRX/hDaxx complex may contribute to the maintenance of repression 
of viral genomes by assisting in heterochromatin formation via interacting with the co-
repressor complexes. The existing evidence, however, is not conclusive enough to suggest 
that the mechanisms of heterochromatin assembly acting on viral genomes reflect those 
that assemble on densely packed cellular heterochromatin. One of the hypotheses driving 
the current line of research states that the factors implicated in repressed chromatin   201
assembly and maintenance of the cellular heterochromatin may also be involved to some 
extent in repressed chromatin assembly on viral genomes. 
 
Evidently, the precise molecular mechanisms that are involved in formation of DNA 
repressor complexes would need to be further clarified. Therefore, one of the aspects for 
future work should be aimed at identifying novel components involved in the formation of 
such chromatin complexes. The primary candidates for studies should undoubtedly be 
those proteins that are involved in direct histone and DNA interactions and maintenance of 
repressed chromatin structures. These have been mentioned throughout and include such 
proteins such as HP1 and MeCP2. These proteins have previously been observed to 
localise to ND10 (Luciani et al, 2006; Nan et al, 2007). Despite the fact that HDACs do not 
reside at ND10 (Li et al, 2000), PML interacts with HDAC1 to induce transcriptional 
repression (Wu et al, 2001). These properties make HP1, MeCP2 and HDACs obvious 
candidates to study ND10-mediated anti-viral intrinsic resistance. Evidently, in EBV 
infection, transcriptional repression regulated by MeCP2/HDAC-dependent mechanisms of 
certain genes and induced by the expression of EBV latent membrane protein 1 correlates 
with the increased invasive potential of EBV-transformed tumourigenic cells (Tsai et al, 
2006). Although gamma-herpesviruses differ substantially in their life cycles from alpha- 
and beta-herpesviruses, this evidence may indicate that these cellular factors may play 
similar roles in transcriptional repression during HSV-1 and HCMV infection. In addition, 
other candidate proteins for analysis that are involved in regulation of repressed or active 
chromatin structures may include a histone chaperone HIRA and centromeric proteins 
(CENPs) that are recruited to pericentromeric heterochromatin. CENP-A, -B and -C have 
all been demonstrated to be degraded by HSV-1 ICP0 (Everett et al, 1999a; Lomonte & 
Morency, 2007; Lomonte et al, 2001). CENP-A is a histone H3 variant (Black & Bassett, 
2008), and its ICP0-mediated degradation may provide the link between the counteracting 
function of ICP0 and the low histone occupancy on replicating viral genomes. HIRA, 
which also localises to ND10 (Zhang et al, 2005), functions as the H3.3 chaperone and is 
required for H3.3 enrichment at active and repressed chromatin sites (Goldberg et al, 2010). 
Downregulation of HIRA results in reduction in H3.3 incorporation in HSV-1 infected 
cells (Placek et al, 2009), indicating a role for HIRA in the regulation of histone deposition 
on lytic viral promoters. Further research should focus on how this regulation correlates 
with viral infectivity and the ability to establish and maintain latency.   
 
The reported interaction between PML and several HDACs (Wu et al, 2001) and between 
Sp100 and HP1 (Seeler et al, 1998), may provide a link between PML-, Sp100- and   202
ATRX/hDaxx-mediated repression during viral infection. Indeed, residence of the 
heterochromatin-associated proteins at ND10 (Luciani et al, 2006) can yield useful clues to 
the assembly of ND10 chromatin repressor complexes on the incoming viral DNA. 
Investigating the requirement for the interactions within these complexes may unravel the 
complexities that underlie assembly of the chromatin repressor complexes on cellular and 
viral genomes.  
 
Although ATRX and hDaxx still remain largely uncharacterised in various aspects of their 
transcriptional regulation, their potential in chromatin assembly appears to be significant 
but requires further understanding. The work presented in this thesis suggests novel clues 
to the regulation of HSV-1 and HCMV infection by heterochromatin. Expanding these 
issues into the context of other herpesviruses and deeper understanding of the mechanisms 
involved in the regulation of repressed viral genomes can potentially contribute to the 
development of the new approaches aimed to prevent reactivation and transmission of 
these viruses.   
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